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Priming dendritic cells for th2 polarization: 
lessons learned from helminths and 
implications for metabolic disorders
Leonie Hussaarts, Maria Yazdanbakhsh and Bruno Guigas 




1. immune resPonses 
Mammalian immune responses are a result of interplay between the non-specific innate 
immune system and the adaptive immune system. The innate immune system provides a 
first line of defense, while the adaptive immune system is antigen-specific and required for 
long-term protection against infections. CD4+ T helper (Th) are members of the adaptive 
immune system that regulate immunity and inflammation through the secretion of specific 
cytokines. Different classes of pathogens require activation of specific Th cell subsets, and 
immune responses are therefore often classified based on the central Th cell subsets involved. 
In case of rapidly replicating microorganisms, such as bacteria and viruses, an antimicrobial 
type 1 immune response is invoked. The principal regulators of the type 1 immune response 
are Th1 cells, which secrete the pro-inflammatory cytokine interferon-γ (IFN-γ). IFN-γ stimulates 
macrophage activation, antigen uptake and presentation, and intracellular killing of microbes. 
The type 2 immune response, on the other hand, encompasses the host response to parasitic 
worms (also known as helminths), and is characterized by the presence of Th2 cells, which 
secrete interleukin-4 (IL-4), IL-5 and IL-13 to mediate B cell activation and IgE antibody 
production. Furthermore, type 2 immune responses are characterized by an expanding group 
of innate immune cells, including eosinophils, mast cells, group 2 innate lymphoid cells, and 
alternatively activated macrophages. Together, these cells control infection and/or mediate 
parasite expulsion through smooth muscle contraction and mucus production (reviewed in 
(1;2)). In addition to Th1 and Th2 cells, different T helper cell subsets have been discovered over 
the past ten years, including Th17 which protect against protect against extracellular bacteria 
and fungi, and Th22 and Th9 cells, which have a range of functional activities (3). 
Aside from anti-helminth immunity, it has become increasingly clear that type 2 immune 
responses have additional functions. For example, literature has described a close association 
between type 2 immune responses and wound repair (4-7). Strikingly, recent evidence indicates 
that multiple facets of the type 2 immune response can also regulate metabolism and protect 
against insulin resistance. For just one example, the prototypical Th2 cytokine IL-4 can regulate 
the balance between fatty acid and glucose oxidation in hepatocytes (8). Conversely, pro-
inflammatory immune responses have been shown to participate in the pathogenesis of diet-
induced diabetes (9;10). By studying the molecular mechanisms that govern helminth-induced 
Th2 polarization, we may therefore learn valuable lessons for both the protection against 
helminth infection and pathways involved in metabolic regulation. 
2. an introduction to schistosomes
Schistosomes are helminths frequently used to study T helper 2 polarization, not only 
because of their prevalence, but also because of their ability to infect both mice and 
humans. Schistosomes are the causative agent of schistosomiasis and chronically infect over 
200 million people worldwide (11). There are five species of schistosomes, of which Schistosoma 
japonicum, S. mansoni, and S. heamatobium are the most common. The life cycles of these three 
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schistosomes are largely comparable. Briefly, when infected individuals urinate or defecate 
in water, eggs are excreted that hatch to release miracidiae, which can penetrate the fresh 
water snail. In the snail, the miracidiae develop into sporocysts, which generate cercariae 
that can infect the human host. Upon infection, the cercariae lose their tail and become 
schistosomulae, which enter circulation and migrate through several tissues to the hepatic 
portal vein, where the mature male and female worms form pairs. Schistosome pairs then 
migrate to the mesenteric veins (S. japonicum and S. mansoni), or to the venous plexus of the 
bladder (S. heamatobium), where the female starts to produce hundreds of eggs per day. The 
eggs penetrate through the tissues to the intestine or the bladder, and are again released with 
feces or urine. Not all eggs go through this process though. Depending on the species, the 
blood flow carries many eggs to the liver, where they induce granuloma formation, or to the 
bladder, where they can promote bladder cancer (11).   
Since mice are highly susceptible to S. mansoni infection, the host immune response to 
this species has been the most widely studied (12). The first weeks after infection, during 
schistosomulae migration, are characterized by a T helper 1 (Th1) response. After 5-6 weeks 
post infection, with the onset of egg deposition in the liver and intestines, the immune response 
changes. The Th1 component decreases and a strong egg-specific Th2 response, characterized 
by IL-4, IL-5 and IL-13 cytokine expression, develops (11). The development of the Th2 response 
is essential for reducing morbidity of the host by excessive Th1-like inflammatory reactions: wild 
type (C57BL/6) mice enter a chronic phase of egg accumulation 8 weeks post infection, however 
IL-4-deficient mice die of uncontrolled Th1-associated inflammatory reactions to parasites (13). 
Although it is clear that the induction of Th2 responses serves an important host-protective 
role during the initial stage of infection, persistent type 2 cytokine responses may also result 
in immunopathology and morbidity (14;15). Egg-induced granuloma formation is detrimental 
to the host as it is associated with the induction of IL-13-dependent liver fibrosis. As such, 
schistosome-infected mice in which IL-13 is blocked fail to develop liver fibrosis, which leads 
to prolonged survival of these mice (16-18). Therefore, to prevent Th2-associated damage 
to the host, controlling the Th2 response is at least equally important as its generation. Th2 
cell control becomes visibly active around week 12 post infection, when the chronic phase 
of infection emerges. Egg production continues but the Th2 response diminishes and newly 
formed liver granulomas have a smaller size than those formed at earlier times during infection 
(11). At this stage, control of the Th2 response is provided by regulatory T cells (Treg cells) 
(19;20), alternatively activated macrophages (7;21), and regulatory B cells (22).   
3. dendritic cells and t helPer 2 Polarization
The mechanisms that initiate the Th2 response in helminth infection are still not fully 
understood, although it is clear that dendritic cells (DCs) (23), the most efficient antigen-
presenting cells (APCs) in the immune system, play a crucial role (24). DCs are located in 
peripheral tissues, where they continuously sample the environment to capture antigens from 




undergo phenotypic changes that allow them to migrate to the lymph nodes and to provide 
the signals required for the activation of T cells (25;26). The importance of DCs in Th2 skewing is 
highlighted by studies showing that depletion of CD11c+ DCs interferes with the induction of a 
Th2 response to S. mansoni and Helimosomoides polygyrus (27-29). Interestingly, it has become 
increasingly clear that distinct DC subsets induce different Th responses (reviewed in (24;30)), 
and in the last few years, several studies analyzed the role of DC subsets in the initiation of 
Th2 responses to helminth infection.
3.1 Dendritic cell subsets associated with Th2 polarization
Two independent groups recently showed that the development of a Th2 response to 
Nippostrongylus brasiliensis depends on dermal CD301b+ DCs (31;32). Specifically, depletion 
of CD301b+ DCs prior to infection reduces IL-4 production by CD4+ T cells, without affecting 
the percentage of T follicular helper (Tfh) cells or germinal center B cells (31). Mechanistically, 
Th2-inducing PDL2+CD301b+ DCs were shown to depend on DC-specific expression of the 
transcription factor interferon regulatory factor 4 (IRF4) (32). In line with these findings, 
CD11cintMHCIIhi dermal DCs expressing PDL2 and CD301b were also identified as a Th2-
priming DC subset in N. brasiliensis infection (33). Of note, CD301b+ DCs alone are insufficient 
to generate a Th2 response in vitro (32) or in vivo (31), suggesting that additional requirements 
exist. For example, optimal localization of DCs within the lymph node may play a crucial role. In 
H. polygyrus infection, CXCR5-expressing CD11c+ DCs migrate to the lymph node and localize 
adjacent to B cell follicles (34). Depletion of CXCR5 or B cell-derived lymphotoxin alters the 
localization of the DCs and, as a consequence, impairs the development of Tfh and Th2 cells 
(34). In addition, it has been suggested that DCs require signals from basophils (35) and group 
2 innate lymphoid cells (ILC2s) (36) to prime Th2 responses to allergens. Together, these studies 
suggest that specific DC subsets, as well as the microenvironment in which these subsets 
encounter CD4+ T cells, are important for Th2 development in vivo. 
3.2 Sensing helminth-derived antigens
DCs are equipped with pattern recognition receptors (PRRs) that recognize a wide array 
of PAMPs. The classical paradigm describes that triggering of PRRs, including the Toll-like 
receptors (TLRs), RIG-I-like receptors, NOD-like receptors, scavenger receptors, and C-type 
lectin receptors (CLRs), induces DC maturation and subsequent antigen-specific activation of 
T helper cells (37). 
While signaling through most TLRs induces Th1/Th17 responses (38), Th2-inducing helminth-
derived molecules have also been described to interact with DCs through TLR2, 3 and 4 (39-42). 
Although the schistosome-related glycan LNFPIII, which contains Lewis X (LeX) trisaccharides, 
requires TLR4 for Th2 skewing (43), various studies suggest that TLRs are dispensable for Th2 
polarization by helminth antigens. For example, bone marrow-derived DCs (BMDCs) from TLR2- 
and TLR4-knockout mice can still skew Th2 when pulsed with S. mansoni soluble egg antigens 
(SEA) (44), and the TLR adaptor protein MyD88 is not required for Th2 skewing by SEA-stimulated 
splenic DCs (45). Interestingly, human monocyte-derived dendritic cells (moDCs) stimulated 
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with phosphatidylserine lipids from schistosomes induce IL-10-producing T cells through TLR2 
(40). Therefore, helminth products may employ TLRs for the induction of regulatory responses, 
but it seems that other PRRs are required for the initiation of a Th2 response.
Indeed, CLRs that sense helminth glycans play an important role in Th2 skewing. For 
example, SEA is internalized by moDCs through DC-specific ICAM-3-grabbing nonintegrin 
(DC-SIGN), macrophage galactose-type lectin (MGL) and mannose receptor (MR) (46), and binds 
to Dectin-2 on BMDCs (47). Binding of SEA to DC-SIGN was shown to depend on LeX (48), and 
a recent study showed that blocking DC-SIGN-associated signaling inhibits Th2 skewing (49). 
Likewise, excretory/secretory products from the tapeworm Taenia crassiceps (TcES) bind MR 
and MGL on BMDCs (50), and the Th2-skewing capacity of TcES is glycan-dependent (51). In 
sum, these studies indicate that helminth-derived antigen preparations can bind a variety of 
PRRs, which may induce distinct intracellular events that promote Th2 polarization.
3.3 Intracellular mechanisms associated with Th2 polarization
PRR-mediated signaling classically induces DC maturation via mitogen-activated protein 
kinases (MAPK) (52). However, in contrast to microbial ligands, helminth products often fail 
to induce classical signs of maturation and are well-known to downregulate TLR-mediated 
maturation (46;53-59). Indeed, unlike many TLR ligands, Th2-inducing compounds fail to 
phosphorylate p38 MAPK but instead promote phosphorylation of p42/p44 MAPK (ERK1/2) 
(reviewed in (60)). ERK1/2 stabilizes c-Fos, and inhibiting either c-FOS or ERK1/2 enhances 
IL-12 production by moDCs (61), suggesting that activation of this pathway suppresses Th1-
polarizing cytokines. Likewise, TSLP promotes ERK1/2 phosphorylation (62) and fails to induce 
IL-12 production by myeloid DCs (63;64).
It was noted that the NF-ĸB signaling pathway also seems involved in Th2 polarization, as 
SEA- or LNFPIII-stimulated BMDCs from NF-ĸB1 knockout mice fail to prime a Th2 response 
(65;66). Furthermore, it was recently demonstrated that LeX residues, via DC-SIGN, activate 
LSP1 in moDCs, leading to nuclear accumulation of the atypical NF-ĸB family member Bcl3 
and downregulation of IL-12 mRNA. These events also seem required for SEA-induced T cell 
polarization, since silencing either LSP1 or Bcl3 interferes with Th2 skewing (49). Similarly, the 
Th2-inducing capacity of TSLP was shown to involve activation of NF-κB and STAT5 (62;67). 
Lastly, SEA can signal through spleen tyrosine kinase (Syk) downstream of Dectin-2, 
activating the Nlrp3 inflammasome and increasing TLR-triggered release of IL-1β by BMDCs. 
However, infection of various inflammasome-deficient mice with S. mansoni demonstrated 
that activation of this pathway does not seem to favor any particular Th response (47). Thus, 
helminth antigens can activate signaling, and certain members of the NF-κB and ERK pathways 
in particular seem to play a role in Th2 polarization. 
In addition to signaling-dependent mechanisms, a number of studies identified a role 
for cysteine protease inhibitors secreted by filarial nematodes (cystatins) in regulating host 
immune responses by interfering with antigen processing (reviewed in (68)). Therefore, 
helminths may employ both signaling-dependent and independent mechanisms to condition 




3.4 Primed DCs and initiation of T cell polarization 
A major difference between Th1 and Th2 development is that a Th1 response requires 
persistent production of Th1-polarizing cytokines, like IL-12, which are exclusively produced 
by APCs. By contrast, once primed DCs induce IL-4 production by a few activated T helper cells, 
the Th2 response is self-sustained through autocrine production of IL-4 (69;70). Therefore, in 
order to understand mechanisms of Th2 polarization, it is critical to identify the DC-associated 
polarizing signals that control early IL-4 production by activated T cells.
3.4.1 Soluble factors and surface molecules
As discussed above, DCs stimulated with helminth molecules or TSLP fail to express IL-12. 
Moreover, injection of IL-12 can block the development of a Th2 response to S. mansoni eggs 
(71). These findings led to the so-called ‘default concept’, which states that Th2 differentiation 
spontaneously occurs in the absence of a Th1-priming signal like IL-12. However, mice lacking 
IL-12 do not develop a Th2 response to microbial pathogens (72), and blocking the mTOR 
pathway in moDCs skews a potent Th2 response without affecting IL-12 (73), suggesting that 




























Figure 1. Possible mechanisms by which helminth molecules modulate DCs for Th2 polarization. 
Helminth antigens are recognized by DCs through ligation of pattern recognition receptors (PRRs), 
such as Toll-like receptors (TLRs) and C-type lectin receptors (CLRs). Depending on the antigen, 
binding promotes phosphorylation of ERK1/2, nuclear accumulation of NF-κB or Bcl3, and/or 
activation of the Nlrp3 inflammasome which mediates IL-1β secretion. Phosphorylation of ERK1/2 
stabilizes c-Fos, leading to downregulation of IL-12 expression. In addition, DCs can upregulate 
expression of Th2-associated CD40 and Jagged, which are under the control of NF-κB and ERK1/2, 
respectively (74;75). Upon encounter of T cells expressing CD40L, signaling through CD40 promotes 
OX40L expression in an autocrine manner. Alternatively, PRRs may mediate uptake of antigens that 
interfere with antigen presentation on MHCs, such as cystatins. In addition, helminth products 




Such a signal may be provided by a soluble factor secreted by DCs, like RELMα, which was 
shown to promote IL-10 and IL-13 secretion by lymph node cells following adoptive transfer 
of SEA-stimulated BMDCs (74). However, supernatants from SEA-primed moDCs do not skew 
towards Th2 (75), and SEA-stimulated BMDCs do not induce Th2 when separated from CD4+ 
T cells in transwells (76), indicating that an active polarizing signal in these studies is likely 
provided by surface molecules. Indeed, the Notch ligands Delta-4 and Jagged-2 have been 
linked to Th1 and Th2 polarization, respectively (77), and helminth antigens were shown to 
upregulate Jagged-2 on BMDCs (78;79) and to suppress Delta-4 expression in moDCs (80). 
However, Jagged-2-deficient BMDCs can still skew Th2 when challenged with SEA (78;79), 
suggesting that other molecules may be involved. For example, CD40 has been suggested 
to provide a polarizing signal, as its expression on SEA-stimulated BMDCs is required for 
the induction of a Th2 response (81), and mice lacking CD40 ligand suffer from impaired 
Th2 development during S. mansoni infection (82). Mechanistically, signaling through CD40 
promotes OX40L expression, which is essential for optimal Th2 skewing by SEA-conditioned 
BMDCs (83) and moDCs (75), as well as TSLP-conditioned myeloid DCs (64). However, treatment 
with anti-OX40L does not significantly affect the Th2 response to N. brasiliensis infection 
(84), and it has been suggested that OX40L acts as a costimulatory molecule rather than a 
polarizing signal, since SEA-treated OX40L-knockout DCs induce Th2 cells, but fail to stimulate 
appropriate T cell expansion (83). Altogether, these studies suggest that there may not be one 
specific DC-associated molecule required for Th2 polarization, but rather a combination of 
signals that mediate both optimal T cell priming and expansion. 
3.4.2 A role for the T cell receptor
Early reports have described that the antigen dose can determine the outcome of Th 
differentiation, with a high dose generally favoring Th1 development (85-87). These findings 
were confirmed in a recent report, which also indicated that Th1-inducing adjuvants promote 
a higher Ca2+ flux (representing T cell receptor (TCR)-signaling strength), and induce larger 
synapse size, than Th2-promoting molecules (88). In addition, it has been suggested that T cells 
activated by Th2-inducing ligands are less proliferative, as priming of splenic DCs with SEA 
reduces the frequency of CD4+ T cells progressing through the cell cycle, and drug-induced 
arrest of cell cycle progression promotes Th2 polarization (45). Together, these observations 
suggest that helminth molecules may reduce TCR triggering, impairing T cell proliferation 
in favor of Th2 differentiation. Indeed, treatment of splenic DCs with SEA results in shorter 
T cell-DC interaction times and lower TCR signaling when compared to a Th1-inducing adjuvant 
(88). Omega-1, a glycosylated identified as the major component in SEA (55), was also shown 
to reduce the capacity of BMDCs to form T cell-DC conjugates and to diminish the frequency 
of CD4+ T cells progressing through the cell cycle (76). Mechanistically, interaction between 
T cells and DCs was shown to depend at least in part on the co-stimulatory molecule CD80 (88). 
As discussed above, helminth products fail to induce upregulation of costimulatory molecules, 
which may also explain why DCs treated with helminth molecules are less capable of forming 




4. imPlications for metabolic disorders
A growing body of literature indicates that obesity is associated with chronic low-grade 
inflammation of metabolic organs, in particular adipose tissue. In healthy adipose tissue, a wide 
variety of immune cell types play an important role in housekeeping, removal of apoptotic 
cells, and maintenance of homeostasis (89). However, fat accumulation results in chemokine 
secretion by adipocytes, attracting classically activated M1 macrophages that secrete pro-
inflammatory cytokines like  interleukin (IL)-1β and tumor necrosis factor-α (TNF-α) (10;90;91). 
These cytokines interfere with  insulin signaling (92;93) and induce lipolysis (94;95), thereby 
increasing circulating free fatty acids which promote peripheral insulin resistance (96). In 
addition to M1 macrophages, other pro-inflammatory immune cells have been associated with 
insulin resistance, including Th1 cells, Th17 cells, CD8+ T cells and B lymphocytes (97) (figure 2).
By contrast, alternatively activated macrophages, also called M2 macrophages, prevail in 
lean white adipose tissue (WAT) and are involved in the maintenance of adipose tissue insulin 
sensitivity, partly through secretion of the anti-inflammatory cytokine IL-10 (10;98). The M2 
phenotype is promoted by Th2-type cytokines IL-4, IL-5 and IL-13, which were shown to be 
secreted by WAT eosinophils (99) and ILC2s (100). In addition, various reports have shown that 
Th2-inducing conditions, such as N. brasiliensis infection (99;101), allergic inflammation (8), or 
SEA administration (102), improve insulin sensitivity and glucose tolerance in diet-induced 



















IL-4   IL-13   IL-10
INSULIN SENSITIVITY
Figure 2. Obesity and inflammation of adipose tissue. As obesity develops, the expanding adipose tissue 
promotes the transition from an anti-inflammatory to a pro-inflammatory state.
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the development of atherosclerotic lesions in mice, and adoptive transfer of CD4+ T cells (mostly 
via Th2 cells) and IL-4 treatment can protect against diet-induced insulin resistance (8;105). 
Lastly, type 2-associated ILC2s (100;106) and eosinophils (99) were shown to play a crucial role in 
maintenance of whole-body metabolic homeostasis by sustaining adipose tissue alternatively 
activated M2 macrophages.  These findings are in line with epidemiological studies indicating 
that infection with helminths inversely correlates with metabolic syndrome (107;108). These 
landmark studies identify the interplay between helminths and energy metabolism as an 
exciting new area that needs further dissection. 
5. scoPe of the thesis
Over the last few decades, a wide array of studies have shed light on the possible mechanisms 
by which helminth molecules condition DCs for Th2 skewing. Nevertheless, due to the complex 
nature of many helminth-derived antigen preparations, it proved difficult to pinpoint specific 
receptors and/or mechanism involved. Therefore, the identification of omega-1, a glycosylated 
RNase, as the major immunomodulatory component in SEA has provided us with a powerful 
tool to further dissect the molecular mechanisms underlying Th2 polarization (55;76). The first 
part of this thesis centers on the following question: 
How does omega-1 modulate dendritic cells for T helper 2 polarization?
Chapter 2 studies the molecule omega-1, and analyzes the requirement of glycosylation and 
RNase activity in the modulation of DCs for Th2 polarization, in vitro and in vivo.
In chapter 3 we study the role of the mTOR pathway in the induction of Th2 responses by 
moDCs stimulated with SEA and omega-1.
Chapter 4 further characterizes moDCs primed for Th2 polarization by SEA or omega-1 using 
a mass spectrometry-based approach.
The second part of this thesis builds on landmark studies showing that type 2 inflammatory 
responses protect against metabolic disorders. These studies have identified the interplay 
between helminths and metabolic homeostasis as an exciting new area that needs further 
dissection. We focus on the following question:
What are the effects of chronic S. mansoni infection and SEA administration on metabolic 
homeostasis?
In chapter 5, we study the effects of chronic Schistosoma mansoni infection and SEA treatment 




obesity. We perform in-depth metabolic profiling and analyze the immune cell composition 
of metabolic organs. 
The MR is a marker for M2 macrophages, and was identified in Chapter 2 as the main receptor 
responsible for internalization of omega-1 by moDCs. In chapter 6, we therefore study the 
effect of HFD-feeding on metabolic homeostasis and immune cell polarization in mice 
deficient for the MR.
Chapter 7 summarizes the importance of our findings within the larger body of literature, and 
provides directions for future research towards understanding the link between schistosomes, 
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Omega-1, a glycosylated T2 ribonuclease (RNase) secreted by Schistosoma mansoni eggs 
and abundantly present in soluble egg antigen (SEA), has recently been shown to condition 
dendritic cells (DCs) to prime Th2 responses. However, the molecular mechanisms underlying 
this effect remain unknown. We show here by site-directed mutagenesis of omega-1 that both 
the glycosylation and the RNase activity are essential to condition DCs for Th2 polarization. 
Mechanistically, we demonstrate that omega-1 is bound and internalized via its glycans by 
the mannose receptor (MR) and subsequently impairs protein synthesis by degrading both 
ribosomal and messenger RNA. These studies reveal an unrecognized pathway, involving MR 
and interference with protein synthesis that conditions DCs for Th2 priming.
26
2
MechanisMs of oMega-1-driven Th2 priMing
introduction
Dendritic cells (DCs) play a central role in the development and maintenance of immune 
responses during infection, as they govern both the activation and polarization of adaptive T 
helper (Th) cells. Classically, upon recognition of invading pathogens, resting DCs undergo a 
process of activation, so-called maturation, that involves stable presentation of peptides in the 
context of major histocompatibility complex (MHC)-I and -II, up-regulation of co-stimulatory 
molecules, and production of polarizing cytokines, that collectively enable DCs to potently 
activate and direct CD4+ T cell responses (1). 
This paradigm is largely based on observations of responses towards pathogens, like 
bacteria, viruses and fungi. These pathogens harbor pathogen-associated molecular patterns 
that lead to classic DC activation by engaging several classes of innate pattern recognition 
receptors, including the Toll-like receptors (TLRs). Binding of pathogen-associated molecular 
patterns to these receptors initiates signaling cascades that generally result in the conditioning 
of DCs for priming of Th1- or Th17-biased responses which are instrumental in combating 
prokaryotic and single cell eukaryotic pathogens (2). In contrast to this classical view of DC 
activation, components derived from parasitic helminths, when co cultured with DCs, fail to 
induce the traditional signs of DC maturation. However, although overt maturation is not 
observed, unlike immature DCs, helminth antigen-treated DCs are altered such that they prime 
Th2-polarized immune responses (3). 
Despite this consistent picture, the pathways through which helminth antigens manipulate 
DC function and drive Th2 responses are still poorly understood (4). The majority of the 
studies have been conducted with a complex mixture of soluble egg antigens (SEA) from the 
trematode Schistosoma mansoni. SEA is regarded as one of the most potent helminth-derived 
antigenic extracts that instruct DCs to drive Th2 polarization (3;5). So far these studies have 
mainly suggested that carbohydrate structures play a role in DC modulation by SEA, given 
that chemical modification of glycans on proteins present in SEA is known to abolish their 
capacity to induce Th2 polarization (6). In this respect, another class of pattern recognition 
receptors expressed by DCs, the carbohydrate-binding C-type lectin receptors (CLRs), have 
been suggested to play a role in modulation of DC function by SEA (7). For instance, SEA 
contains carbohydrate structures, such as Lewis-x (Lex), that can be recognized by DC SIGN 
(DC-specific intercellular adhesion molecule-3-grabbing non-integrin; 8-10). Engagement of 
this receptor by components from pathogens such as Helicobacter pylori has been shown to 
suppress IL-12 production and modulate TLR-induced DC activation and T cell polarization 
(8;11). In addition, more recently it has been shown that SEA can modulate cytokine responses 
through another CLR, dectin-2 (12). Finally, a number of studies have raised the possibility 
that TLRs are involved in SEA-mediated Th2 induction (13;14). However, direct evidence for 
involvement of specific receptors or downstream pathways in SEA-driven Th2 polarization 
has been missing.
The recent identification of omega-1, a glycosylated T2 RNase, as the major component 
in schistosome eggs that is responsible for conditioning DCs for Th2 polarization (15-17), has 
allowed us to dissect the molecular pathways involved in a precise manner. Through site-
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directed mutagenesis we show that both the RNase activity and the glycosylation of omega-1 
are essential for programming of DCs for Th2 induction. Furthermore, we provide evidence 
that MR is critical for omega-1-driven Th2 responses and that internalization via this receptor 
is needed for biological activity of omega-1, as it allows omega-1 to interfere with translation, 
by degrading rRNA and mRNA, and thereby to condition these cells to prime Th2 responses.
results
Omega-1 requires both its glycosylation and RNase activity to condition DCs for 
priming of Th2 responses
The RNase activity of omega-1 has been proposed to play a role in the conditioning of DCs 
to prime Th2 responses (16). However, this was based on a chemical inactivation of the RNase 
activity by diethylpyrocarbonate-treatment, which can result in off-target modification 
of histidines as well as other amino acids that could alter the function or structure of the 
protein (18).Therefore, we addressed the role of RNase activity in a more stringent and 
specific manner by creating a mutant of recombinant wildtype (WT) omega-1 lacking RNase 
activity by site-directed mutagenesis. Specifically, a histidine residue in its catalytic domain, 
known from other T2 RNases to be essential for the enzymatic activity (19), was replaced by 
phenylalanine (omega-1 H58F) (Fig. 1 A). Apart from RNase activity, glycosylation of omega-1 
may also be important for its Th2-priming capacity, since chemical modification of glycans 
on proteins present in SEA is known to abolish the ability of SEA to induce Th2 polarization 
(6). Moreover, potentially Th2-polarizing Lex glycan motifs have recently been described to 
be present in glycans on omega-1 (20). To address the role of glycosylation in Th2 priming 
by omega-1, a glycosylation mutant was generated by a single amino-acid replacement at 
each of the two N-linked glycosylation sites (omega-1-N71/176Q) (Fig. 1 A) (17;20). An RNase 
assay showed that the RNase mutant did not have any RNase activity, while the RNase activity 
of the glycosylation mutant was unaffected (Fig. 1 B). In addition, the banding patterns of 
recombinant WT omega-1 and the mutants on silver stained SDS-PAGE and anti-omega-1 
Western blots were in line with the absence of carbohydrates on the glycosylation mutant as 
evident by a single band instead of the three glycoforms of the recombinant WT omega-1 and 
the RNase mutant (Fig. 1 C). With regard to the glycans present on recombinant WT omega-1 
and the RNase mutant, mass spectrometric analysis of tryptic glycopeptides showed the 
presence of N-glycans on Asn176 with the monosaccharide composition Hex3HexNAc6Fuc2/3 
(Fig. 1 D). This composition is indicative of the presence of GalNAcβ1-4(Fucα1-3)GlcNAc 
(LDN-F) antennae, a glycan element previously found on a protein from HEK293 cells (21), 
the cell type in which recombinant omega-1 is expressed. LDN-F motifs frequently occur on 
helminth glycoproteins, and the characteristics of LDN-F with respect to binding to CLRs are 
similar to those of the Lex element (9;10;20;22).
To assess the role of glycosylation and RNase activity in omega-1-driven Th2 polarization, 
a well- established in vitro culture system of human monocyte-derived DCs (moDCs) and naïve 
CD4+ T cells was used, which mimics in vivo DC-mediated Th cell polarization (1). Similar to 
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Figure 1. Generation and evaluation of glycosylation and RNase mutants of recombinant omega-1. 
(A) The amino acid sequence of omega-1 (Acc.No. ABB73003.1) is shown in which the mutation sites are 
depicted. The two conserved amino acid sequence (CAS)-domains essential for catalytic activity are 
marked in grey and the two N-linked glycosylation sites are depicted in white boxes. (B) RNA from PBMCs 
was incubated for 1 h with the different omega-1 variants (500 ng/ml and 100ng/ml) and analyzed on a 
2% agarose gel for breakdown. RNase A was used a positive control. One of two experiments is shown. 
(C) The omega-1 mutants were run under non-reducing conditions by SDS-PAGE and silver stained. 
A Western Blot by staining with a specific anti-omega-1 monoclonal antibody was in line with the 
absence of glycosylation only on the omega-1 glycosylation mutant. (D) MALDI-TOF mass spectrum 
of glycopeptides from a tryptic digest of recombinant WT omega-1, covering the glycosylation site 
N176. Recombinant omega-1 was subjected to SDS-PAGE under reducing conditions and stained 
with Colloidal blue. Stained bands were excised, subjected to reduction and alkylation and digested 
with trypsin. The MALDI-TOF-MS spectrum derived from the upper band in the SDS-PAGE pattern is 
depicted. Signals ([M+H+]) are labeled with monoisotopic masses. Composition of the glycan moieties 
are given in terms of hexose (H), N-acetylhexosamine (N) and fucose (F). Differences in fucose content 
are indicated by double-headed arrows. Signals that cannot be assigned to glycopeptides are marked 
with asterisks (*). 
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natural omega-1 (15), recombinant WT omega-1 consistently and significantly suppressed in 
a concentration dependent manner the lipopolysaccharide (LPS)-induced upregulation of the 
costimulatory molecule CD86 (Fig. 2 A), as well as the production of IL-12 p70 following CD40 
ligation (Fig. 2 B), which is an important characteristic of Th2-priming DCs (3). However, both 
the glycosylation mutant and the RNase mutant failed to alter LPS-induced CD86 expression 
or IL-12 production of DCs at any of the concentrations tested. Importantly, in contrast to DCs 
primed with recombinant WT omega-1, those conditioned with either mutant did not prime 
a Th2 response (Fig. 2 C+D). Similar results were obtained with cultures in which DCs were 
conditioned by the omega-1 mutants in the absence of LPS (Fig. 2 E). These data show that 
the RNase activity and the glycosylation of omega-1 are both essential, but as single property 
not sufficient, for the induction of Th2 responses via DCs.
Omega-1 requires both its glycosylation and RNase activity to prime Th2 responses 
in vivo
To test whether the in vivo Th2-priming capacity of omega-1 is dependent on glycosylation 
and RNase activity, recombinant WT omega-1 or its mutants were administered to 4get/KN2 
IL-4 dual-reporter mice (23). In these mice IL-4-competent cells are GFP+ and IL-4-producing 
cells additionally express huCD2, allowing the direct visualization of Th2 differentiation and 
IL-4 production. Following the s.c. injection of the antigens into the footpad, the draining 
popliteal lymph nodes (LNs) were harvested on day 7 and CD4+CD44high effector T cells were 
analyzed for the expression of GFP and huCD2 directly ex vivo. Injection of SEA resulted in a 
significant increase of GFP+ and huCD2+ cells, reflecting the induction of Th2 differentiation 
and IL-4 production in vivo (Fig. 3). Importantly, while recombinant WT omega-1 induced a 
marked Th2 response and the production of IL-4, both mutants were significantly impaired 
to prime this response as evident from lower frequencies (Fig. 3 A and B) as well as total 
numbers of huCD2+ T cells (Fig. 3 C) in the draining LN. Taken together, these data show that 
the glycosylation and the RNase activity of omega-1 play a crucial role in Th2 polarization 
induced by omega-1 in vivo.
Omega-1 is internalized by DCs via the mannose receptor (MR) 
To get a better understanding of how glycosylation is involved in omega-1-driven Th2 
polarization, we tested whether recognition of omega-1 by human DCs was dependent on the 
glycans present on omega-1. While human DCs were capable of binding fluorescently-labeled 
recombinant WT omega-1 or the RNase mutant as determined by FACS analysis, DCs failed to 
bind the glycosylation mutant, demonstrating that glycans present on omega-1 are essential 
for recognition by DCs (Fig. 4 A). Given the importance of glycosylation of omega-1 for binding 
to DCs, we explored the involvement of carbohydrate-binding CLRs in the recognition and 
uptake of omega-1. While DCs readily bound fluorescently-labeled omega-1, binding of natural 
omega-1 was totally prevented when DCs were pre-incubated with the calcium-chelator 
EGTA, which abolishes CLR binding to carbohydrate ligands (Fig. 4 B). In contrast, treatment 
of DCs with EGTA after 1 h incubation with omega-1, could not reduce the fluorescent signal 
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Figure 2. The glycosylation and RNase activity of omega-1 are essential for conditioning human 
DCs to prime Th2 responses. (A) Human moDCs were pulsed for 48 h with increasing concentrations 
of the mutant variants of recombinant omega-1 in combination with LPS (100 ng/ml) as a maturation 
factor and surface expression of CD86 was determined by FACS analysis. The expression levels, based 
on geometric mean fluorescence, are shown relative to the DCs stimulated with LPS alone, which is 
set to 1. Data are based on two independent experiments and shown as mean ± SD. (B) Conditioned 
DCs were co-cultured for 24 h with a CD40-L expressing cell line, to mimic the interaction with T cells. 
IL-12p70 cytokine expression levels are shown relative to the DCs stimulated with LPS alone, which 
is set to 1. Data are representative of triplicate wells from one of 2 independent experiments and 
shown as mean ± SD. (C) DCs conditioned as described in (A) were cultured with allogeneic naive 
CD4+ T cells for 12 days in the presence of staphylococcal enterotoxin B and IL-2. Intracellular cytokine 
production was assayed by FACS 6 h after the stimulation of primed T cells with phorbol 12-myristate 
13-acetate (PMA) and ionomycin. Based on intracellular cytokine staining, the ratio of T cells single-
positive for either IL-4 or IFN-γ was calculated relative to the control condition. Data are based on 
2 independent experiments and shown as mean ± SD. (D) An example of T cell polarization assay as 
described in (C) induced by the different recombinant omega-1 variants. The frequencies of each 
population are indicated as percentages in the plot. One representative result from 5 independent 
experiments is shown. (E) T cell polarization assay as described in (C) but in the absence of LPS. 
Data are representative of 3 independent experiments. Bars represent mean ± SD. # P < 0.05, for 
significant differences compared to control conditions (*) or between test conditions (#) based on 
paired analysis (two-sided paired t-test). ω-1, omega-1; WT, wild type: H58F, RNase mutant; N71/176Q, 
glycosylation mutant.
of omega-1, indicating that by then all bound omega-1 had been internalized. This suggests 
that DCs recognize and rapidly internalize omega-1 in a CLR dependent manner. SEA has 
been reported to be recognized and endocytosed by human moDCs via the CLRs DC-SIGN 
and MR (7) that have the capacity to bind fucose-residues such as those found in Lex (9;10;24), 
a glycan motif present on natural omega-1 (20). To determine whether MR and DC-SIGN are 
involved in recognition and internalization of natural omega-1, DCs were pre-incubated with 
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Figure 3. Glycosylation and 
RNase activity are essential 
for omega-1 to prime Th2 
responses in vivo. 4get/
KN2 IL-4 dual reporter mice 
were injected s.c. with SEA 
(20 μg) or 3 μg WT mutant 
recombinant omega-1 into 
the footpad. After 7 days the 
frequency of GFP+ and huCD2+ 
within the CD4+CD44high 
effector T cell population was 
determined by flow cytometry 
in the draining popliteal 
lymph nodes. Depicted are (A) 
concatenated FACS plots, (B) 
frequencies of huCD2+ within 
the CD4+CD44high population 
and (C) total huCD2+ T cell 
numbers in draining lymph 
nodes of combined data 
of 4 mice per group. (A) 
The frequencies of each 
population are indicated as 
percentages in the plots. One 
of 3 independent experiments 
is shown. Bars represent mean 
± SD. *,# P < 0.05, ** P <0.01, *** 
P <0.001 for values significantly 
different from the PBS control 
(*) or between test conditions 
(#) based on two-sided 
t-test. WT, wild type; H58F, 
RNase mutant; N71/176Q, 
glycosylation mutant.
mannan (a natural ligand that competes for binding to DC-SIGN and MR), or DC-SIGN- and 
MR-specific blocking antibodies, followed by a 1 h incubation with fluorescently-labeled 
SEA or natural omega-1. As reported previously (7), uptake of SEA by human moDCs could 
be reduced by mannan and either DC-SIGN or MR blocking antibodies in an additive manner 
(Fig. 4 C). With regard to omega-1, pre-treatment with mannan could fully block binding 
and uptake of omega-1 by DCs. Interestingly, binding and uptake of natural omega-1 were 
significantly reduced by MR but not by DC-SIGN blocking antibodies (Fig. 4 C). Pre-incubation 
with the combination of both blocking antibodies did not have any additional effect on the 
uptake of omega-1 as compared to pre-incubation with anti-MR antibody alone. In addition, 
we found that recombinant omega-1 was recognized and internalized by DCs in a similar 
MR-dependent fashion as natural omega-1 (Fig. 4 D). To further investigate the observations 
of selective recognition and uptake of omega-1 by MR, we made use of the K562 and 3T3 cell 
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Figure 4. Mannose Receptor (MR) mediates recognition and internalization of omega-1 by human 
DCs. (A) Human moDCs were incubated for 1 h with PF-647-labeled recombinant WT omega-1, the 
glycosylation mutant or the RNase mutant and analyzed for uptake of antigens by FACS analysis. One 
representative experiment with duplicate samples out of 2 experiments is shown. Bars represent mean 
± SD. (B) Human moDCs were incubated for 1 h with PF-647-labeled omega-1 and, where indicated, 
either pre-incubated (‘pre’) with EGTA to prevent omega-1 binding to CLRs a priori, or treated afterwards 
with EGTA (‘post’) to remove any CLR-bound omega-1 from the cell surface. One of two independent 
experiments is shown and data represent mean ± SD of duplicates. (C+D) A binding/internalization 
assay of natural (C) and recombinant omega-1 (D) by immature moDCs was performed analogous to 
(B) following pre-incubation with indicated reagents. Binding and internalization are shown relative 
to control pre-treatment. (C) Data are based on 5 experiments and are shown as mean ± SD. (D) One of 
two independent experiments is shown and data represent mean ± SD of duplicates. (E) 3T3 cell-line 
expressing MR and (F) K-SIGN expressing DC-SIGN or parental control cell lines (3T3 and K-562) were 
incubated with PF-647-labeled omega-1 and SEA in the presence or absence of EGTA to determine 
specificity. One representative experiment based on duplicate samples out of 2 is shown. Bars represent 
mean ± SD. *,# P < 0.05, **,## P < 0.01, *** P < 0.001 for significant differences between control conditions 
(*) or between test conditions (#) based on two-sided t-test. WT, wild type: H58F, RNase mutant; N71/176Q, 
glycosylation mutant.
lines selectively expressing human DC-SIGN and MR, respectively. Fluorescently-labeled SEA 
was readily bound by both the DC-SIGN- and MR-expressing cells, which was not observed 
upon pre-incubation with EGTA or in parental control cell lines lacking CLR expression. In 
line with the DC-binding and uptake data, omega-1 binding could be observed in the cell 
line expressing MR (Fig. 4 E), but not in the cell line expressing DC-SIGN (Fig. 4 F). It should be 
noted that in these uptake experiments (Fig. 4 C+D), blocking with anti-MR antibody was not 
complete (±40% reduction). However, given that blocking the binding of omega-1 to the cell 
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line selectively expressing MR with the anti-MR antibody was not complete either (data not 
shown), it is likely that a low affinity of the anti-MR antibody accounts for this finding rather 
than that other receptors are involved. Taken together, our data show that recognition and 
internalization of omega-1 by human DCs is dependent on its glycosylation and that MR is a 
major CLR involved in this process.
Omega-1 suppresses DC function by interfering with protein synthesis 
Next we examined the molecular mechanism through which the RNase activity of omega-1 
exerts its modulatory effects on human DCs. We noted that omega-1-stimulated DCs in 
response to CD40 ligation were not only impaired in their capacity to produce IL-12 p70, as 
reported previously (15), but also to secrete other cytokines and chemokines (Fig. 5 A). This 
suggested that the suppression may not be gene specific, but could be the result of general 
inhibition of protein synthesis. Indeed, following exposure of DCs to omega-1 or SEA, a dose-
dependent reduction of protein synthesis could be observed, similar to what is found in 
DCs exposed to ricin, a well-known protein synthesis inhibitor (25) (Fig. 5 B). In addition, this 
inhibition by omega-1 was time-dependent and observed in both the presence and absence 
of LPS (Fig. 5 C). The capacity to inhibit protein synthesis was dependent on its RNase activity 
and uptake via its glycans, since the RNase as well as the glycosylation mutant failed to 
interfere with protein synthesis (Fig 5 D). As several fungal ribonucleolytic proteins, so-called 
ribotoxins, have been described to inhibit protein synthesis through cleavage of ribosomal 
RNA (rRNA) following translocation into the cytosol (26), we first evaluated the localization of 
omega-1 in human DCs following uptake. We found that omega-1 was efficiently internalized 
Figure 5. Omega-1 suppresses protein synthesis through breakdown of rRNA and mRNA. (A) After 
human moDCs had been pulsed for 40 h with omega-1 (125, 250 and 500 ng/ml) in combination with 
LPS (100 ng/ml), the cells were co-cultured for 24 h with the J558 cell-line, expressing CD40-L, to mimic 
the interaction with T cells. Bars represent mean ± SD of triplicate wells of one of two independent 
experiments. * P < 0.05, ** P <0.01, *** P <0.001 for values significantly different from the LPS control. 
(B) Following 16 h incubation of human DCs with a concentration range of indicated reagents in the 
presence of LPS (100 ng/ml), protein synthesis was assessed after a 2 h pulse with radioactively-labeled 
methionine. Ricin, as potent inhibitor of protein synthesis, was taken along as positive control (25). 
One of 2 experiments is shown. (C) As described in (B), protein synthesis by human DCs was followed 
over time after exposure to omega-1 (500 ng/ml) either in the presence or absence of LPS (100 ng/ml). 
Data are shown relative to unstimulated or LPS-stimulated controls as depicted by the dotted line. 
Data are representative of two independent experiments and are depicted as mean ± SD. (D) Protein 
synthesis by human moDCs following exposure to increasing concentrations of the recombinant 
omega-1 variants was assessed as described in (B). Data are shown relative to LPS-stimulated DCs. 
Data are representative of two independent experiments and are depicted as mean ± SD. (E) DCs were 
stimulated with FITC-labeled recombinant omega-1 for 1 h and uptake was visualized by confocal laser 
scanning microscopy. Nuclei were stained with Hoechst. One of three experiments is shown. Scale bar 
represents 10 µm. See Fig. S1 for a video of Z-stacked images. (F) Cytoplasmic fractions of human DCs 
stimulated for 3 h with omega-1 were run under non-reducing conditions by SDS-PAGE and analyzed 
by Western Blot for presence of omega-1 or silver-stained to control for input. DCs incubated at 4°C 
were taken along as controls as these cells have surface-bound, but not internalized omega-1. One 
of two experiments is shown. (G) human DCs were stimulated with FITC-labeled omega-1 (1 µg/ml) 
34
2
MechanisMs of oMega-1-driven Th2 priMing
and after 2 h fixed and stained for rRNA. Subcellular localization of omega-1 was determined by 
confocal microscopy. One representative cell from three independent experiments is shown. Scale bar 
represents 10 µm. (H) After rabbit reticulocyte lysate containing functional ribosomes was incubated 
for 1 h with omega-1 (1 and 5 µg/ml), IPSE (1 and 5 µg/ml) as negative control, or ES (schistosome 
egg excretory/secretory products) (25 µg/ml), containing omega-1, isolated rRNA was analyzed for 
breakdown on a 2% agarose gel. The RNase α-sarcin was taken along as positive control as it should 
give a single rRNA cleavage product when incubated with functional ribosomes (white arrowhead) 
(28). One of three independent experiments is shown. (I) rRNA isolated from 24 h omega-1-stimulated 
human DCs and was visualized by running a lab-on-a-chip picogel. One of three experiments is shown. 
(J+K) rRNA or mRNA expression of indicated genes in DCs was assessed by real time-qPCR at different 
time points after stimulation with omega-1 (500 ng/ml and 2 µg/ml) in the presence or absence of 
LPS (100 ng/ml). Data are shown relative to unstimulated or LPS-stimulated controls, which were set 
to 1. RNA expression was normalized based on a genomic real time-qPCR for ccr5. Data represent the 




by DCs and present throughout the cell after 1 h (Fig. 5 E and Fig. S1). In addition, Western 
blots revealed the presence of omega-1 in the cytosolic fraction of omega-1-stimulated DCs 
after 3 h (Fig. 5 F). In line with this, co-localization experiments using immunofluorescence 
confocal microscopy by staining for rRNA, showed that 2 h after stimulation of DCs with 
omega-1, omega-1 partially co-localized with rRNA (Fig. 5 G). We next tested whether 
omega-1 could cleave rRNA in the context of functional ribosomes in a cell free assay. 
Omega-1 was able to break down rRNA, while IPSE, another S. mansoni egg-derived protein 
that lacks RNase activity but has identical glycans as omega-1 (27), did not induce any rRNA 
degradation (Fig. 5 H), indicating that omega-1 is able to interfere with ribosomal function 
by cleavage of rRNA. Analysis of the integrity of rRNA isolated from omega-1-exposed DCs 
by gel electrophoresis showed a preferential breakdown of 28S rRNA (Fig. 5 I). This was 
confirmed by real time-PCR, which additionally revealed breakdown of 18S at later time 
points (Fig. 5 J). Since the known T2 RNases have no sequence-specific RNase activity (19), 
we evaluated whether omega-1, which belongs to the T2 RNase family, may additionally 
impair protein synthesis by degrading not only rRNA but also mRNA transcripts in a generic 
manner. When DCs were stimulated with omega-1, both in the presence or absence of LPS, a 
concentration and time dependent loss in mRNA transcripts of housekeeping genes TAF1 and 
GAPDH as well as IL12B could be observed (Fig. 5 K), suggesting that omega-1 targets mRNA 
transcripts in a general manner in DCs as well. Taken together, these data support the notion 
that the RNase activity enables omega-1 to modulate human DC function by interfering 
with protein synthesis through cleavage of rRNA and mRNA following translocation into 
the cytosol. 
MR mediates omega-1-induced protein synthesis inhibition, DC modulation and 
Th2 polarization
To address the role of omega-1 binding by MR in mediating RNase-dependent DC modulation 
and Th2 priming by omega-1, we used blocking antibodies directed against MR or DC-SIGN. 
Blocking of MR during the stimulation of human DCs with omega-1 significantly prevented 
the inhibition of protein synthesis (Fig. 6 A), while blocking of DC-SIGN had no effect, showing 
that the interference with protein synthesis by omega-1 is dependent on MR. In line with 
these observations, blocking of MR significantly reduced the capacity of omega-1 to suppress 
LPS-induced CD86 expression (Fig. 6 B) and IL-12 production following CD40 ligation (Fig. 6 C) 
or to condition DCs to induce a Th2 response (Fig. 6 D). The importance of MR was further 
substantiated by the observations that in contrast to their WT counterparts, MR-/- murine DCs, 
when conditioned with omega-1, failed to prime a Th2-skewed allogeneic T cell response in 
vitro (Fig. 6 E). These data establish that MR is essential for the omega-1-driven Th2 polarization 
via DCs in vitro. 
Omega-1 requires MR to prime Th2 responses in vivo
Finally, to investigate the role of MR in Th2-priming by omega-1 in vivo, natural omega-1 
or PBS were injected subcutaneously into the footpad of WT and MR-/- mice. After 7 days 
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the draining popliteal LNs were harvested and restimulated in vitro with PBS, omega-1 or a 
polyclonal stimulus PHA and analyzed for cytokine production. Antigen-specific restimulation 
of omega-1-primed LNs from WT mice resulted in a Th2-polarized response as evidenced by 
elevated levels of Th2-associated cytokine IL-5 but not of Th1-associated cytokine IFN-γ, which 
was absent in LN cells derived from MR-/- (Fig. 7 A). Furthermore, intracellular staining for IFN-γ 
and IL-4 following antigen-specific restimulation of CD4+ T cells from omega-1-primed LNs, 
showed a significant increase in IL-4-producing T cells from WT but not MR-/- mice (Fig. 7 B). 
The failure of MR-/- mice to prime a Th2-polarized response in response to omega-1 was not 
due to a general failure of MR-/- cells to produce these cytokines as the responses to PHA were 
comparable in WT and MR-/- mice (Fig. 7 A and B). Taken together, these data show that MR is 
essential for priming of Th2 responses by omega-1 in vivo.
discussion
Using omega-1, a single glycosylated T2 RNase secreted by Schistosoma mansoni eggs, we 
studied the molecular mechanisms involved in conditioning dendritic cells to induce Th2 
responses. By generating mutants of omega-1 we could show that both the glycosylation and 
the RNase activity of omega-1 are essential for its potent Th2-inducing activity both in vitro 
and in vivo. The glycan structures on omega-1 suggested that CLRs might play a role in its 
interaction with DCs. Although both MR and DC-SIGN have been shown to mediate binding 
and uptake of fucosylated antigens by DCs (29) and omega-1 harbors fucose-containing Lex-
glycan moieties, we observed that omega-1 significantly bound only to a MR-, but not to a 
DC-SIGN-expressing cell-line and that internalization by DCs was mainly MR-dependent and 
did not involve DC-SIGN. Lack of strong binding and uptake of omega-1 by DC-SIGN might 
be explained by the fact that in most DC-SIGN binding studies polyvalent Lex-containing 
beads or conjugates have been used, which may be bound by DC-SIGN with a higher affinity 
than soluble glycoproteins, such as omega-1, that would present Lex at a low valency (22). 
In line with this observation, DC-SIGN blocking experiments suggest that interaction with 
DC-SIGN does not play a major role in omega-1-driven Th2 polarization via DCs. On the 
other hand, the importance of MR in recognition and uptake of omega-1 was substantiated 
by the finding that conditioning of both human and murine DCs for Th2 polarization by 
omega-1 were significantly impaired when MR was blocked or when the DCs were deficient 
for MR, respectively. Furthermore, we confirmed and extended the importance of MR in Th2 
polarization by omega-1 in vivo by showing that an antigen-specific Th2 response induced 
in MR-/- mice following footpad injection of omega-1 was strongly reduced compared to the 
response elicited in WT mice. In this respect it is important to note that human and murine MR 
have a similar carbohydrate binding specificity (30). Thus, this establishes that omega-1 relies 
on MR to drive Th2 polarization. Apart from schistosome egg-derived antigens, it was recently 
shown that MR can also recognize glycosylated antigens derived from schistosome larvae in 
the skin (31), and that MR-/- mice display a Th1-biased antigen-specific T cell response in the 
skin-draining LNs following infection with cercaria. This study along with our data, indicate 
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Figure 6. MR mediates omega-1-induced DC modulation and Th2 polarization in vitro. Following 
1 h pre-incubation with blocking antibodies against MR, DC-SIGN or an isotype control (20 μg/ml), 
human moDCs were pulsed for 16 h (A) or 48 h (B-D) with natural omega-1 (500 ng/ml) in combination 
with LPS (100 ng/ml). (A) Protein synthesis was assessed as described in Fig. 5 B. One representative 
experiment based on duplicate samples out of 3 experiments is shown. Data are shown as mean ± SD. 
(B) The expression levels of CD86 on human DCs assessed by FACS are based on geometric mean 
fluorescence, relative to the DCs stimulated with LPS alone, which is set to 1 (dashed line). Data are 
based on 3 independent experiments and shown as mean ± SD. (C) Conditioned human DCs were co-
cultured for 24 h with a CD40-L expressing cell line, to mimic the interaction with T cells. IL-12p70 cytokine 
that MR may play a role in shaping of Th2-polarized immune responses during different stages 
of schistosome infection. 
In vitro studies with DCs have shown has that MR-crosslinking with antibodies (32) or by 
mannosylated antigens (33;34) can drive an anti-inflammatory cytokine program in DCs away 
from a Th1-promoting profile (32) and that allergen-driven Th2 polarization by DCs is in part 
dependent on MR (35;36). These studies suggest that engagement of MR may be sufficient to 
promote Th2 polarization, potentially via signaling events. However, our data demonstrate 
that MR binding alone is not sufficient for Th2 induction by omega-1, since glycans present on 
omega-1, in absence of RNase activity, fail to program DCs to induce Th2 responses. This is in 
line with the observation that IPSE/alpha-1, another major glycoprotein secreted by S. mansoni 
eggs with identical glycosylation as omega-1 (27), which can bind the cell line expressing MR 
(unpublished data) but lacks RNase activity, is unable to prime Th2 responses (15).
Apart from its glycosylation, omega-1 requires its RNase activity to induce a Th2 response 
via modulation of human DCs. It was observed that omega-1 in an RNase-dependent manner 
impaired protein synthesis and that DCs exposed to omega-1 displayed a progressive 
reduction in mRNA content of several unrelated genes as well as in rRNA levels. The drop in 
mRNA transcripts from both housekeeping genes (TAF1 and GAPDH), inducible genes (IL12B), 
as well as rRNA (28S and 18S), suggests that omega-1 does not degrade specific transcripts, 
but targets the global RNA pool in DCs. While it currently remains to be determined what the 
relative contribution of each of these processes and their relative timing is to the impairment 
of protein synthesis, it is most likely that the observed inhibition in protein synthesis is a 
combined effect of degradation of mRNA transcripts and interference with ribosomal integrity 
due to rRNA cleavage. These data support the view that as a consequence of RNA breakdown, 
reduced protein synthesis is the mode of action through which the RNase activity enables 
omega-1 to condition DCs for priming of Th2 responses. Some RNases have been linked to 
Th2 polarization before. The major birch pollen allergen, Bet v 1 (37), was identified as an 
RNase. Furthermore, some fungal RNases that appear to selectively cleave rRNA, such as 
mitogillin and Asp f 1, are known to be allergens (38). Interestingly, for Aspf-1 it was found that 
its allergenicity was lost when its capacity to interfere with ribosomal function was abolished 
(39). In addition, a report has linked an endogenous RNase, the eosinophil-derived neurotoxin, 
to DC-mediated Th2 polarization (40). Although these studies have not specifically addressed 
the role of RNase activity in direct priming of Th2 responses, they do highlight the possibility 
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expression levels are shown relative to the DCs stimulated with LPS alone, which is set to 1 (dashed 
line). Data are based on 3 independent experiments and shown as mean ± SD. (D) Conditioned human 
moDCs were cultured with allogeneic naive CD4+ T cells for 12 days in the presence of staphylococcal 
enterotoxin B and IL-2, and T cell polarization was analyzed as described in figure 1. FACS plots of one 
representative experiment out of 6 is shown. Bar graphs are based on 6 independent experiments and 
represent mean ± SD. (E) Murine splenic WT or MR-/- DCs from a C57BL/6 background were co-cultured 
with naive Balb/c CD4+ T cells in the presence 2 µg/ml omega-1. After an expansion with rIL-2 at d 3, 
T cells were restimulated on d 6 with PMA and ionomycin and analyzed for intracellular cytokines. 
1 representative experiment out of 3 is shown. *,# P < 0.05, **,## P <0.01, *** P <0.001 for significant 
differences with the LPS control (*) or between test conditions (#) based on paired analysis (two-sided 
paired t-test). ω-1, omega-1.
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that Th2 priming through interference with ribosomal function may not be a unique feature 
of S. mansoni-derived omega-1, but may be shared by other RNases as well. In this respect, it is 
interesting to note that RNase T2 homologs can be identified in the genomes of S. japonicum 
and S. haematobium, as well as of the nematodes Brugia malayi, Loa loa and Ascaris suum (41-43). 
However, it is currently unknown whether these parasites actually express these T2 RNases and 
if they do, whether they play any role in Th2 polarization in their host. Taken together, our data 
suggest that for an RNase to harbor a Th2-priming capacity, it needs to be recognized by DCs 
and routed to reach the cytosol where in turn its enzymatic activity would result in suppression 
of protein synthesis, yet without shutting down DC function altogether or inducing cell death 
before T cell priming has occurred. 
It remains to be established how omega-1 would be able to reach the ribosomes present 
in the cytosol. Some ribosome-inactivating proteins have been shown to translocate from the 
ER into the cytosol after retrograde transport or by direct escape from endosomes into the 
cytosol (44). In this respect, since omega-1 is internalized via MR, it is interesting to note that 
cross-presentation of OVA by DCs, a process that requires translocation of the antigen from 
endosomes into the cytosol, has been shown to be dependent on MR (45;46). Mechanistically, it 
was demonstrated that binding of the MR to OVA leads to poly-ubiquitination of MR, resulting 
in the recruitment of the ATPase p97, a member of the ER-associated degradation machinery, 
towards the endosomal membrane. p97 in turn was found to provide the energy to pull out the 
MR ligand into the cytoplasm (47). This suggests that the MR itself can regulate the transport 
of its ligand, into the cytoplasm and provides a mechanism through which omega-1 could be 
translocated into the cytosol of DCs. 
The suppression of protein synthesis in DCs by omega-1, would be in line with the 
documented inhibitory effects of omega-1 as well as SEA on DC activation and TLR-induced 
expression of co-stimulatory molecules and cytokines (15;16). In addition, this mode of action 
would also provide an explanation for the finding that omega-1 alters DC morphology as a 
result of cytoskeletal changes (16), since halting of translation and concomitant stress responses 
can affect actin rearrangements and thereby cell morphology (48). Importantly, during 
interactions with naïve T cells, omega-1-conditioned DCs will, in contrast to unconditioned 
DCs, be largely refractory to respond to CD40 ligation by T cells, as their protein synthesis 
machinery is impaired. As a consequence, T cells are primed in the absence of IL-12 and in 
the context of low antigen presentation, a situation that is known to favor the induction of 
Th2 responses (49;50). This mechanism would be different from a ‘default hypothesis’ for Th2 
induction (51-53) as it represents a dominant and active suppression of signals during DC-T 
cell interactions. Such a model of active suppression of DC signals for Th2 polarization would 
be in line with recent data showing that SEA-pulsed DCs, although still capable of processing 
antigen to present it on MHC-II, are impaired in their upregulation of surface MHC-II and CD86 
or expression of IL-12 in response to CD40 ligation (15;54), as well as with the observation that 
omega-1-primed DCs have a reduced capacity to form T cell-DC conjugates (16). 
Taken together, based on our data we propose a model in which the glycans present on 
omega-1 do not play a dominant role in functional modulation of DC function for induction 
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of Th2 responses, but instead are essential for efficient recognition and internalization by 
DCs via the MR. Subsequently, following translocation into the cytosol, omega-1 programs 
DCs to drive Th2 polarization in an RNase-dependent manner by interfering with ribosomal 
function and protein synthesis. These studies have uncovered a novel mechanism through 
which DCs can be programmed to drive Th2 responses. It will be of great interest to study 
whether targeting of MR and the protein synthesis machinery to condition DCs for priming 
Th2 responses is unique to schistosome-driven Th2 polarization, or a mechanism that is 
also involved in the initiation of other Th2-polarized immune responses, found during other 
helminth infections or allergies. In addition, the insight may help the design of Th2-polarizing 
molecules, that could be used in the development of vaccines against parasitic worm 
infections or approaches to counterbalance unwanted Th1 responses in hyper-inflammatory 
diseases (55;56).
Figure 7. MR is essential for omega-1-driven Th2 polarization in vivo. MR-/- and WT Bl/6 mice were 
injected s.c. with omega-1 (2 μg in 30 μl PBS) or PBS into the footpad. (A) After 7 days the cells from 
the draining lymph node (LNs) were restimulated in vitro for 4 days with PBS, omega-1 (2 μg/ml) or 
PHA (10 μg/ml), as polyclonal stimulus, after which cytokine production was determined by EL ISA. (B) 
Intracellular cytokine production of the CD3+/CD4+ T cells from these LNs was assayed by FACS after an 
additional 6 h restimulation with PMA and ionomycin. FACS plots show concatenated data from 4 mice 
are shown. The bar graphs represent the percentage of T cells single-positive for either IL-4 or IFN-γ. One 
of 2 independent experiments is shown. Data are means ± s.e.m. of 4 mice per group based on pooled 
triplicate wells for each mouse. * P < 0.05, ** P <0.01 for significant differences based on paired analysis 




Preparation and purification of S. mansoni egg-derived antigens 
SEA, omega-1 and IPSE/alpha-1 were prepared and isolated as described previously (15;57). 
The purity of the preparations was controlled by SDS-PAGE and silverstaining. Protein 
concentrations were tested using the Bradford or BCA procedure. (58;59)
Generation and production of WT, glycosylation mutant and RNase mutant forms 
of recombinant omega-1
Site-directed mutagenesis was used to generate a glycosylation and RNase mutant by mutating 
the two putative N-linked glycosylation sites (N71/176Q) or by targeting a conserved amino-
acid residue (H58F) that is known to be critical for enzymatic activity in homologous T2 RNases 
(17;19), respectively. H58F and N71/176Q mutants were created by polymerase chain reaction 
(PCR) using mutagenic primers on a DH5α/pProExHtb plasmid (Invitrogen) containing the 
WT omega-1 sequence (Acc.No. ABB73003.1). Successful mutation was confirmed by DNA 
sequencing. Subsequently, using restriction enzymes Sfi I and ApaI the templates for WT and 
mutant omega-1 were subcloned into a pSecTag2 plasmid (Invitrogen) for stable transfection 
into HEK cells (15). Secreted recombinant omega-1 forms were sequentially purified from the 
HEK cell culture medium by immobilized metal affinity chromatography and size exclusion 
chromatography as described previously (15). 
Human DC culture, stimulation and analysis 
Monocytes were isolated from venous blood from healthy volunteers according to protocols 
approved by the Institutional Review Board of Leiden University Medical Center by density 
centrifugation on ficoll followed by CD14+ MACS isolation (Miltenyi) or a Percoll gradient 
as described (60) and were cultured in RPMI medium supplemented with 10% FCS, human 
rGM-CSF (50 ng/ml, Invitrogen) and human rIL-4 (25 units/ml) (R&D Systems). On day 3, culture 
medium including the supplements was replaced and on day 6 immature DCs were stimulated 
with the indicated reagents in the presence of ultrapure LPS (100 ng/ml) (E. coli 0111 B4 strain, 
InvivoGen). For CLR blocking indicated cells were pre-incubated with 20 μg/ml anti-DC-SIGN 
(clone AZN-D1, Beckman Coulter) or 20μg/ml anti-MR (clone 15.2, Biolegend) for 60 min at 
37 °C. As a Th1 control DCs were also pulsed with IFN-γ (1000 U/ml). After 48 h, DCs were 
harvested for co-culture with naïve T cells. In addition, 1x104 matured DCs were co-cultured 
with 1x104 CD40L-expressing J558 cells for 24 h to determine cytokine production by the 
DCs following activation by CD40L. IL-12p70 concentrations were determined by ELISA using 
mouse anti-human IL-12, clone 20C2 as capture antibody and biotinylated mouse-anti-human 
IL-12, clone C8.6 as detection antibody (both BD) Concentrations of IL-10, TNF-α, MIP-1β and 
RANTES were determined by a multiplex LUMINEX assay according to the manufacturer’s 
instruction (InvivoGen). The expression of CD86 on pulsed DCs was determined by FACS 
(FACSCanto) through staining with CD86-FITC (BD).
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Murine T cell polarization assay 
Splenic CD11c+MHCII+ DCs and CD62L+ CD4+ T cells were isolated by sorting from naive 
splenocytes derived from C57BL/6 and Balb/c mice, respectively. 2.5 × 105 CD4+ T cells were 
co-cultured with 1.25 × 105 splenic DCs and stimulated with 2 μg/ml omega-1. At d 3, T cells 
were expanded with 30 u/ml rIL-2 (R&D systems) and at d 6 restimulated with 50 ng/ml phorbol 
12-myristate 13-acetate plus 2 μg/ml ionomycin for 5 h. 10 μg/ml brefeldin A was added during 
the last 2 h (all Sigma). The cells were stained with a combination of IL-4-PE and IFN-γ-APC 
antibodies (BD). 
Human T cell culture and determination of T cell polarization 
To determine T cell polarization, 5 x 103 48 h-pulsed DCs were co-cultured with 2 x 104 naïve 
T cells that were purified using a human CD4+/CD45RO- column kit (R&D) in the presence of 
staphylococcal enterotoxin B (10 pg/ml; Sigma) in 96-well flat-bottom plates (Corning). On day 
5, rhuIL-2 (10 U/ml, R&D) was added and the cultures were expanded for another 7 days. For 
intracellular cytokine production, the primed CD4+ T cells were restimulated with 50 ng/ml 
phorbol 12-myristate 13-acetate plus 2 μg/ml ionomycin for 6 h. 10 μg/ml brefeldin A was 
added during the last 2 h (all Sigma). The cells were stained with a combination of IL-4-PE and 
IFN-γ-FITC antibodies (BD). 
DC-SIGN- and MR-expressing cell line 
K562 cell line stably expressing DC-SIGN (a gift from K. Figdor, Radboud University Nijmegen 
Medical Centre, Nijmegen, Netherlands; (61)) or 3T3 cell line stably expressing human MR (a gift 
from J.L. Miller, University of Oxford, Oxford, England, UK and G. Brown, University of Aberdeen, 
Aberdeen, Scotland, UK; (62)) and their respective parental control cell lines were seeded 
overnight in a 96-well plate at 10.000 cells/well. Where indicated, cells were pre-incubated 
with 10mM EGTA for 30 min at 37 °C. Subsequently, cells were incubated with 2 μg/ml PF-647-
labeled SEA or 500 ng/ml PF-647-labeled omega-1 at 37 °C for 1 h and washed in ice cold PBS 
before analysis using flowcytometry.
Protein synthesis inhibition 
Immature DCs were seeded overnight in 96-well flat bottom plates before stimulation 
with indicated reagents in the presence of LPS. At indicated time points after stimulation 
protein synthesis was determined by a 2 h pulse at 37 °C with 3µCi /0,05 ml [35S]-methionine 
(EasyTag Express Protein labeling mix, Perkin Elmer) in serum-, cysteine and L-methionine 
free RPMI-1640. After a double washing step in PBS, cells were lysed for 5 min in AV-lysis 
buffer (20mM Tris HCl, pH7.6, 150 mM NaCl, 0.5% DOC, 1.0% NP40, 0.1% SDS) in the presence 
of protease inhibitors Leupeptin and Aprotinin 200ug/ml. Lysates were transferred on a 
filter (Perkin Elmer) and dried. After radioactive labeled proteins were precipitated on the 
filter with trichloroacetic acid, filters were washed with 96% ethanol and dried. Using a 
liquid scintillation cocktail for aqueous solution the radioactivity present on the filters was 
measured in a β-counter.
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RNase activity assay 
RNA was extracted from PBMC using the RNeasy kit (Qiagen). RNA was incubated for 1 h at 37 ̊ C 
with indicated antigens in 0.01M Tris 0.02% Cu. Subsequently, RNA breakdown was visualized 
by running the samples on a 2% agarose gel containing ethidium bromide.
Ribosomal RNA breakdown 
Rabbit Reticulocyte Lysate (Promega) was incubated with antigens as described by others (28). 
Briefly, following 1 h incubation at 37 °C in Tris-HCl (15 mM NaCl, 50 mM KCl, 2,5 mM EDTA), the 
reaction was stopped with 10% SDS and RNA was extracted from the ribosomes with phenol/
chloropform. Next, isolated ribosomal RNA was denatured at 95°C and visualized by running 
the samples on a 2% agarose gel containing ethidium bromide.
Analysis of ribosomal RNA integrity in human DCs 
mRNA was isolated from DCs conditioned by omega-1 for indicated time points using RNeasy 
mini Kit (Qiagen) according to the manufacturers recommendations. Integrity of rRNA was 
visualized using Agilent RNA 6000 Pico Kit in a 2100 Bioanalyzer (Agilent) according to the 
manufacturers recommendations.   
RNA and DNA isolation, DNase treatment and cDNA synthesis 
Total DNA and RNA was simultaneously extracted using Qiagen DNeasy blood and tissue kit 
as per manufacturer’s instruction, except for that no RNase reaction was performed. DNase 
treatment was done using RQ1 RNase-Free DNase (Promega) as per manufacturer’s instruction. 
cDNA synthesis was performed following standard procedures.
Analysis of gene expression levels 
Primers and Taqman probes were provided as a Taqman gene expression kit (Applied 
Biosystems) or designed using Primer Express (Applied Biosystems) and synthesized by 
Biolegio. Primers for DNA PCR for CCR5 was a generous gift from E. Boon (Leiden University 
Medical Centre, Leiden, Netherlands (63)). Real time qPCR was performed using ABI PRISM 
7700 Sequence Detection System (SDS, Applied Biosystems). mRNA expression levels 
were normalized based on DNA input as determined by CCR5 PCR. Data were visualized as 
heatmaps using Tableau software (http://www.tableausoftware.com)
Antigen uptake by human DCs 
SEA and omega-1 were fluorescently labeled with PF-647 using the Promofluor labeling kit 
(Promokine) and according to the manufacturers recommendations. 10.000 immature DCs/
well were seeded in a 96 well plate. Where indicated cells were pre-incubated with 10mM 
EGTA, 100 μg/ml Mannan (Sigma-Aldrich), 20μg/ml anti-DC-SIGN (clone AZN-D1, Beckman 
Coulter) or 20 μg/ml anti-MR (clone 15.2, Biolegend) for 60 min at 37 °C. Subsequently, cells 
were incubated with 2 μg/ml PF-647-labeled SEA or 500 ng/ml PF-647-labeled omega-1 at 
37 °C for 1 h and washed in ice cold PBS before analysis using flowcytometry.
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Confocal microscopy 
For live cell imaging, purified HEK-omega-1 was fluorescently labeled with N-hydroxysuccinimide 
(NHS)-fluorescein (Thermo-Scientific) according to the manufacturer’s instructions. After 
protein labeling, nonreacted NHS-fluorescein was removed using Zeba desalt spin columns 
(Thermo-Scientific). Live cell imaging was performed with a TCS Sp5 inverse confocal laser 
scanning microscope (Leica) and analyzed with LAS AF software. In detail, 2.5 x 104 DCs were 
added to a channel of an IV0.4 µ-slide (Ibidi) and incubated for 2 h at 37°C and 6% CO2 with 10 µl 
fluorescein-labeled HEK-omega-1 (0.3 mg/ml). Nuclei of the cells were then counterstained with 
Hoechst 33342 (1:10,000) for 30 min. For confocal microscopy of fixed DCs, cells were allowed to 
adhere to Poly-D-Lysine coated cover slips overnight at a concentration of 80-100.000 cells/2 ml 
in 10% FCS/RPMI. DCs were incubated with omega-1 for 2 h at 37 °C (1 μg/ml). Incubated cells 
were washed three times in 1% BSA/RPMI, fixed for 15 minutes with 4% paraformaldehyde 
(Sigma) in PBS, and washed twice in PBS. Next, cells were permeabilized with 0.1% Triton-X 
in PBS for 1 minute, washed twice in PBS and blocked for 15 minutes with 1% BSA/PBS. Cells 
were subsequently incubated with antibodies against rRNA (Abcam), followed by a secondary 
incubation step with a GαM-AF546 antibody (Invitrogen) in 1% BSA/PBS. Cells were washed in 
PBS and cover slips were mounted on glass slides with Vectashield and analyzed by confocal 
microscopy. Leica AOBS SP2 confocal laser scanning microscope (CLSM) system was used, 
containing a DM-IRE2 microscope with glycerol objective lens (PL APO 63x/NA1.30) and images 
were acquired using Leica confocal software (version 2.61).
Cytoplasmic omega-1 Western blot 
Cytoplasmic extracts of omega-1-incubated DCs were prepared using Nuclear Extraction Kit 
(Active Motif) as per manufacturer’s instructions. Cytoplasmic extracts were concentrated 
10-fold and subjected to 12% SDS-PAGE followed by silver staining or blotting onto 
nitrocellulose membrane. For silver staining 30 µg/cm were applied, for Western blotting 
100 µg/cm. Omega-1 was then detected by the monoclonal anti-omega-1 antibody 140-3E11 
and an alkaline phosphatase-labeled goat anti-mouse IgG (1:10,000) detection antibody 
(Dianova). Visualization was done by the substrate/chromogen mixture of 0.033% (w/v) nitro 
blue tetrazolium and 0.017% (w/v) 5-bromo-4-chloro-indolyl phosphate (Serva) in 0.1 M Tris-
buffered saline, pH 9.5. 
In vivo experiments
4get/KN2 (64) mice were bred and housed in the animal facility of the Trudeau Institute 
and used at 8-12 weeks of age. MR-/- mice on a C57BL/6 background were provided by 
Dr. M. C. Nussenzweig (Rockefeller University, New York, NY) and were bred and housed in 
the animal facility of the Institutes of Molecular Medicine and Experimental Immunology at 
the University Hospital, Bonn. All experimental procedures were approved by the Institutional 
Animal Care and Use Committee of the Trudeau Institute, and Molecular Medicine and 
Experimental Immunology at the University Hospital of Bonn and by the Animal Studies 
Committee of Washington University School of Medicine. Mice were immunized s.c. into one 
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hind footpad with SEA (20 µg), omega-1 (3 µg), in a volume of 50 µl and the draining popliteal 
lymph nodes were analyzed one week later. 
In vitro restimulation of lymph node cells 
1.5 × 106 popliteal LN cells/ml from individual animals were restimulated with 10 μg/ml SEA or 
2 μg/ml omega-1. IL-5, IL-4 and IFN-γ were measured by ELISA in day 4 supernatants according 
to the manufacturer’s recommendations (R&D). Following removal of the supernatants, cells 
were restimulated with 50 ng/ml phorbol 12-myristate 13-acetate plus 2 μg/ml ionomycin for 
6 h. 10 μg/ml brefeldin A was added during the last 2 h (all Sigma). The cells were stained with 
a combination of IL-4-PE and IFN-γ-FITC antibodies (BD).
Statistical analysis 
Data were analyzed for statistical significance using a two-sided paired Student’s t-test or 
where indicated a two-sided unpaired Student’s t-test. All p-values < 0.05 were considered 
significant. 
Online supplemental material 
Online supplemental material can be found at: http://jem.rupress.org/content/209/ 
10/1753/suppl/DC1. Fig S1 shows a movie of z-stacked images of live DCs internalizing omega-1.
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abstract
Recent reports have attributed an immunoregulatory role to the mammalian target of 
rapamycin (mTOR), a key serine/threonine protein kinase integrating input from growth factors 
and nutrients to promote cell growth and differentiation. In the present study, we investigated 
the role of the mTOR pathway in Th2 induction by human monocyte-derived dendritic cells 
(moDCs). Using a co-culture system of human lipopolysaccharide (LPS)-matured moDCs and 
allogeneic naive CD4+ T cells, we show that inhibition of mTOR by the immunosuppressive 
drug rapamycin reduced moDC maturation and promoted Th2 skewing. Next, we investigated 
whether antigens from helminth parasites, the strongest natural inducers of Th2 responses, 
modulate moDCs via the mTOR pathway. In contrast to rapamycin, neither Schistosoma 
mansoni-soluble egg antigens (SEA) nor its major immunomodulatory component omega-1 
affected the phosphorylation of S6 kinase (S6K) and 4E-binding protein 1 (4E-BP1), downstream 
targets of mTORC1. Finally, we found that the effects of rapamycin and SEA/omega-1 on 
Th2 skewing were additive, suggesting two distinct underlying molecular mechanisms. We 
conclude that conditioning human moDCs to skew immune responses towards Th2 can be 




mTOR-independenT Th2 skewing by Omega-1
introduction
The interface of immunology and metabolism is an emerging field that focuses on the relation 
between cell-intrinsic metabolic processes and the responses of immune cells (1;2). The area 
has received increasing attention, as it is now recognized that the behavior of the cells of 
the immune system is at least partially controlled by various metabolic pathways (2). Among 
them, the mammalian target of rapamycin (mTOR) pathway was recently shown to have an 
important role in dendritic cell (DC)-mediated T helper cell differentiation (3;4). mTOR is a 
serine/threonine protein kinase constituting the catalytic subunit of two functionally distinct 
multiprotein complexes, designated mTORC1 and mTORC2. mTORC1 integrates input from 
growth factors and nutrient sensors, upon which it interacts with its downstream targets S6 
kinase (S6K) and eukaryotic initiation factor 4E-binding protein  1 (4E-BP1) to promote or inhibit 
cell growth. mTORC2 mediates cytoskeletal organization, predominantly via interaction with 
protein kinase C family members and serum/glucocorticoid-regulated kinase 1 (5). The two 
complexes differ, among others, in that mTORC1 is highly sensitive to acute inhibition by the 
immunosuppressive drug rapamycin, while mTORC2 is not (6;7).
The role of the mTOR pathway in DC-mediated T-cell differentiation has mainly been 
studied in murine models. A decade ago, an early report showed that silencing of PI3K, which 
is located upstream of mTOR, increases DC IL-12 production and promotes protective Th1 
responses against Leishmania major infection (8). More recent studies have demonstrated that 
differentiation of murine bone marrow-derived DCs with granulocyte-macrophage colony-
stimulating factor (GM-CSF) and IL-4 in the presence of rapamycin generates DCs with low levels 
of co-stimulatory molecules (9;10) which are weak stimulators of CD4+ T cells and promote the 
expansion of regulatory T cells (10). In addition, upon exposure to lipopolysaccharide (LPS), 
rapamycin-treated bone marrow-derived DCs were shown to promote IL-4 secretion by T cells 
while decreasing IL-17 and IL-2 production (11), hinting towards a link between mTOR inhibition 
and Th2 induction. 
In the present study, we therefore investigated the role of the mTOR pathway on Th2 
polarization by human monocyte-derived DCs (moDCs). For this purpose, we compare the 
effects of rapamycin to those of Schistosoma mansoni-soluble egg antigens (SEA), the strongest 
natural inducer of Th2 responses (12), and omega-1, a single molecule recently identified to be 
the major SEA component involved in Th2 skewing (13-15).
results
In order to investigate the effect of mTOR inhibition on Th2 polarization by human DCs, we 
used a co-culture system of human LPS-matured moDCs and allogeneic naive CD4+ T cells, 
a well-characterized model reflecting the in vivo polarization of immune responses against 
pathogens and pathogen-derived compounds (13;16). Blocking the mTOR pathway in moDCs 
using rapamycin prior to Toll-like receptor-4 ligation reduced the LPS-driven upregulation 
of the maturation markers CD40, CD80 and CD86 (Figure 1a, Supplementary Figure S1). In 
addition, like SEA and omega-1, rapamycin modulated  moDCs to instruct T cells towards a 
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Th2 response characterized by increased expression of IL-4 and decreased interferon (IFN)-γ 
production (Figures 1b and c, Supplementary Figure S2). Interestingly, in contrast to SEA and 
omega-1, rapamycin skewed Th2 responses without affecting the pro-inflammatory cytokine 
IL-12 (Figure 1d). Of note, Torin1, a second-generation highly selective inhibitor of both mTORC1 
and mTORC2 (17), also induced skewing towards Th2 when added to moDCs (Figures 1b and c, 
a b 






















































































































































Figure 1. Rapamycin lowers DC maturation and primes for Th2 responses without affecting DC IL-12 
production. (a) moDCs were either pulsed with SEA or omega-1 in the presence of LPS, or incubated 
for 90 min with rapamycin or its vehicle dimethyl  sulfoxide (DMSO) prior to LPS stimulation. After 48 
h, expression of maturation markers was analyzed by flow cytometry. The expression levels, based on 
the geometric mean fluorescence of at least nine independent experiments, are shown relative to the 
moDCs stimulated with LPS or LPS + DMSO alone, which were set to 1 for each marker (dashed line).  (b) 
moDCs were either pulsed with SEA or omega-1 in combination with LPS, or incubated for 90 min with 
rapamycin, Torin1 or their vehicle DMSO prior to LPS stimulation. After 48 h of stimulation, moDCs were 
cultured with allogeneic naive CD4+ T cells for 11 days. Intracellular IL-4 and IFN-γ were analyzed by 
flow cytometry after a 6-h stimulation with phorbol myristate acetate and ionomycin. IFN-γ-stimulated 
moDCs were taken along as a Th1-inducing control. The percentages of T cells uniquely positive for 
either IL-4 or IFN-γ are expressed relative to the LPS condition. Data represent at least four independent 
experiments. (c) Representative FACS plots from one out of the four independent experiments are shown 
for conditions described for Figure 1b. (d) Following stimulation as described for Figure 1a, conditioned 
moDCs were co-cultured with a CD40L-expressing cell line. Supernatants were collected after 24 h and 
IL-12p70 concentrations were determined by ELISA. IFN-γ-stimulated moDCs were taken along as an IL-12 
inducing control. Bars represent mean values + s.e.m.; *P<0.05; **P<0.01; ***, ###P<0.001 for significant 
differences with the control (*; either LPS or LPS + DMSO) or between test conditions (#), based on 
one-sided Wilcoxon-signed rank testing. ω-1, omega-1; Rapa, rapamycin.
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Supplementary Figure S2). However, Torin1 was a less potent Th2-inducer than rapamycin, 
even though blocking of mTORC1 by Torin1 and rapamycin was equally effective (data not 
shown). This difference in potency may reflect the complex and distinct molecular mechanisms 
by which the two drugs operate (18), which for rapamycin has even been described to differ 
between cell types (7).
As both helminth antigens and rapamycin reduce CD86 on moDCs and prime for Th2 
skewing, we hypothesized the existence of a common underlying mechanism involving 
inhibition of mTOR activity. We therefore addressed the question whether SEA and omega-1, 
like rapamycin, inhibit the mTOR pathway and thereby modulate moDCs for Th2 polarization. 
To this end, moDCs were stimulated with LPS in the presence of helminth antigens or rapamycin 
for 6 and 48 h, and the phosphorylation states of mTOR and the mTORC1 downstream targets 
S6K and 4E-BP1 were determined.  Although rapamycin strongly inhibited LPS-induced 
mTORC1 activity at 6 and 48 h, as shown by reduced phosphorylation of both S6K and 4E-BP1, 
no such effects were observed with either SEA or omega-1 (Figures 2a and b). A similar trend 
was observed when phosphorylation of mTOR was analyzed (Figure 2a). Interestingly, co-
stimulation with rapamycin and SEA or omega-1 promoted a stronger Th2 response than 
stimulation with rapamycin, SEA or omega-1 alone (Figures 2c and d, Supplementary Figure S3), 
suggesting the existence of both mTOR-dependent and -independent mechanisms for 
Th2 skewing.
discussion
Recent studies have indicated that signaling pathways involved in the regulation of metabolism 
can control immune-cell fate and functions (2). Although much is known about the control of 
Th1 and Th17 differentiation, the mechanisms by which  DCs skew Th2 remain largely unknown 
to date (19). In this study, we analyzed the role of the mTOR pathway in the induction of Th2 
responses by human moDCs. To our knowledge, the present study is the first one reporting 
that inhibition of the mTOR pathway using the immunosuppressive drug rapamycin primes 
human moDCs to induce strong Th2 responses characterized by increased IL-4 and decreased 
IFN-γ production. This finding apparently differs from the one reported by Turnquist et al. (11), 
showing that rapamycin-conditioned human  moDCs promote the expansion of both IL-4 and 
IFN-γ-producing T cells. However, it is important to note that in the study by Turnquist et al. 
(11), moDCs were differentiated using IL-4 and GM-CSF in the presence of rapamycin. It has 
been described that GM-CSF activates the mTOR pathway, and differentiation of moDCs in the 
presence of rapamcyin hampers the survival and the immunostimulatory capacity of moDCs 
(20). In contrast, in our model, moDCs were exposed to rapamycin after differentiation. Our 
findings are therefore complementary to the study by Turnquist et al. (11), and highlight that 
the effect of rapamycin on moDC-mediated T-cell polarization critically depends on the timing 
and the duration of exposure to rapamycin.
In addition to the effect of rapamycin on T-cell skewing, we found that exposure to the 
drug reduces moDC maturation. These effects are similar to those induced by the helminth 
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antigens, SEA and omega-1, which suppress DC maturation and are the strongest natural 
inducers of Th2 responses (12;13;15). Importantly, we demonstrate that SEA and omega-1, unlike 
rapamycin, do not affect the phosphorylation of mTOR and the mTORC1 downstream targets 
S6K and 4E-BP1. The finding that rapamycin and helminth antigens affect moDCs in a distinct 
manner is further supported by the differential effect of rapamycin and SEA or omega-1 on 
moDC IL-12 production. 
Although both SEA and omega-1 reduce IL-12 levels, as reported previously (13), rapamycin 
does not. Secretion of IL-12 by antigen-presenting cells has classically been associated with 
Th1 differentiation (21), and the mere absence of IL-12 and other Th1-inducing molecules was 
suggested to promote a Th2 response (22). As rapamycin, unlike SEA and omega-1, does not 














































































Figure 2. Unlike rapamycin, SEA and omega-1 do not affect the mTOR pathway to condition DCs for 
Th2 priming. MoDCs were stimulated as described in the legend of Figure 1. (a,b) moDC lysates were 
collected after 6 and 48 h of stimulation. Proteins were visualized by western blotting using antibodies 
against S6K and S6K phosphorylation at Thr421, and mTOR and mTOR phosphorylation at Ser2448. 
Western blot results were quantified using ImageJ software. The pS6K-on-S6K and pmTOR-on-mTOR 
ratios were calculated relative to the LPS condition. Representative blots from one out of five (6 h) 
or four (48 h) independent experiments are shown. (b) moDC lysates were collected after 6 and 48 h 
of stimulation. 4E-BP1 phosphorylation at Thr37/46 was assessed by western blotting. (c,d) moDCs 
stimulated for 48 h were cultured with allogeneic naive CD4+ T cells for 11 days and T-cell cytokine 
production was analyzed as described in the legend of Figure 1. Data represent at least five independent 
experiments. Bars represent mean values + s.e.m.; *,#P<0.05 for significant differences with the control 
(*; either LPS or LPS + DMSO) or between test conditions (#) based on one-sided Wilcoxon-signed rank 
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explain the dominant Th2 response induced by rapamycin. Our   results  suggest  the   existence 
of  mTOR-dependent   and -independent   mechanisms   for   Th2   skewing,  which   is  further 
supported  by  experiments  that  show  an  additive  effect on  Th2 priming by moDCs co-
stimulated with both rapamycin and helminth antigens. Needless to say, we do not exclude 
the possibility that rapamycin and helminth antigens target other common downstream 
pathways. Whether rapamycin may have similar effects on T-cell polarization by different DC 
subsets, remains an intriguing area of research, as it has been demonstrated that rapamycin 
differentially affects moDCs and myeloid DCs (20).
In summary, our observations suggest that conditioning human DCs to skew immune 
responses towards Th2 can be achieved by an mTOR-dependent and an mTOR-independent 
mechanism by rapamycin and helminth antigens, respectively. These findings are important 
when considering the increasing interest in DC-based immune  therapy for cancer (23), 
transplantation  and autoimmunity (24). This   requires   in-depth   understanding   of   the 
different   modes and mechanisms, whereby DCs can be accurately modulated for clinical use.
methods
Preparation and purification of S. mansoni-derived antigens
SEA and omega-1 from S. mansoni were prepared as described previously (25;26). The purity of 
the preparations was controlled by SDS-PAGE and silver staining. The protein concentrations 
were determined using the Bradford or BCA procedure. 
Human DC culture, stimulation and analysis
Peripheral blood mononuclear cells were isolated from venous blood of healthy volunteers 
diluted in an equivalent volume of HBSS, by means of a Ficoll density gradient. Monocytes 
were isolated by positive magnetic cell sorting using CD14-beads (Miltenyi Biotec, Bergisch 
Gladbach, Germany)   and cultured in RPMI supplemented with 10% FCS, human rGM-CSF 
(20 ng/ml;    BioSource/Invitrogen, Carlsbad, CA, USA) and human rIL-4 (0.86 ng/mL, R&D 
Systems, Minneapolis, MN, USA). The culture medium including supplements was replaced 
on day 2 or 3. Immature moDCs were stimulated on day 6. Indicated conditions were 
preincubated with rapamycin (100 nM; Sigma-Aldrich, Zwijndrecht, The  Netherlands)  or 
Torin1 (100 nM; a kind gift from Dr. Thomas Weichhart) or their vehicle  dimethyl  sulfoxide 
for 90min prior to stimulation with ultrapure LPS (100 ng/mL;  Escherichia coli 0111 B4 strain, 
InvivoGen, San Diego, CA, USA) supplemented with human rGM-CSF. Alternatively, moDCs 
were pulsed with SEA (50 μg/mL), omega-1 (500 ng/mL) or IFN-γ (1000 U/mL) in the presence 
of ultrapure LPS (100 ng/mL) and human rGM-CSF. After 48 h of stimulation, surface expression 
of co-stimulatory molecules was determined by FACS (FACS- Canto,  BD  Biosciences, Breda, 
The  Netherlands) using the following antibodies: CD86 FITC, CD40 APC, CD80 Horizon V450 
(all BD Biosciences), HLA-DR APC-eFluor 780 (eBioscience, San Diego, CA, USA) and CD83 
PE (Beckman-Coulter, Fullerton, CA, USA). Only live cells, which were negative for 7AAD 
(eBioscience), were included in the analysis. In addition, 1x104 matured moDCs were co-
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cultured with 1x104 CD40L-expressing J558 cells. Supernatants were collected after 24 h and 
IL-12p70 concentrations were determined by ELISA using mouse anti-human IL-12 (clone 20C2) 
as a capture antibody and biotinylated mouse-anti-human IL-12 (clone C8.6) as a detection 
antibody (BD Biosciences).
Human T-cell culture and analysis of T-cell polarization
For analysis of T-cell polarization, 48-h-pulsed moDCs were cultured with allogeneic naive 
CD4+ T cells for 11 days in the presence of staphylococcal enterotoxin B (10 pg/mL). On days 6 
and 8, rhuIL-2 (10 U/mL, R&D Systems) was added and the T cells were expanded until day 11. 
Intracellular cytokine production was analyzed after restimulation with 100 ng/mL phorbol 
myristate acetate plus 2 μg/mL ionomycin for 6 h; 10 μg/ml brefeldin A was added during 
the last 4 h and the cells were fixed with 3.7% paraformaldehyde (all Sigma-Aldrich). The cells 
were permeabilized with 0.2% saponin (Sigma-Aldrich) and stained with PE- and FITC-labelled 
antibodies against IL-4 and IFN-γ, respectively, (BD Biosciences).
Western blot analysis
moDC lysates were collected after 6 and 48 h of stimulation. Western blotting was performed 
as described previously,(27) the primary antibodies used were: mTOR; mTOR-Ser2448; S6K-
Thr421; p4E-BP1-Thr37/46 (Cell Signaling Technology, Danvers, MA, USA) and S6K (Santa Cruz 
Biotechnology, Dallas, TX, USA). Western blot results were quantified using ImageJ software 
(NIH, Bethesda, MD, USA) and the phosphorylations of S6K (pS6K) and mTOR (pmTOR) were 
expressed relative to their total proteins as the pS6K-on-S6K ratio and the pmTOR-on-mTOR 
ratio, respectively.
Statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.00 (GraphPad Software, La 
Jolla, CA, USA) for Windows.
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suPPlemental data
Figure S1. Rapamycin lowers LPS-induced DC maturation. moDCs were either pulsed with SEA or 
omega-1 in the presence of LPS, or incubated for 90 minutes with rapamycin or its vehicle DMSO prior 
to LPS stimulation. After 48 hours, expression of maturation markers was analyzed by flow cytometry. 
Representative histograms from 1 out of 9 independent experiments are shown. Filled histograms 
represent control conditions (either LPS or LPS + DMSO).
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Figure S2. Rapamycin primes DCs for Th2 responses. moDCs were either pulsed with SEA or omega-1 
in combination with LPS, or incubated for 90 minutes with rapamycin, Torin1 or their vehicle DMSO 
prior to LPS stimulation. After 48 hours of stimulation, moDCs were cultured with allogeneic naive CD4+ 
T cells for 11 days. Intracellular IL-4 and IFN-γ were analyzed by flow cytometry after 6h stimulation with 
PMA and ionomycin. IFN-γ-stimulated moDCs were taken along as a Th1-inducing control. The ratio of 
T cells uniquely positive for either IL-4 or IFN-γ was calculated. Data represent at least 4 independent 
experiments. Bars represent mean values + s.e.m; **P <0.01; ***, ### P<0.001 for significant differences 
with the LPS control (*) or between test conditions (#) based on one-sided Wilcoxon signed rank testing. 
ω-1, omega-1; Rapa, rapamycin.
Figure S3. Co-stimulation with rapamycin and SEA or omega-1 primes a stronger Th2 response than 
stimulation with rapamycin, SEA or omega-1 alone. moDCs were either pulsed with SEA or omega-1 
in combination with LPS, and / or incubated for 90 minutes with rapamycin, or its vehicle DMSO prior to 
stimulation. T cell responses were analysed as described for Supplementary figure 2. Bars represent mean 
values + s.e.m.; *,# P <0.05; for significant differences with the LPS control (*) or between test conditions 
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abstract
Dendritic cells (DC) are the sentinels of the immune system. Upon recognition of a pathogen, 
they undergo maturation and migrate to the lymph node to polarize T helper (Th) subsets. 
Although it is known that helminths and helminth-derived molecules condition dendritic cells 
to polarize T cells towards Th2, the underlying mechanism remains unknown. We chose to 
conduct a proteome analysis of the dendritic cells, in order to gain more insight into the cellular 
processes associated with their ability to polarize cellular immune responses. We analyzed 
DC maturation and polarization in nine different donors and at three different time points, 
using liquid chromatography and high-resolution Fourier transform ion cyclotron resonance 
mass spectrometry (LC-FTICRMS) for relative quantitation. We report that lipopolysaccharide-
induced maturation had the strongest effect on the DC proteome, and promoted expression 
of proteins related to metabolic, cellular and immune system processes or transport. 
LPS-DCs additionally stimulated with IFN-γ, a Th1-inducing stimulus, differentially expressed 
cytoskeletal proteins and proteins involved in immune regulation, after 6h of stimulation, 
suggesting that they undergo accelerated maturation. Stimulation of LPS-DCs with omega-1 
and SEA strongly increased 60S acidic ribosomal protein P2 (RPLP2). In addition, both SEA and 
omega-1 decreased expression of proteins related to antigen processing and presentation. In 
conclusion, our data support the hypothesis that reduced interaction between T cells and DCs 
at the level of the immunological synapse may promote Th2 polarization, and provide novel 
leads for the identification of molecular mechanisms for Th2 polarization. 
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introduction 
Dendritic cells (DCs) (1) are professional antigen-presenting cells located in peripheral tissues, 
that continuously sample the environment to capture antigens from invading microbes. 
Upon recognition of pathogens-associated molecules, DCs undergo maturation and migrate 
to the draining lymph nodes where they present antigen to antigen-specific T helper (Th) 
cells. Different classes of pathogens polarize DCs for the induction of different types of Th cell 
responses. In general, rapidly replicating intracellular microorganisms such viruses and certain 
bacteria activate Th1 cells. The principal regulators of anti-helminth immunity are Th2 cells, 
and fungi and extracellular bacteria give Th17 responses (2-4). 
While much is known about the regulation of Th1 and Th17 responses, the mechanisms that 
control Th2 activation are still not fully understood (5). Although helminths are strong inducers 
of Th2 responses, it proved difficult to pinpoint the specific mechanisms involved due to the 
complex nature of many helminth-derived antigen preparations. For example, Schistosoma 
mansoni soluble egg antigen (SEA), among the most widely used preparations for studying 
immune responses to helminth antigens, contains more than 600 different proteins (6). The 
identification of omega-1 as the major immunomodulatory component in SEA therefore 
provided an opportunity to further dissect the molecular mechanisms underlying Th2 skewing 
(7;8). We have previously shown that omega-1 is a glycosylated T2 RNase that conditions DCs 
for Th2 induction by suppressing protein synthesis (9). However, it remains unclear which 
mechanisms subsequently enable Th2 skewing. 
Maturation of DCs is largely controlled at the posttranscriptional and posttranslational 
level (10;11). Therefore, as a representative indicator of cell function and phenotype, various 
groups have studied the proteome of pro-Th2 DCs. Using semi-quantitative gel-based 
techniques, three cytoplasmic proteins were found to be exclusive to the Th2-inducing 
proteome of human monocyte-derived DCs (12). In mouse bone marrow-derived DCs (BMDCs), 
four proteins were significantly affected by stimulation with helminth antigens (13). A third 
study on pro-Th2 BMDCs used iTRAQ labeling for relative quantitation of plasma membrane 
proteins, and showed that pro-Th2 BMDCs upregulated proteins related to cell metabolism 
and downregulated proteins associated with the cytoskeleton (14). Although these studies 
provide valuable directions for future research, the use of 2-DE and iTRAQ does not allow for 
high-throughput analysis and direct comparison of a large number of biological replicates. This 
is especially relevant when donor-to-donor variation is expected, for example when working 
with DCs from human donors, and may explain why only very few proteins were found in 
common between different gel-based studies on lipopolysaccharide (LPS)-matured human 
DCs (15-18). 
As such, the introduction of a high-resolution label-free and gel-free method for 
quantitative analysis of DC proteomes would be highly beneficial. In this study, we analyzed 
DC maturation and polarization using liquid chromatography Fourier transform ion cyclotron 
resonance mass spectrometry (LC-FTICRMS) for accurate mass measurement and relative 
quantitation (19;20). This method allowed us to include a total of nine DC donors and four 
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different stimuli. We included an early (6h) and a late (32h) time point in addition to baseline 
(0h), to reflect maturation stages associated with migration and antigen presentation. Using 
SEA, a complex antigen preparation, and omega-1, a single molecule for Th2 polarization, we 
focus on the identification of proteins associated with the pro-Th2 DC proteome.
results 
Functional characterization of human DCs
Immature DCs (iDCs) generated from nine donors were matured with LPS, in the presence or 
absence of IFN-γ as a Th1-inducing stimulus, and SEA or omega-1 as Th2-inducing conditions. 
To functionally characterize these DCs, a co-culture system of human LPS-matured DCs and 
allogeneic naïve CD4+ T cells was used. DCs expressed high levels of CD1a and no CD14, as 
expected (Fig. 1A), and strongly upregulated CD86 expression upon LPS stimulation (Fig. 1B). 
Additional stimulation with IFN-γ did not affect LPS-induced CD86 expression but strongly 
induced IL-12p70 production (Fig. 1C), while SEA and ω-1 decreased expression of both CD86 
and IL-12p70, as described previously (9). Analysis of T cell cytokine production confirmed that 
omega-1 and SEA induced a Th2 response, characterized by a high frequency of IL-4-producing 
T cells (Fig. 1D), while stimulation of DCs with IFN-γ promoted a Th1 response (Fig. 1E). 
Protein Identifications
To establish the effect of maturation and polarization on the DC proteome, iDCs and LPS-



































































Figure 1. Functional characterization of pro-Th1 and pro-Th2 DCs. Monocyte-derived DCs were 
either left untreated or pulsed with LPS in the presence or absence of IFN-γ, SEA, or omega-1. After 
48h, expression of surface markers was analyzed by flow cytometry. (A) Representative histograms for 
expression of CD1a and CD14 are shown. Filled histograms represent unstained controls. (B) Expression 
levels of CD86, based on the geometric mean fluorescence, are shown relative to LPS, which was set to 1. 
(C) Following stimulation, moDCs were co-cultured with a CD40L-expressing cell line. Supernatants were 
collected after 24 h and IL-12p70 concentrations were determined by ELISA. (D) 48h-matured DCs were 
cultured with allogeneic naive CD4+ T cells for 11 days. Intracellular cytokine production as analyzed by 
flow cytometry after 6h of stimulation with phorbol myristate acetate and ionomycin. The percentages 
of T cells uniquely positive for either IL-4 or (E) IFN-γ are shown. Bars represent mean values + s.e.m.; 
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donors at three different time points: before stimulation (0h), six hours after stimulation 
(6h) and 32 hours after stimulation (32h). Proteins were digested after which peptides were 
identified using LC-MS/MS in an ion trap, resulting in the identification of 1159 unique 
peptides from 439 unique proteins with a false-discovery rate (FDR) of 1.0%. These were 
used for matching with and querying the LC-FTICRMS data for label-free quantitation (19;20). 
In total, 208 proteins were quantified with multiple peptides in each biological replicate and 
at each time point. 
Effects of maturation on the human DC proteome
To identify proteins that were differentially expressed due to stimulation, the stimulus-induced 
fold change in abundance was determined for each protein, by calculating the mean fold 
change of the nine donors. Corresponding p-values were obtained from a paired Student’s 
t-test after log-transformation. Proteins were considered differentially expressed when P<0.05 
and the stimulus-induced fold change was more than 1.5-fold decreased or increased (i.e. fold 
change <0.67 or >1.5). LPS-induced maturation displayed a pronounced effect on the DC 
proteome. Compared to iDCs, LPS promoted differential expression of ten proteins after 6h 
(Table 1). Analysis of protein classification according to Gene Ontology terms indicated that 
the eight upregulated proteins are mostly involved in transport or cell communication. The 
two downregulated proteins were both cytoskeletal proteins. After 32 hours, LPS promoted 
differential expression of 22 proteins (Table 1). The majority of proteins was upregulated and 
related to different metabolic, cellular and immune system processes or transport. The protein 
most strongly upregulated by LPS stimulation was TNF receptor-associated factor 1 (TRAF1), 
an adapter molecule that regulates activation of NF-ĸB and JNK. In addition, actin cross-linking 
proteins Fascin and Myristoylated alanine-rich C-kinase substrate (MARCS) were profoundly 
induced, as well as the MHC class I molecule HLA-B, involved in antigen presentation. Among 
the four downregulated proteins, Macrophage mannose receptor 1 is involved in antigen 
uptake, cathepsins play a role in antigen processing, and Ganglioside GM2 activator (GM2A) 
mediates presentation of lipids (21-23). 
Effects of polarizing stimuli on the human DC proteome
LPS-matured DCs additionally stimulated with IFN-γ, a Th1-inducing stimulus, differentially 
expressed ten proteins after 6h of stimulation compared to stimulation with LPS alone 
(Table 2). Five proteins were downregulated, of which three were members of the cytoskeleton. 
The proteins most strongly upregulated were Heat Shock Protein HSP 90-alpha (HSP90AA1), 
which mediates inflammatory responses, and cytoplasmic tryptophan--tRNA ligase (WARS), 
also known as Interferon-induced protein 53. After 32h, four proteins were downregulated 
(Table 2), including a tyrosine-protein kinase involved in regulation of immune responses 
(FGR), and Peptidyl-prolyl cis-trans isomerase A (PPIA), also known as Cyclophilin A, which plays 
an important role in protein folding, trafficking, and immune cell activation (24).
Following 6h of stimulation with Th2-inducing SEA, five proteins were upregulated 
compared to stimulation with LPS alone (Table 2). Interestingly, in contrast to 32h of 
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Table 1. Differentially expressed proteins in LPS-DCs versus iDCs.
Accession Protein
6 hours 32 hours
Fold P-val Fold P-val
LPS-induced, 6 hours
P45880 Voltage-dependent anion-selective channel protein 2 2.74 0.04 1.81 0.57
P30040 Endoplasmic reticulum resident protein 29 2.59 0.00 1.67 0.64
Q13077 TNF receptor-associated factor 1 2.25 0.01 14.95 0.00
P61604 10 kDa heat shock protein. mitochondrial 2.23 0.03 1.68 0.76
P05362 Intercellular adhesion molecule 1 1.89 0.00 3.60 0.01
P30464* HLA class I histocompatibility antigen, B-15 alpha chain 1.83 0.02 7.89 0.00
P29966 Myristoylated alanine-rich C-kinase substrate 1.77 0.02 10.76 0.00
Q9BQE5 Apolipoprotein L2 1.64 0.05 2.95 0.00
Q71U36 Tubulin alpha-1A chain 0.63 0.03 1.58 0.82
P06396 Gelsolin 0.62 0.00 1.96 0.48
LPS-induced, 32 hours
Q13077 TNF receptor-associated factor 1 2.25 0.01 14.95 0.00
P29966 Myristoylated alanine-rich C-kinase substrate 1.77 0.02 10.76 0.00
P30464* HLA class I histocompatibility antigen, B-15 alpha chain 1.83 0.02 7.89 0.00
Q16658 Fascin 1.26 0.61 5.48 0.00
P04179 Superoxide dismutase [Mn], mitochondrial 1.20 0.68 4.66 0.00
P23381 Tryptophan--tRNA ligase, cytoplasmic 0.98 0.55 3.77 0.00
Q9UL46 Proteasome activator complex subunit 2 0.92 0.25 3.68 0.00
P05362 Intercellular adhesion molecule 1 1.89 0.00 3.60 0.01
P80723 Brain acid soluble protein 1 1.21 0.54 3.46 0.00
P27348 14-3-3 protein theta 0.96 0.40 3.00 0.00
Q9BQE5 Apolipoprotein L2 1.64 0.05 2.95 0.00
P19971 Thymidine phosphorylase 1.00 0.76 2.79 0.04
Q14974 Importin subunit beta-1 0.98 0.38 2.39 0.02
P02786 Transferrin receptor protein 1 1.14 0.77 2.20 0.00
P08107 Heat shock 70 kDa protein 1A/1B 1.19 0.41 1.93 0.02
P20700 Lamin-B1 1.34 0.40 1.85 0.04
P34931 Heat shock 70 kDa protein 1-like 1.16 0.52 1.55 0.04
Q9BZQ8 Protein Niban 1.14 0.32 1.54 0.01
P07339 Cathepsin D 1.68 0.76 0.63 0.03
P22897 Macrophage mannose receptor 1 0.98 0.36 0.63 0.02
P17900 Ganglioside GM2 activator 1.40 0.19 0.58 0.02
Q9UBR2 Cathepsin Z 1.30 0.01 0.56 0.00
*HLA serotypes originate from the same gene and share common peptides. The serotype attributed to the 
identification may therefore not be accurate.
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stimulation with IFN-γ, SEA induced strong upregulation of PPIA. SEA also increased 
expression of Eukaryotic initiation factor 4A-I, involved in translation initiation, Endoplasmin 
(HSP90B1), HSP90AA1, and Fascin. After 32h, SEA promoted differential expression of six 
proteins (Table 2). Among those, four proteins were downregulated, including WARS which 
was induced by IFN-γ, and HLA-B and CD44 which are involved in antigen presentation and 
T cell activation (25). The protein most strongly upregulated by 32h of SEA stimulation was 
60S acidic ribosomal protein P2 (RPLP2), which plays an important role in the elongation step 
of protein synthesis. 
Omega-1 induced upregulation of five proteins after 6h, and seven proteins after 32 hours 
(Table 2), most of which were ribosomal proteins, chaperones or enzymes. Among those, 
several proteins were highly upregulated, including mitochondrial Thioredoxin-dependent 
peroxide reductase (6h), a protein involved in redox regulation of the cell, RPLP2 (32h), 
and the chaperone Calnexin (32h). After 32h of omega-1 stimulation, seven proteins were 
downregulated. In particular, omega-1 strongly decreased expression of HLA-B, HLA-C and 
CD44, as well as MARCS. 
Analysis of proteins exclusive to the Th2-inducing proteome
The identification of proteins uniquely associated with the Th2-inducing DC proteome could 
provide valuable leads for understanding initiation of Th2 responses by DCs. We therefore 
analyzed proteins affected by stimulation with SEA as well as omega-1, by looking at protein 
expression dynamics and individual donor responses. As can be appreciated from Table 2, 
omega-1 and SEA did not share differentially expressed proteins after 6h of stimulation. 
After 32h, however, they shared five differentially expressed proteins. Among those five, 
Transferrin receptor protein 1 is seemingly downregulated by omega-1 and SEA, but also by 
IFN-γ (P=0.051), suggesting that this may not be a Th2-exclusive protein. 
Analysis of protein expression dynamics of the four remaining Th2-associated proteins 
showed that RPLP2 was strongly upregulated by 32h of stimulation with SEA and omega-1 in 
at least eight out of nine donors (Fig. 2A). Synaptic vesicle membrane protein VAT-1 homolog 
(VAT1) was upregulated by SEA and omega-1 in at least seven donors after 32h of stimulation 
(Fig. 2B), but was also mildly increased by IFN-γ stimulation in the majority of donors. CD44 
was significantly downregulated by SEA in seven donors, and by omega-1 nine donors (Fig. 2C). 
Lastly, LPS-induced upregulation of HLA-B was inhibited by SEA and omega-1 in eight donors 
(Fig. 2D). These findings suggest that in particular upregulation of RPLP2, and downregulation 
of CD44 and HLA-B, are characteristics of pro-Th2 DCs. 
Further exploration of the data by association analysis
To explore whether there are specific networks and functional classifications significantly 
affected by Th2-inducing stimuli, we analyzed our data using GeneMANIA software. For 
hypothesis-generating purposes, less stringent thresholds were applied. First, all proteins 
significantly affected by stimulation (i.e. fold change P<0.05); and second, those proteins with 
P<0.1 and a fold change of <0.67 or >1.5, were included. For a complete list of all accessions (with 
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Table 2. Differentially expressed proteins in pro-Th1 and pro-Th2 DCs versus LPS-DCs. (Continued)
Accession Protein
IFN-γ SEA Omega-1
Fold P-val Fold P-val Fold P-val
IFN-y-induced, 6 hours
P07900 Heat shock protein HSP 90-alpha 2.42 0.02 2.98 0.02 2.42 0.14
P23381 Tryptophan--tRNA ligase, cytoplasmic 2.13 0.04 1.20 0.43 1.07 0.61
P13639 Elongation factor 2 1.82 0.01 1.64 0.12 1.34 0.33
P30508* HLA class I histocompatibility antigen, Cw-12 alpha chain 1.78 0.03 1.61 0.41 1.29 0.97
P09467 Fructose-1.6-bisphosphatase 1 1.69 0.02 1.54 0.07 1.53 0.25
P26038 Moesin 0.66 0.04 0.86 0.16 1.12 0.58
P67936 Tropomyosin alpha-4 chain 0.66 0.02 0.90 0.18 1.08 0.36
P02545 Prelamin-A/C 0.64 0.00 0.95 0.21 1.09 0.73
P16070 CD44 antigen 0.63 0.01 1.01 0.40 0.89 0.21
P10599 Thioredoxin 0.52 0.02 2.31 0.33 1.10 0.07
IFN-y-induced, 32 hours
P40926 Malate dehydrogenase. mitochondrial 0.59 0.00 0.99 0.29 0.97 0.38
P62937 Peptidyl-prolyl cis-trans isomerase A 0.58 0.02 2.38 0.44 3.71 0.59
P04908 Histone H2A type 1-B/E 0.55 0.00 1.07 0.15 1.31 0.20
P09769 Tyrosine-protein kinase Fgr 0.65 0.03 0.68 0.01 0.95 0.40
SEA-induced, 6 hours
P62937 Peptidyl-prolyl cis-trans isomerase A 4.02 0.45 11.27 0.01 1.62 0.54
Q9BZQ8** Protein Niban 1.10 0.85 9.78 0.00 1.03 0.89
P14625 Endoplasmin 1.47 0.58 4.14 0.04 2.31 0.88
P60842 Eukaryotic initiation factor 4A-I 1.83 0.32 3.21 0.04 1.17 0.47
P07900 Heat shock protein HSP 90-alpha 2.42 0.02 2.98 0.02 2.42 0.14
Q16658 Fascin 1.15 0.92 1.74 0.04 1.40 0.32
SEA-induced, 32 hours
P05387 60S acidic ribosomal protein P2 1.68 0.17 2.27 0.01 4.63 0.01
Q9BZQ8** Protein Niban 1.19 0.20 2.20 0.01 1.20 0.73
Q99536 Synaptic vesicle membrane protein VAT-1 homolog 1.29 0.20 1.59 0.03 1.53 0.02
P16070 CD44 antigen 1.47 0.81 0.63 0.02 0.47 0.00
P23381 Tryptophan--tRNA ligase, cytoplasmic 1.45 0.34 0.60 0.00 0.92 0.19
P02786 Transferrin receptor protein 1 0.75 0.05 0.56 0.00 0.49 0.00
P30464* HLA class I histocompatibility antigen, B-15 alpha chain 1.27 0.79 0.45 0.00 0.40 0.00
Omega-1-induced, 6 hours
P30048 Thioredoxin-dependent peroxide reductase, 
mitochondrial
7.06 0.14 2.56 0.64 4.03 0.04
P05388 60S acidic ribosomal protein P0 1.47 0.06 1.31 0.64 1.86 0.02
P30041 Peroxiredoxin-6 1.33 0.63 1.44 0.33 1.77 0.02
Q01813 6-phosphofructokinase type C 1.39 0.02 1.13 0.43 1.65 0.01
P61158 Actin-related protein 3 1.47 0.50 2.11 0.67 1.61 0.04
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corresponding gene names) included for GeneMANIA analysis, see Table S1. In addition to the 
genes of the differentially expressed proteins, we allowed for display of ten associated genes.
After 6h of stimulation, SEA promoted differential expression of proteins in a network 
enriched for mitochondrial matrix proteins (FDR = 0.055) and MHC class II protein complex 
binding (FDR = 0.002) (Fig. S1). The two SEA-responsive proteins involved in MHC class II 
protein complex binding were the MHC class II molecule HLA-DRA and Heat Shock Protein 
HSP90AA1, which were increased by SEA treatment (Table S1). By contrast, after 32h of 
treatment, SEA decreased expression of HLA-DRB1, another MHC class II molecule, in line 
with previous studies on long-term SEA treatment of DCs (26). GeneMANIA analysis indicated 
that 32h of SEA treatment affected proteins in a network enriched for antigen processing and 
presentation (FDR = 0.001) (Fig. S2). Examination of the three SEA-responsive proteins within 
this functional classification indicated that all three proteins (HLA-B, HLA-DRB1 and CD74) 
were downregulated.
Stimulation with omega-1 induced differential expression of proteins in a network enriched 
for phagocytosis (FDR = 0.000, proteins were both up- and downregulated) and glycolysis (FDR 
= 0.039) (Fig. S3). Related to glycolysis, omega-1 increased expression of 6-phosphofructokinase 
Table 2. Differentially expressed proteins in pro-Th1 and pro-Th2 DCs versus LPS-DCs. (Continued)
Accession Protein
IFN-γ SEA Omega-1
Fold P-val Fold P-val Fold P-val
Omega-1-induced, 32 hours
P05387 60S acidic ribosomal protein P2 1.68 0.17 2.27 0.01 4.63 0.01
P27824 Calnexin 1.32 0.93 1.76 0.51 2.64 0.05
P55084 Trifunctional enzyme subunit beta, mitochondrial 1.72 0.14 1.48 0.13 2.52 0.05
P63104 14-3-3 protein zeta/delta 1.60 0.55 1.51 0.18 2.33 0.04
P50502 Hsc70-interacting protein 1.29 0.48 1.45 0.06 2.05 0.02
P30041 Peroxiredoxin-6 0.94 0.32 1.46 0.32 2.02 0.02
Q99536 Synaptic vesicle membrane protein VAT-1 homolog 1.29 0.20 1.59 0.03 1.53 0.02
P17900 Ganglioside GM2 activator 1.04 0.20 1.26 0.68 0.65 0.03
P30508 HLA class I histocompatibility antigen, Cw-12 alpha chain 1.02 0.29 1.01 0.05 0.63 0.01
P29966 Myristoylated alanine-rich C-kinase substrate 1.19 0.78 0.73 0.06 0.58 0.01
P04179 Superoxide dismutase [Mn]. mitochondrial 1.30 0.85 1.24 0.37 0.52 0.01
P02786 Transferrin receptor protein 1 0.75 0.05 0.56 0.00 0.49 0.00
P16070 CD44 antigen 1.47 0.81 0.63 0.02 0.47 0.00
P30504* HLA class I histocompatibility antigen, Cw-4 alpha chain 0.72 0.10 1.88 0.21 0.47 0.02
P30464* HLA class I histocompatibility antigen, B-15 alpha chain 1.27 0.79 0.45 0.00 0.40 0.00
*HLA serotypes originate from the same gene and share common peptides. The serotype attributed to the 
identification may therefore not be accurate.**The signal attributed to the VLTSEDEYNLLSDR peptide in NIBAN is likely 
coming from the 13C1-peak of the YCLQLYDETYER peptide from the SEA-derived protein Interleukin-4-inducing protein 






















Figure 2. Protein expression dynamics of Th2-associated differentially expressed proteins. Monocyte-
derived DCs were stimulated as described in the legend of figure 1. Protein expression was analyzed by 
LC-FTICRMS. Differentially expressed proteins shared between 32h of stimulation of with omega-1 and SEA 
are shown. The top panel of each figure shows the protein expression dynamics, the bottom panel shows 
the normalized intensity relative to LPS, which was set to 1 at 6h and at 32h (dashed line). (A) 60S acidic 
ribosomal protein P2. (B) Synaptic vesicle membrane protein VAT-1 homolog. (C) CD44 antigen. (D) HLA-B. 
72
4
  Proteome-wide analysis of matured and Polarized human dCs
type C (PFKP), which catalyzes the third step of glycolysis, while expression of Glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) that catalyzes the sixth step was decreased (Table S1). Like 
SEA, 32h of omega-1 treatment affected proteins in a network enriched for antigen processing 
and presentation (FDR = 0.000; Fig. 3). Out of the four omega-1-responsive proteins within this 
functional classification, three were downregulated (HLA-B, HLA-C and Cathepsin D). In addition, 
32h of omega-1 stimulation affected proteins in a network significantly enriched for translational 
elongation (FDR = 0.001). Within this functional classification, RPLP2 and Elongation factor 1-delta 
(EEF1D) were upregulated, while Ubiquitin-60S ribosomal protein L40 (UBA52) was downregulated.
Figure 3. Network analysis of 32h omega-1-response proteins. Monocyte-derived DCs were stimulated 
as described for the legend of figure 1, and protein expression was analyzed by LC-FTICRMS. For 
GeneMANIA analysis, all 32h omega-1-responsive proteins with P<0.05, and those proteins with P<0.1 
and a fold change of <0.67 or >1.5, were included. Black and/or striped nodes represent genes of which 
the proteins were differentially expressed (query genes); grey nodes represent associated genes added 




Over the past decade, studies on the proteome of matured or polarized DCs relied on label- and 
gel-based techniques. Such approaches do not allow for high-throughput analysis of many 
different conditions or biological replicates, which might explain why only few proteins were 
found in common between different reports (15-18;27). Here, we used ion traps for tandem 
mass spectrometry and LC-FTICRMS for label- and gel-free quantitation (19), which had 
previously been used for the analysis of the plasma proteome (20). This approach allowed us 
to analyze the proteomes of LPS-matured and pro-Th1 versus pro-Th2 DCs from nine different 
human donors. 
As expected, LPS-induced maturation displayed the most pronounced effect on the 
DC proteome. After 6h of maturation, proteins involved in intracellular transport and cell 
communication were upregulated, and cytoskeletal proteins were either up- or downregulated. 
These processes may reflect that the DCs are preparing for migration, which requires profound 
alterations in cell morphology and motility (28). The strongest effect on the DC proteome 
was observed after 32h of LPS-induced maturation, when many proteins were upregulated 
at least 3-fold. Among the proteins most strongly induced was mitochondrial Superoxide 
dismutase (SODM). Indeed, DCs are known to upregulate reactive oxygen species in response 
to stimulation with LPS (29;30), and subsequent upregulation of superoxide dismutases has 
also been reported (31). In addition, stimulation with LPS induced Fascin, an actin cross-linking 
that plays a critical role in migration of mature DCs into lymph nodes. Specifically, actin 
bundling by Fascin was shown to promote membrane protrusions and mediates disassembly 
of podosomes, which are specialized structures for cell-matrix adhesion (32). A second actin 
cross-linking protein, MARCS, was also profoundly induced, in line with a previous report (33). 
The other two proteins most strongly affected by LPS stimulation were MHC class I molecule 
HLA-B, involved in antigen presentation, and TRAF1, an adapter molecule that regulates 
activation of NF-ĸB and JNK. Indeed, NF-ĸB activation was previously shown to be required 
for DC maturation (34). The proteins downregulated after 32h of LPS stimulation were involved 
in antigen uptake, processing and presentation of lipids. Together, these findings reflect that 
after 32h of stimulation, LPS-DCs have become specialized for entering lymph nodes and 
presenting antigen to naïve T cells, which identifies the FTICR-ion trap cluster as an appropriate 
method to for high-throughput quantitative analysis of dendritic cell lysates. 
Importantly, we find many differentially expressed proteins in common with a proteomics 
study by Ferreira et al. (35), which further validates our method. In our and their study, maturation 
reduces expression of cathepsins and GM2A, and increases expression of Apolipoprotein L2, 
Fascin, Proteasome activator complex subunit 2, and SODM. Furthermore, in line with another 
report (11), we observe an increase in Heath shock protein (Hsp) expression. Unique to our 
study, the FTICR method allowed us to perform statistical analysis on protein expression data 
from nine biological replicates. In addition, multiple time points were included, which provides 
information about protein expression dynamics. Our study therefore strengthens and expands 
previous reports on maturation of human DCs. 
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Using the cytokine IFN-γ, we polarized LPS-DCs for Th1 skewing, and observed that pro-Th1 
DCs differentially expressed cytoskeletal proteins and proteins involved in inflammatory 
processes after 6h of stimulation, compared to LPS-DCs. Among those proteins, HSP90AA1 
and WARS were most strongly upregulated. Indeed, under inflammatory conditions, heat 
shock proteins (HSPs) can act as chaperones to facilitate antigen presentation and enhance 
the immune response (36). In line with our results, Ferreira et al. also described upregulation of 
WARS in DCs following LPS + IFN-γ treatment (35). It has been demonstrated that transcription 
of WARS is responsive to IFN-γ treatment in in non-lymphoid cell lines (37), and tryptophan 
catabolism was shown to promote DC-mediated T cell tolerance (38), but role of WARS in DC-
mediated T cell activation remains to be determined. After 32h of IFN-γ stimulation, the effect 
on the DC proteome was less pronounced, as only 4 proteins were downregulated, including 
FGR and PPIA involved in immune regulation and activation. These findings may suggest 
that IFN-γ treatment induces strong effects early after treatment, reminiscent of accelerated 
maturation. 
Interestingly, in contrast to 32h of treatment with IFN-γ, short-term (6h) stimulation of DCs 
with Th2-inducing SEA induced strong expression of PPIA, also known as Cyclophilin A, which 
is the primary  binding protein of Cyclosporin A, an immunosuppressive drug that antagonizes 
calcium-dependent T cell activation (39). How the the expression of Cyclophilin A affects the 
polarizing capacity of DCs remains to be investigated.  
Since only few proteins were differentially expressed by 6h SEA or omega-1 treatment, we 
also performed association analysis using GeneMANIA, applying less stringent thresholds for 
hypothesis generation. SEA induced differential expression of proteins in a network enriched 
for mitochondrial matrix proteins, and omega-1 affected proteins in a network enriched for 
glycolysis. Although the differentially expressed proteins within those functional classifications 
were both up- and down-regulated, these findings may suggest that 6h after stimulation, 
SEA and omega-1 may affect cellular metabolism. In line with these findings, recent studies 
have indicated that modulation of metabolic pathways within dendritic cells can regulate DC 
function and the outcome of the immune response (40;41). Whether omega-1 and SEA indeed 
modulate cellular metabolism, and whether this contributes to Th2 polarization, requires 
further studies.
The most profound effect of Th2-inducing stimuli was observed after 32h of stimulation, 
when SEA and omega-1 both strongly increased expression of ribosomal protein RPLP2. Since 
the presence of ribosomal P proteins may enhance ribosomal performance (42), we speculate 
that the increase in RPLP2 may represent a feedback mechanism secondary to SEA- and omega-
1-induced ribosome degradation. In addition, SEA and omega-1 decreased expression of CD44 
and suppressed LPS-induced upregulation of HLA-B. Interestingly, CD44 expression by DCs 
was shown to promote CD4 T cell proliferation (25). Together, these findings may suggest 
that Th2-inducing conditions interfere with efficient antigen presentation to T cells. Indeed, 
GeneMANIA analysis indicated that SEA and omega-1 both decreased expression of proteins 
in a protein network enriched for antigen processing and presentation. It has been suggested 
that T cells are polarized towards Th2 if the interaction between DCs and T cells is weak (43-45). 
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In addition, it was demonstrated that omega-1 reduces the capacity of bone marrow-derived 
DCs to form T cell-DC conjugates (8). Taken together, these studies suggest that reduced 
interaction between T cells and DCs at the level of the immunological synapse may promote 
Th2 polarization by helminth antigens. 
In conclusion, our work has identified the FTICR-ion trap cluster as an appropriate method 
for quantitative high-throughput analysis of cell lysates. Our data on DC polarization suggest 
that pro-Th1 DCs undergo accelerated maturation compared to LPS-DCs, and indicate that 
pro-Th2 DCs may affect cellular metabolism and decrease expression of proteins involved in 
antigen processing and presentation. Future research should therefore focus on studying the 
contribution of metabolic pathways, TCR signaling, and the possible relation between the two, 
to further dissect the mechanisms of helminth-induced T helper 2 polarization via dendritic 
cells. Such investigations will not only improve our fundamental understanding of DC biology, 
but may also provide leads for the development of DC-based immunotherapies. 
methods
Human DC culture, stimulation, and analysis
Monocytes isolated from venous blood of 9 healthy volunteers were differentiated as described 
previously (46). On day 6 the immature DCs (iDCs) were stimulated with SEA (50 mg/mL), omega-1 
(250 ng/mL) or IFN-γ (1000 U/mL) in the presence of 100ng/mL ultrapure LPS (E. coli 0111 B4 strain, 
InvivoGen) and human rGM-CSF (20 ng/ml;    Life Technologies). At the indicated time points, 
samples were collected for protein extraction and digestion as described below. Alternatively, 
after 48 hours of stimulation, expression of surface molecules was determined by flow cytometry 
(FACSCanto, BD Biosciences) using the following antibodies: CD14 PerCP, CD86 FITC (both BD 
Biosciences), and CD1a PE (Beckman-Coulter). In addition, 1x104 48h-matured DCs were co-
cultured with 1x104 CD40L-expressing J558 cells. Supernatants were collected after 24h and 
IL-12p70 concentrations were determined by ELISA using mouse anti-human IL-12 (clone 20C2) as 
a capture antibody and biotinylated mouse anti-human IL-12 (clone C8.6) as a detection antibody 
(BD Biosciences). Volunteers signed informed consent forms and the samples were handled 
according to the guidelines described by the Dutch Federation of Medical Scientific Societies in 
the Code of Conduct for the responsible use of human tissue for medical research (47). 
Human T cell culture and analysis of T cell polarization
For analysis of T cell polarization, 5x103 matured DCs were cultured with 2x104 allogeneic naïve 
CD4+ T cells that were isolated from buffy coat (Sanquin) peripheral blood mononuclear cells 
using a CD4+/45RO- Naive T Cell Enrichment Column (R&D Systems). Co-cultures were performed 
in the presence of staphylococcal enterotoxin B (10 pg/mL). On days 6 and 8, rhuIL-2 (10 U/mL, 
R&D Systems) was added and the T cells were expanded until day 11. Intracellular cytokine 
production was analyzed after restimulation with 100 ng/mL phorbol myristate acetate plus 
1 µg/mL ionomycin for 6h; 10 µg/mL brefeldin A was added during the last 4h and the cells 
were fixed with 3.7% paraformaldehyde (all Sigma-Aldrich). The cells were permeabilized with 
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0.5% saponin (Sigma-Aldrich) and stained with PE- and FITC-labelled antibodies against IL-4 
and IFN-γ, respectively (BD Biosciences).
Protein extraction and in-solution digestion
Cells were harvested with PBS at the indicated time points and centrifuged at 522 g for 
8 minutes at 4°C, after which they were transferred with 1 mL PBS to a microcentrifuge tube 
and centrifuged for 5 minutes at 5,000 g, 4°C. The supernatant was removed and pellets were 
snap-frozen in liquid nitrogen and stored at -80°C. Samples were thawed in 30 µL lysis buffer 
consisting of 1% SDS, 125 U/mL benzonase nuclease (Sigma), 2 mM MgCl2, and protease 
inhibitors (cOmplete ULTRA tablets, mini, EDTA-free, Roche) in 50 mM ammonium biocarbonate 
(ABC). Samples were placed at 95°C for 5 minutes and following centrifugation at 16 000 g for 
30 min, the supernatant was collected. A BCA assay (Pierce Biotechnology) was conducted 
to determine the protein concentration. An equivalent of 10 μg protein was dissolved in 
25 µL ABC and reduced using 10 mM DTT (Sigma) for 5 minutes at 95°C, followed by 1 hour 
alkylation using 40 mM iodoacetamide (Sigma) at room temperature. Using 3 kDa spin filters, 
the remainder of the lysis buffer was exchanged for ABC according to manufacturer’s protocol 
(Millipore), and samples were digested for 17 hours with sequencing-grade trypsin (Promega) 
at an enzyme to protein ratio of 1:50. The digestion was quenched with 2% trifluoracetic acid 
to lower the pH. Peptide samples were stored at -35°C until analysis. 
Liquid chromatography - mass spectrometry
All samples were analyzed using a splitless NanoLC-Ultra 2D plus (Eksigent) system for parallel 
liquid chromatography (LC) with additional trap columns for desalting. The LC systems were 
configured with 300 µm-i.d. 5-mm PepMap C18 trap columns (Thermo Fisher Scientific) and 
15-cm 300 µm-i.d. ChromXP C18 columns (Eksigent). Peptides were separated by a 90-minute 
linear gradient from 4 to 33% acetonitrile in 0.05% formic acid with the 4 µl/min flow rate. The 
LC systems were coupled on-line to amaZon speed ETD high-capacity 3D ion traps and a 12 
T solariX FTICR system (all from Bruker Daltonics) in an FTICR-ion trap cluster (19). For peptide 
identification in the ion traps, we generated three sample pools. Pool 1 contained a fraction 
of each sample that was stimulated for 32h with LPS or LPS + IFN-γ. Pool 2 contained a fraction 
of each 0h and 6h iDC sample. Pool 3 contained a fraction of each uneven sample (all samples 
received a random number). These sample pools were run in triplicate on the ion traps. Up to 
ten abundant multiply charged precursors in m/z 300-1300 were selected for MS/MS in each 
MS scan in a data-dependent manner. After having been selected twice, each precursor was 
excluded for one minute. The LC systems were controlled using the HyStar 3.4 (Bruker) with a 
plug-in from Eksigent, the amaZon ion trap by trapControl 7.0, and the solariX FTICR system 
by solariXcontrol 1.3 (both Bruker).
Data analysis
The raw datasets from ion trap LC-MS/MS and LC-FTICRMS were converted to mzXML (48). The 
mzXML files were analysed using a scientific workflow called “Label-free proteomics using 
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LC-MS” (http://www.myexperiment.org/workflows/4552.html). The workflow was designed 
using the Taverna workflow management system (49).
The LC-MS/MS data was used for identification. The TANDEM application (50) from the 
X!Tandem provided in Trans Proteomics Pipeline V4.7.7 was run to match the spectra with tryptic 
peptide sequences derived from UniProt Homo sapiens reference proteome database retrieved 
on 25.07.2014, for each pooled sample. The k-score plug-in was selected for the search with a 
minimum ion count of 1, and 2 maximum missed cleavage sites. The allowed parent monoisotopic 
mass error was ±5.0 Da, and the allowed fragment monoisotopic mass error was 0.4 Da. After 
peptide assignments to MS/MS spectra, the results were converted to pepXML format, an 
XML-based format that is used in peptide-level analysis (51), using the Tandem2XML application.
To use the high-resolution MS profiles for more precise quantification, each pepXML file 
was aligned with one master LC-FTICRMS data file. The alignment was done with pepAlign (52), 
which uses a genetic algorithm to align the two chromatographic time scales with a partial linear 
function. The output from pepAlign was the breakpoints of this function. The alignment was 
based on the X! Tandem expect scores and allowed a mass measurement error of ±50 ppm. The 
retention times in each pepXML file were changed according to the chromatographic alignment 
function by the pepWarp program. The accuracy of the peptide assignments to tandem mass 
spectra was assessed by PeptideProphet using the xinteract application provided in Trans 
Proteomics Pipeline V4.6.3 (53). This application also combined the input datasets, so that all 
identifications with assigned probabilities were contained in a single output file. This validated 
pepXML was then aligned with each individual LC-FTICRMS dataset. For quantitation of identified 
peptides, we used only peptides with PeptideProphet probabilities higher than 0.9369, giving 
a peptide-spectrum match false discovery rate of 1.0%. Modified peptides were not included. 
The monoisotopic mass was calculated for each peptide of interest and the maximum 
intensity corresponding to this mass was extracted from a window ±60 seconds relative to 
the aligned retention time and ±25 ppm relative to the calculated mass. As the final output of 
the workflow, all peptide quantifications were combined into a single table where each row 
represents a peptide sequence and each column contains the intensity of that peptide in each 
sample. Missing values were imputed from a normal distribution representing the background 
signal removed during acquisition. A final matrix was created with proteins identified by 
more than two peptides, where the abundance of each protein was calculated as the median 
intensity of its peptides and normalized to the total signal intensity of all proteins in the entire 
LC-MS dataset. Fold changes in protein abundance between conditions were calculated in 
R based on the mean fold change of the nine different donors, and corresponding p-values 
were obtained from paired Student’s t-testing of log-transformed protein intensities for each 
treatment and time point. Analysis of Gene Ontology terms was performed using Protein 
Annotation THrough Evolutionary Relationship (PANTHER) (54;55), and association analysis was 
performed using GeneMANIA (56). Associations were analyzed based on genetic interactions, 
pathways, and physical interactions. In addition to the differentially expressed proteins, we 
allowed for display of 10 related proteins and 10 related attributes, and Gene Ontology network 
weighting was based on biological processes.
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Figure S1. Network analysis of 6h SEA-response proteins. Monocyte-derived DCs were pulsed with LPS 
in the presence of SEA or omega-1, and protein expression was analyzed by LC-FTICRMS. For GeneMANIA 
analysis, all 6h SEA-responsive proteins with P<0.05, and those proteins with P<0.1 and a fold change 
of <0.67 or >1.5, were included. Black and/or striped nodes represent genes of which the proteins were 
differentially expressed (query genes); grey nodes represent associated genes added by GeneMANIA. 
Colored nodes highlight significantly enriched Gene Ontologies.  
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Figure S3. Network analysis of 6h omega-1-response proteins. Monocyte-derived DCs were pulsed and 
analyzed as describe for figure S1. For GeneMANIA analysis, all 6h omega-1-responsive proteins with P<0.05, 
and those proteins with P<0.1 and a fold change of <0.67 or >1.5, were included. Black and/or striped nodes 
represent genes of which the proteins were differentially expressed (query genes); grey nodes represent 
associated genes added by GeneMANIA. Colored nodes highlight significantly enriched Gene Ontologies. 
Figure S2. Network analysis of 32h SEA-response proteins. Monocyte-derived DCs were pulsed and 
analyzed as describe for figure S1. For GeneMANIA analysis, all 32h SEA-responsive proteins with P<0.05, 
and those proteins with P<0.1 and a fold change of <0.67 or >1.5, were included. Black and/or striped nodes 
represent genes of which the proteins were differentially expressed (query genes); grey nodes represent 
associated genes added by GeneMANIA. Colored nodes highlight significantly enriched Gene Ontologies. 
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Table S1. Differentially expressed proteins included for GeneMANIA analysis. (Continued)
Accession Gene Name Fold Change P-value
SEA-induced, 6 hours
P62937 PPIA 11.27 0.012
P14625 HSP90B1 4.14 0.039
P06576 ATP5B 3.44 0.075
P60842 EIF4A1 3.21 0.042
P07900 HSP90AA1 2.98 0.019
P01903 HLA-DRA 2.39 0.056
P21333 FLNA 2.07 0.091
Q06830 PRDX1 1.90 0.062
P55084 HADHB 1.79 0.093
Q16658 FSCN1 1.74 0.041
P05387 RPLP2 1.71 0.066
P09467 FBP1 1.54 0.074
O60664 PLIN3 1.36 0.035
P21796 VDAC1 0.78 0.048
Q5K4L6 SLC27A3 0.77 0.005
SEA-induced, 32 hours
P05387 RPLP2 2,27 0,006
P50395 GDI2 1,60 0,093
Q99536 VAT1 1,59 0,028
P04229 HLA-DRB1 0,70 0,018
P04233 CD74 0,69 0,020
P09769 FGR 0,68 0,009
P16070 CD44 0,63 0,023
P23381 WARS 0,60 0,004
P02786 TFRC 0,56 0,002
P30464 HLA-B 0,45 0,003
Omega-1-induced, 6 hours
P30048 PRDX3 4.03 0.036
Q9ULZ3 PYCARD 2.08 0.074
P05388 RPLP0 1.86 0.021
O15145 ARPC3 1.80 0.052
P30041 PRDX6 1.77 0.020
Q01813 PFKP 1.65 0.006
P61158 ACTR3 1.61 0.038
P27348 YWHAQ 1.46 0.014
Q9UL46 PSME2 1.43 0.005
Q9H223 EHD4 1.42 0.020
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Table S1. Differentially expressed proteins included for GeneMANIA analysis. (Continued)
Accession Gene Name Fold Change P-value
Q16555 DPYSL2 1.24 0.022
P62258 YWHAE 1.16 0.010
P62987 UBA52 0.83 0.041
P04406 GAPDH 0.72 0.043
P50995 ANXA11 0.72 0.043
Omega-1-induced, 32 hours
P55084 HADHB 2.52 0.045
P63104 YWHAZ 2.33 0.035
P60842 EIF4A1 2.30 0.086
P50502 ST13 2.05 0.024
P30041 PRDX6 2.02 0.020
Q99536 VAT1 1.53 0.016
P06753 TPM3 1.43 0.049
P29692 EEF1D 1.35 0.001
P29966 MARCKS 0.58 0.015
P04179 SOD2 0.52 0.006
P02786 TFRC 0.49 0.002
P30504 HLA-C 0.47 0.019
P16070 CD44 0.47 0.002
P30464 HLA-B 0.40 0.002
Q9Y3Z3 SAMHD1 1.70 0.070
P27824 CANX 2.64 0.047
P05387 RPLP2 4.63 0.013
P30508 HLA-C 0.63 0.012
P17900 GM2A 0.65 0.026
P62987 UBA52 0.70 0.025
P07339 CTSD 0.73 0.036
P07858 CTSB 0.74 0.029
Q9BQE5 APOL2 0.76 0.031
P80723 BASP1 0.76 0.042
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Chronic low-grade inflammation associated with obesity contributes to insulin resistance 
and type 2 diabetes. Helminth parasites are the strongest natural inducers of type 2 immune 
responses, and short-lived infection with rodent nematodes was reported to improve glucose 
tolerance in obese mice. Here, we investigated the effects of chronic infection (12 weeks) 
with Schistosoma mansoni, a helminth that infects millions of humans worldwide, on whole-
body metabolic homeostasis and white adipose tissue (WAT) immune cell composition in 
high-fat diet-induced obese C57BL/6 male mice. Our data indicate that chronic helminth 
infection reduced body weight gain (-62%), fat mass gain (-89%) and adipocyte size; lowered 
whole-body insulin resistance (-23%) and glucose intolerance (-16%); and improved peripheral 
glucose uptake (+25%) and WAT insulin sensitivity. Analysis of immune cell composition by 
flow cytometry and quantitative PCR revealed that S. mansoni promoted strong increases 
in WAT eosinophils and alternatively activated M2 macrophages. Importantly, injections 
with S. mansoni soluble egg antigens recapitulated the beneficial effect of parasite infection 
on whole-body metabolic homeostasis and induced type 2 immune responses in WAT and 
liver. Taken together, we provide novel data suggesting that chronic helminth infection and 
helminth-derived molecules protect against metabolic disorders by promoting a T helper 2 
response, eosinophilia and WAT M2 polarization.
88
5
  SchiStoSoma manSoni improves insulin sensitivity
introduction
The obesity epidemic represents a growing threat to public health, not only in industrialized 
countries but also in urban centers of developing countries. Obesity significantly increases 
the risk for the development of type 2 diabetes, cardiovascular diseases, and eventually 
cancer (1;2) and is often associated with a state of chronic, low-grade inflammation, which 
contributes to tissue-specific insulin resistance and whole-body metabolic dysfunction (3). 
Among the underlying molecular mechanisms, classically activated (M1) macrophages were 
shown to accumulate in white adipose tissue (WAT) from obese mice, where they secrete 
pro-inflammatory cytokines such as  interleukin (IL)-1β and tumor necrosis factor-α (TNF-α) 
(4-6). These cytokines interfere with insulin signaling (7;8) and induce lipolysis (9;10), thereby 
increasing circulating free fatty acids which promote peripheral insulin resistance (11). Other 
immune cell types, including neutrophils (12), mast cells (13), B cells (14;15) and CD8+ T cells 
(16), have also been shown to mediate insulin resistance.
By contrast, alternatively activated (M2) macrophages prevail in lean WAT and are involved 
in the maintenance of adipose tissue insulin sensitivity, partly through secretion of the anti-
inflammatory cytokine IL-10 (6;17). The M2 phenotype is promoted by T helper 2 (Th2)-type 
cytokines like IL-4, secreted by WAT eosinophils (18), and IL-5 and IL-13, released from WAT 
innate lymphoid type 2 cells (ILC2s) (19). In addition, Th2 and regulatory T cell responses, as 
well as administration of IL-4, have been associated with protection against insulin resistance 
(20-22). Together, these studies illustrate that type 2 and anti-inflammatory responses are 
beneficial for the expanding adipose tissue environment and the maintenance of tissue-
specific insulin sensitivity and whole-body glucose homeostasis.
Helminth parasites are the strongest natural inducers of type 2 inflammatory responses, 
and epidemiological studies in India and rural China revealed that helminth infections inversely 
correlate with metabolic syndrome (23-25). In addition, seminal papers recently reported that 
the rodent nematode Nippostrongylus brasiliensis, which is spontaneously cleared within two 
weeks of infection, improves glucose tolerance in diet-induced obese mice (18;26), associated 
with WAT eosinophilia (18) or increased M2 gene expression (26). Furthermore, Schistosoma 
mansoni soluble egg antigens could protect against atherosclerosis in hyperlipidemic LDLR 
knockout mice (27). These studies suggest that manipulation of the immune system by 
helminths or their molecules might be beneficial for metabolic homeostasis. However, it 
remains unclear which aspects of whole-body energy metabolism are affected by the worms, 
and the immunological changes that take place in WAT have not yet been characterized at 
the cellular level.
Furthermore, as most helminth infections in humans are chronic in nature, it would be 
important to test whether the beneficial effect on metabolic homeostasis also occurs in a 
model of chronic infection. Of the various helminth species, schistosomes are among the 
most prevalent and chronically infect millions of people worldwide (28). While infection with 
N. brasiliensis induces a strong Th2 response that mediates parasite rejection within two weeks 
after infection, the Th2 response in schistosomiasis emerges after 5-6 weeks of infection, 
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with the onset of egg production that also triggers the development of M2 macrophages 
(29). In most individuals, infection often reaches a chronic stage, characterized by a decline 
in Th2 inflammation and the presence of regulatory B and T cells (30;31). In the present study, 
we therefore investigated the impact of S. mansoni infection for 12 weeks on whole-body 
metabolic homeostasis, WAT insulin sensitivity, and WAT immune cell composition in mice fed 
either low- or high-fat diet (HFD). Next, to study the impact of helminth-derived molecules 
on metabolic disorders in a pathogen-free setting, we treated HFD-fed mice with S. mansoni 
soluble egg antigens (SEA) for 4 weeks and assessed whole-body glucose tolerance and insulin 
sensitivity, and the immune cell composition of WAT and liver.
materials and methods
Animals, diet and S. mansoni infection
All mouse experiments were performed in accordance with the Guide for the Care and Use 
of Laboratory Animals of the Institute for Laboratory Animal Research and have received 
approval from the university Ethical Review Boards (Leiden University Medical Center, Leiden, 
The Netherlands; DEC2189). Male C57BL/6J mice (8-10 weeks old; Charles River, L’Arbresle 
Cedex, France) were housed in a temperature-controlled room with a 12-hour light-dark cycle. 
Throughout the experiment, food and tap water were available ad libitum. Mice were fed a 
high-fat diet (45% energy derived from fat, D12451, Research Diets, Wijk bij Duurstede, The 
Netherlands) or a low-fat diet (10% energy derived from fat, D12450B, Research Diets), which 
were similar in composition in all respects apart from the total fat content. After 6 weeks, mice 
were randomized according to body weight and fasting plasma glucose and insulin levels 
and percutaneously infected with 36 S. mansoni cercariae, as previously described (32). Mice 
were monitored for 12 additional weeks. The effects of chronic infection were assessed in 2 
independent experiments. Before SEA injections, mice were fed a LFD or HFD for 12 weeks 
after which they were randomized according to body weight, fasting plasma glucose and 
insulin levels, and fat mass. SEA (50 µg) was injected intraperitoneally once every 3 days for a 
period of 4 weeks. The effects of SEA treatment were assessed in 2 independent experiments.
Plasma analysis
Blood samples were collected from the tail tip of 4-hour-fased mice (food removed at 9 am) by 
use of chilled capillaries. Blood glucose level was determined by use of a glucometer (Accu-
Check, Roche Diagnostics Almere, The Netherlands) and plasma insulin level was measured 
by use of a commercial kit according to the instructions of the manufacturer (Millipore, The 
Netherlands). 
Glucose and insulin tolerance tests
The effect of chronic S. mansoni infection on glucose tolerance was assessed by intravenous 
glucose tolerance test (ivGTT) at week 5 and 11 postinfection. Mice were fasted for 6 hours, 
and the tests were carried out at 2 pm. After an initial blood collection (t=0), a glucose 
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load (2g D-Glucose/kg total body weight of which 50% of the glucose was [6,6-2H2]glucose 
(Sigma-Aldrich, Zwijndrecht, The Netherlands) was administered in conscious mice via 
injection in the tail vein. Blood sampling was performed by tail bleeding at 2.5, 15, 30, 60, 
90 and 120 minutes: 5-10 µL whole blood was spotted on sample carrier paper (Sartorius 
Stedim, Goettingen, Germany) and an additional drop was used to measure glucose using a 
glucometer (Accu-Check, Roche Diagnostics). To analyze peripheral glucose uptake, blood 
spot glucose enrichment was measured by extracting glucose from the filter paper with 75 µl 
water (B. Braun, Oss, Netherlands) and 1 mL methanol. The extracted glucose was derivatized to 
aldonitrile penta-acetate and reconstituted in 100 µL ethyl acetate, of which 1 µL was injected 
for gas chromatography (HP6890II) mass spectrometry (HP5973, Hewlett-Packard Co., Palo 
Alto, CA, USA), as described previously (33). Mass-over-charge ratios of 187, 188 and 189 were 
monitored in selective ion monitoring mode, from which the percentage of unlabeled and 
labeled glucose was calculated based on theoretical isotopic distribution. Concentrations of 
labeled glucose were calculated based on the plasma glucose levels, and values were natural 
log-transformed after which a decay curve was fitted. Individual decay curves were calculated, 
of which the slope represents the peripheral glucose uptake. The effect of SEA treatment on 
glucose tolerance was assessed by an i.p. glucose tolerance test (2 g D-Glucose/kg total body 
weight) in 6-hour fasted mice at week 3 postinjections.
Whole-body insulin sensitivity was determined by an intraperitoneal insulin tolerance 
test (ITT) at 5 and 11 weeks postinfection or at week 3 post-SEA treatment. Mice were fasted 
for 4 hours, and the tests were carried out at 1 pm. After an initial blood collection (t=0), an 
intraperitoneal bolus of insulin (1 U/kg lean body mass; NOVORAPID, Novo Nordisk, Alphen 
aan den Rijn, Netherlands) was administered to the mice. Blood glucose was measured by tail 
bleeding at 15, 30, 60, and 120 minutes after insulin administration by use of a glucometer.
Body composition and indirect calorimetry
Body composition was measured by MRI using an EchoMRI (Echo Medical Systems, Houston, 
TX, USA). Groups of 8 mice with free access to food and water were subjected to individual 
indirect calorimetric measurements at week 11 postinfection for a period of 7 consecutive 
days using a Comprehensive Laboratory Animal Monitoring System (Columbus Instruments, 
Columbus, OH, USA). Before the start of the measurements, the animals were acclimated to 
the cages and the single housing for a period of 48 hours. Feeding behavior was assessed by 
real-time food intake. Spontaneous locomotor activity was determined by the measurement 
of beam breaks. Oxygen consumption and carbon dioxide production were measured at 
15-minute intervals and normalized for body surface area (kg0.75). Respiratory exchange ratio 
and energy expenditure were calculated as described previously (34). 
Isolation of adipocytes and stromal vascular fraction (SVF) from adipose tissue
Gonadal (epididymal), visceral (mesenteric) and subcutaneous (flank) adipose tissues were 
collected from infected and uninfected mice, minced, and digested for 1 h at 37°C in HEPES 
buffer (pH 7.4) containing 0.5g/l type 1 collagenase from Clostridium histolyticum (Sigma-Aldrich) 
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and 2% (w/v) dialyzed bovine serum albumin (Fraction V; Sigma-Aldrich). The disaggregated 
adipose tissue was filtered through a 236 μm nylon mesh. Mature adipocytes were isolated 
from the surface of the filtrate and washed several times with PBS. Cell size was determined 
using an imaging technique implemented in MATLAB which automatically determines size of 
isolated adipocytes from microscopic pictures (~1000 cells/fat tissue sample). The adipocyte 
size distribution, mean adipocyte diameter and volume, and adipocyte number per fat pad 
were calculated, as described previously (35). The residue of the gonadal and visceral adipose 
tissue filtrate was used for the isolation of stromal vascular cells for flow cytometry. In brief, 
after centrifugation (350 g, 10 minutes, room temperature), the supernatant was discarded 
and the pellet was treated with erythrocyte lysis buffer. The cells were washed twice with PBS 
and counted manually or using an automated cell counter (TC10, Bio-Rad, Hercules, CA, USA). 
Following SEA injections, stromal vascular cells from gonadal adipose tissue were isolated 
as described above, with the exception that the disaggregated adipose tissue was passed 
through a 100 μm cell strainer that was washed with PBS supplemented with 2.5 mM EDTA 
and 5% fetal calf serum (FCS).
Isolation of CD45+ cells from liver tissue
Livers were minced and digested for 45 minutes at 37°C in RPMI 1640 + Glutamax (Life 
Technologies, Bleiswijk, The Netherlands) containing 1 mg/mL collagenase type IV from 
Clostridium histolyticum, 2000 U/mL DNase (both Sigma-Aldrich), and 1 mM CaCl2. The 
digested liver tissues were passed through 100 μm cell strainers that were washed with PBS 
supplemented with 2.5 mM EDTA and 5% FCS. Following centrifugation (530 g, 10 minutes, 
4°C), the supernatant of the filtrate was discarded, after which the pellet was resuspended in 
PBS + 2.5 mM EDTA and 5% FCS and centrifuged at 50 g to remove hepatocytes (3 minutes, 
4 degrees).  Next, supernatants were collected and pelleted (530 g, 10 minutes, 4°C). The 
pellet was treated with erythrocyte lysis buffer, and the cells were washed once more 
with PBS + 2.5 mM EDTA and 5% FCS. CD45+ cells were isolated by use of LS columns and 
CD45 MicroBeads (35 µL/liver; Miltenyi Biotec, Bergisch Galdbach, Germany) according to 
manufacturer’s protocol. Isolated CD45+ cells were counted and processed as described 
for the SVF. 
Processing of isolated cells for flow cytometry
For analysis of macrophage and lymphocyte subsets, isolated stromal vascular cells and CD45+ 
cells from liver were stained with the live/dead marker Aqua (Invitrogen), after which they 
were fixed with 1.9% paraformaldehyde (Sigma-Aldrich) and stored in FACS buffer (PBS, 0.02% 
sodium azide, 0.5% FCS) at 4°C in the dark until subsequent analysis. For analysis of cytokine 
production, isolated cells were cultured for 4 hours in culture medium in the presence of 
100 ng/mL phorbol myristate acetate (PMA), 1 µg/mL ionomycin and 10 µg/mL Brefeldin A 
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Flow cytometry
For analysis of lymphocyte subsets, SVF cells were stained with antibodies against CD4 
(GK1.5), CD3 (17A2), B220 (RA3-6B2) or CD19 (1D3; all eBioscience, San Diego, CA, USA), CD8 
(53-6.7), CD45 (104; both BioLegend, San Diego, CA, USA) and NK1.1 (PK136, eBioscience or 
BD Biosciences, San Jose, CA, USA). Following SEA injections, when ILC2s were analyzed, 
additional antibodies were included against Thy1.2 (52-2.1), CD11b (M1/7; both eBioscience), 
CD11c (HL3) and GR-1 (RB6-8C5; both BD Biosciences), to gate on lineage-negative Thy1.2+ 
cells. For analysis of macrophages and eosinophils, cells were permeabilized with 0.5% saponin 
(Sigma-Aldrich) in which they were also stained. Cells were incubated with an antibody against 
Ym1 conjugated to biotin (R&D Systems, Minneapolis, MN, USA), washed, and stained with 
streptavidin-PerCP (BD Biosciences) and antibodies directed against CD45, CD11b, CD11c, 
F4/80 (BM8; eBioscience), Siglec-F (E50-2440; BD Biosciences), and following SEA injections, 
Ly6C (HK1.4; BioLegend). Cytokine production of Th2 cells and ILC2s was analyzed following 
permeabilization, as described above, using antibodies against CD11b, CD11c, GR-1, B220, NK1.1, 
CD3, CD45, CD4, Thy1.2, IL-4 (11B11; eBioscience), IL-13 (eBio13A; eBioscience) and IL-5 (TRFK5; 
BioLegend). Flow cytometry was performed using a FACSCanto (BD Biosciences), and gates 
were set according to Fluorescence Minus One (FMO) controls. Representative gating schemes 
are shown in Supplemental Fig. 1. 
In vivo insulin signaling 
Mice were food-deprived for 4 hours and subjected to an i.p. injection of human recombinant 
insulin (1 U/kg body weight; NOVORAPID, Novo Nordisk) at 1 pm. Mice were sacrificed after 
15 minutes and gonadal and visceral adipose tissues were isolated and immediately snap-
frozen. Subsequently, the tissue samples (~30 mg) were lysed in ice-cold buffer containing 
50 mM Hepes (pH 7.6), 50 mM NaF, 50 mM KCl, 5 mM NaPPi, 1 mM EDTA, 1 mM EGTA, 1 mM 
DTT, 5 mM β-glycerophosphate, 1 mM sodium vanadate, 1% NP40 and protease inhibitor 
cocktail (Complete, Roche Diagnostics). Western blots were performed using phospho-specific 
(Thr308-PKB, Cell Signaling Technology, Leiden, The Netherlands) or total primary antibodies 
(tubulin from Cell Signalling; insulin receptor β (IRβ) from Santa Cruz Biotechnology, Dallas, 
TX, USA), as described previously (36). Bands were visualized by enhanced chemiluminescence 
and quantified by use of ImageJ (NIH, Bethesda, MD, USA).
RNA purification and qRT-PCR 
RNA was extracted from snap-frozen tissue samples (~20 mg) using Tripure RNA Isolation reagent 
(Roche Diagnostics). Total RNA (1 µg) was reverse transcribed and quantitative real-time PCR 
was then performed with SYBR Green Core Kit on a MyIQ thermal cycler (Bio-Rad) using specific 
primers sets: 5’-GCCACCAACCCTTCCTGGCTG-3’ (Itgax-R), 5’-TTGGACACTCCTGCTGTGCAGTTG-3’ 
(Itgax-F),  5’-GTCCCCAAAGGGATGAGAAG-3’ (Tnfa-R), 5’-CACTTGGTGGTTTGCTACGA-3’ 
(Tnfa-F), 5’-TCCTGGACATTACGACCCCT-3’ (Nos2-R), 5’-CTCTGAGGGCTGACACAAGG-3’ (Nos2-F), 
5’-TCAGCCAGATGCAGTTAACGCCC-3’ (Ccl2-R), 5’-GCTTCTTTGGGACACCTGCTGCT-3’ (Ccl2-F), 
5’-CCTGCCCTGCTGGGATGACT-3’ (Retnla-R), 5’-GGGCAGTGGTCCAGTCAACGA-3’ (Retnla-F), 
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5’-ACAATTAGTACTGGCCCACCAGGAA-3’ (Chil3-R), 5’-TCCTTGAGCCACTGAGCCTTCA-3’ 
(Chil3-F), 5’-GACCACGGGGACCTGGCCTT-3’ (Arg1-R), 5’-ACTGCCAGACTGTGGTCTCCACC-3’ 
(Arg1-F), 5’-CCTCACAGCAACGAAGAACA-3’ (Il4-R), 5’-ATCGAAAAGCCCGAAAGAGT-3’ 
(Il4-F), 5’-TGGGGGTACTGTGGAAATGC-3’ (Il5-R), 5’-CCACACTTCTCTTTTTGGCGG-3’ 
(Il5-F), 5’-CCCTGGATTCCCTGACCAAC-3’ (Il13-R), 5’-GGAGGCTGGAGACCGTAGT-3’ (Il13-F), 
5’-CTTTGGCTATGGGCTTCCAGTC-3’ (Emr1-R), 5’-GCAAGGAGGACAGAGTTTATCGTG-3’ (Emr1-F), 
5’-ACTGAAGTACCAAATGGACAATGTTAGT-3’ (Clec4f-R), 5’-GTCAGCATTCACATCCTCCAGA-3’ 
(Clec4f-F). mRNA expression was normalized to RplP0 mRNA content and expressed as fold 
change compared to noninfected LFD-fed mice using the ∆∆CT method. 
Statistical analysis
All data are presented as means ± SEM. Statistical analysis was performed using GraphPad 
Prism version 6.00 for Windows (GraphPad Software, La Jolla, CA, USA) with 2-tailed unpaired 
Student’s t test. Differences between groups were considered statistically significant at P < 0.05. 
For repeated measurements, data were analyzed assuming the same scatter to increase power. 
results
Chronic S. mansoni infection reduces fat mass in HFD-induced obese mice 
To study the effect of chronic helminth infection on whole-body energy homeostasis, C57BL/6 
male mice were fed a LFD or HFD for 6 weeks, before infection with S. mansoni for 12 additional 
weeks. HFD induced a time-dependent increase in body weight (Fig. 1A), fat mass (Fig. 1B,C), and 
mean adipocyte volume (Fig. 1D) when compared with LFD-fed mice. In response to S. mansoni 
infection, HFD-fed mice gained significantly less weight (Fig. 1A), an effect exclusively resulting 
from a reduction in body fat mass without affecting lean body mass (Fig. 1B,C). Morphometric 
analysis of various WATs revealed that chronic S. mansoni infection reduced HFD-induced 
adipocyte hypertrophy (Fig. 1D), while cell numbers remained unaffected (data not shown). 
In LFD-fed animals, S. mansoni induced a small but significant decrease in gonadal adipocyte 
mean volume, but did not affect body weight and fat mass. Next, by use of metabolic cages, 
we found that food intake and spontaneous locomotor activity were not affected by chronic 
infection (Fig. 1E,F), and indirect calorimetry also revealed that infection did not affect the 
respiratory exchange ratio (Fig. 1G) or energy expenditure (Fig. 1H) in HFD-fed animals. 
Chronic S. mansoni infection improves whole-body glucose tolerance and insulin 
sensitivity in HFD-induced obese mice 
We next investigated the effect of chronic S. mansoni infection on whole-body metabolic 
homeostasis in lean and HFD-induced obese mice. As expected, HFD increased fasting plasma 
glucose and insulin levels (Fig. 2A), and HOMA-IR (HOmeostatis Model Assessment of Insulin 
Resistance; Fig. 2B). In addition, HFD impaired whole-body glucose tolerance (Fig. 2C,D), 
peripheral glucose uptake (Fig. 2E,F), and insulin sensitivity (Fig. 2G,H). Chronic S. mansoni 
infection restored fasting blood glucose and insulin levels in mice on HFD (Fig. 2A), resulting 
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in a time-dependent reduction in HOMA-IR (Fig. 2B). Furthermore, chronic infection restored 
HFD-induced whole-body glucose tolerance (Fig. 2C,D), improved peripheral glucose uptake 
(Fig. 2E,F) and promoted whole-body insulin sensitivity (Fig. 2G,H). Of note, except for a slight 
but significant decrease in fasting plasma insulin level, S. mansoni infection did not affect any 
metabolic parameters in LFD-fed mice. Overall, these data indicate that S. mansoni improves 
whole-body glucose tolerance and insulin resistance in diet-induced obese mice.
Chronic S. mansoni infection improves adipose tissue insulin sensitivity in HFD-
induced obese mice 
To study the effect of chronic S. mansoni infection on WAT-specific insulin sensitivity, mice 
were subjected to an acute intraperitoneal insulin injection. The expression of IRβ and insulin-
induced phosphorylation of protein kinase B (PKB) were assessed by Western Blot in both 
gonadal and visceral WAT. As expected, HFD reduced IRβ protein expression (Fig. 2I,K) and 
impaired PKB phosphorylation in response to insulin (Fig. 2J,K) in both gonadal and visceral 
WAT, indicating tissue-specific insulin resistance. Chronic S. mansoni infection restored 
IRβ protein expression and insulin-induced PKB phosphorylation in WAT of HFD-fed mice 
(Fig. 2I-K), suggesting that the beneficial effect of helminths observed at the systemic level 
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Figure 1. Chronic S. mansoni infection reduces body weight gain, fat mass and adipocyte size in diet-
induced obese mice. Mice were fed a LFD or HFD for 6 weeks before infection with S. mansoni cercariae 
or sham-infection for 12 weeks. Body weight was monitored throughout the experimental period (A). The 
change in body composition from the start of infection (B), weight of different fat pads (C) and adipocyte 
mean volume (D) were measured at week 12 postinfection. Food intake (E), spontaneous locomotor 
activity (F), respiratory exchange ratio (RER; G) and energy expenditure (EE; H) were assessed using fully 
automated single-housed metabolic cages during week 11. Results are expressed as means ± SEM. *P<0.05 
HFD vs LFD, #P<0.05 helminth- vs sham-infected group (n = 4-11 animals per group in B, D-H, and 12-19 
































Figure 2. Chronic S. mansoni infection improves whole-body glucose tolerance and insulin sensitivity 
in diet-induced obese mice. Mice were fed a LFD or HFD and were infected with S. mansoni as described 
in the legend of Fig. 1. Plasma glucose and insulin levels (A) were determined in 4h-fasted mice at week 12 
postinfection. HOMA-IR was calculated throughout the experimental period (B). An intravenous glucose 
tolerance test (2g D-glucose with 50% [6,6-2H2]glucose / kg body weight) was performed in 6h-fasted mice 
at week 11. Blood glucose levels were measured at the indicated time points (C) and the area under the 
curve (AUC) of the glucose excursion curve was calculated as a measure for glucose tolerance (D). Blood 
was also collected for determination of the time-dependent change in [6,6-2H2]glucose concentration 
by gas chromatography mass spectrometry (E). For each mouse, a decay curve was fitted of which the 
slope represents peripheral glucose uptake (F). An i.p. insulin tolerance test (1U/kg lean body mass) was 
performed in 4h-fasted mice at week 11. Blood glucose levels were measured at the indicated time points 
(G) and the AUC of the glucose excursion curve was calculated as a measure for insulin resistance (H). 
After 12 weeks of infection, 4h-fasted mice received an intravenous injection of insulin (1 U/kg lean body 
mass) and were sacrificed by cervical dislocation after 15 minutes. Gonadal and visceral adipose tissues 
were collected and immediately snap-frozen. The protein expression of IRβ (I) and the phosphorylation 
state of PKB-Thr308 (J) were assessed by Western blot and quantified by densitometry analysis. Tubulin 
expression was used as internal housekeeping protein. Representative Western blots are shown (K) Results 
are expressed as means ± SEM. *P<0.05 HFD vs LFD, #P<0.05 helminth- vs sham-infected group. Figures 
C, E and G: statistical significance of HFD sham vs LFD sham and HFD infected vs HFD sham is shown (n = 
12-19 animals per group in A and B and 3-11 animals per group in C-J).
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Chronic S. mansoni infection increases adipose tissue eosinophils and alternatively 
activated M2 macrophages 
The immune cell composition of WAT, specifically the eosinophil content and the balance 
between M1 and M2 macrophages, has been shown to play a crucial role in the maintenance of 
adipocyte insulin sensitivity and whole-body metabolic homeostasis (6). To investigate whether 
chronic S. mansoni infection affects the immune cell composition in WAT, the stromal vascular 
fraction (SVF) was isolated from gonadal and visceral WAT of sham- and helminth-infected 
mice, and the immune cell composition was analyzed by flow cytometry (see Supplemental 
Fig. 1 for gating strategy). We found that HFD significantly reduced B cell, NK cell, and NKT cell 
numbers per gram of gonadal WAT (Supplemental Fig. 2A). S. mansoni promoted infiltration of 
leukocytes into gonadal WAT, resulting in increased numbers of all lymphocyte subsets studied 
in both LFD- and HFD-fed mice (Supplemental Fig. 2A). No major effect of diet or infection was 
observed on lymphocytes in visceral WAT (Supplemental Fig. 2B). 
Subsequent analysis of eosinophils, identified by CD45 and Siglec-F expression, revealed 
a trend for a decrease in WAT eosinophil numbers in HFD-fed mice (Fig. 3A,B), in line with a 
previous report (18). Chronic S. mansoni infection induced a strong increase in eosinophil 
infiltration into gonadal and visceral WATs from both LFD- and HFD-fed mice (Fig. 3A,B). 
Finally, the expression of CD11c and Ym1 in CD11b+F4/80+ cells allowed us to discriminate 
between M1 and M2 macrophages, respectively (17) (Fig. 3C). HFD promoted a significant 
increase in M1 macrophages in gonadal WAT (Fig. 3D) and a decrease in M2 macrophages in 
visceral WAT (Fig. 3E). Analysis of adipose tissue gene expression confirmed that M1 markers 
were increased in HFD-fed mice, an effect particularly clear in gonadal WAT, although M2-
associated genes were not down-regulated significantly (Fig. 3G,H). Chronic S. mansoni infection 
had a marginal effect on WAT M1 macrophage counts as determined by flow cytometry 
analysis, but strongly increased M2 macrophage numbers in both gonadal and visceral WAT 
from LFD- and HFD-fed mice (Fig. 3D,E), shifting the M2/M1 ratio toward M2 (Fig. 3F). In line 
with these results, infection induced a strong up-regulation of M2-associated genes in both 
gonadal and visceral WAT from LFD- and HFD-fed mice, whereas the expression of M1-related 
genes was barely affected (Fig. 3G,H). Lastly, mRNA expression of the type 2-associated 
cytokines IL-4 and IL-5 were also significantly up-regulated in WAT from helminth-infected mice 
(Fig. 3G,H). Taken together, these results suggest that chronic S. mansoni infection promotes 
WAT type 2 inflammation characterized by adipose tissue eosinophilia and accumulation of 
M2 macrophages. 
S. mansoni soluble egg antigens improve whole-body metabolic homeostasis and 
promote a type 2 immune response in WAT and liver from obese mice
To exclude that the beneficial effects of helminth infection on metabolic homeostasis are 
simply a result of parasitism, we next investigated whether S. mansoni-derived molecules can 
alleviate diet-induced metabolic disorders. For this purpose, HFD-fed mice were subjected 
to repetitive i.p. injections with SEA, which was shown to promote a strong Th2 response in 
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Figure 3. Chronic S. mansoni infection increases adipose tissue eosinophils and alternatively-activated 
M2 macrophages. Mice were fed a LFD or HFD and infected with S. mansoni as described in the legend of 
Fig. 1. At sacrifice (week 12), various adipose tissues were collected. Small tissue pieces were snap-frozen 
for qPCR analysis and the remaining tissue pieces were used for SVF isolation. Following fixation and 
permeabilization, SVF cells were stained and analyzed by flow cytometry. The complete gating scheme is 
shown in Supplemental Fig. 1. Representative flow cytometry plots from gonadal adipose tissue show the 
percentage of eosinophils based on Siglec-F expression in Aqua-CD45+ cells (A). The numbers of eosinophils 
per gram tissue were determined (B). Macrophages were identified as Aqua-CD45+Siglec-F-CD11b+F4/80+ 
cells. Representative flow cytometry plots from gonadal adipose tissue show the percentage of CD11c+ 
(M1) and Ym1+ (M2) macrophages (C). The numbers of M1 and M2 macrophages per gram tissue in gonadal 
(D) and visceral (E) WAT were determined and the M2/M1 ratios were calculated (F). mRNA expression of 
the indicated genes in gonadal (G) and visceral (H) adipose tissues were quantified by RT-PCR relative to 
RplP0 gene and expressed as fold difference compared with the non-infected LFD-fed mice. Itgax encodes 
CD11c; Retnla encodes Fizz1; Chil3 encodes Ym1. Results are expressed as means ± SEM. *P<0.05 HFD vs 
LFD, #P<0.05 helminth- vs sham-infected group (n = 8-16 animals per group).
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weight nor lean or fat body mass (Fig. 4A), but improved fasting plasma glucose and insulin 
levels (Fig. 4B,C), HOMA-IR (Fig. 4C), and whole-body glucose tolerance (Fig. 4E) and insulin 
sensitivity (Fig. 4F). 
Like the chronic parasite infection, SEA exposure promoted WAT eosinophilia (Fig. 5A), 
associated with accumulation of M2 macrophages (Fig. 5B), leading to a shift in the M2/M1 
ratio toward M2 polarization (Fig. 5C). As we showed that helminth infection promoted gene 
expression of type 2-associated cytokines in WAT (Fig. 3), we next determined the numbers of 
CD4+ T cells and ILCs (lineage-negative Thy1.2+) in gonadal WAT (see Supplemental Fig. 1 for 
gating strategy), and analyzed cytokine expression by these lymphocyte subsets following 
stimulation with PMA and ionomycin (gating strategy shown in fig. 5E). Compared to LFD, 
HFD decreased the total number of CD4+ T cells and ILCs (Fig. 5D), and the percentage of CD4+ 
T cells expressing IL-4, but not IL-5 or IL-13 (Fig. 5F), and did not significantly affect cytokine 
production by ILCs (Fig. 5G). Treatment of HFD-fed mice with SEA strongly enhanced the 
percentage of IL-4-, IL-5- and IL-13-expressing CD4+ T cells in gonadal WAT (Fig. 5F), and slightly 
increased IL-5 production by ILCs (Fig. 5G). These findings were confirmed by quantitative PCR 
(qPCR), which showed that SEA promotes gene expression of M2-associated markers and type 
2 cytokines (Fig. 5H).
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Figure 4. SEA improves whole-body metabolic homeostasis in HFD-induced obese animals. Mice 
were fed a LFD or HFD for 12 weeks, after which they were treated i.p. with PBS or 50 µg SEA once every 
3 days for a period of 4 weeks. Body weight and body composition were analyzed after 4 weeks of 
treatment (A). Plasma glucose (B) and insulin (C) levels were determined in 4h-fasted mice after 4 weeks 
of treatment and HOMA-IR was calculated (D). An i.p. glucose tolerance test (2 g/kg body weight) was 
performed in 6h-fasted mice at week 3. Blood glucose levels were measured at the indicated time points 
and the area under the curve (AUC) of the glucose excursion curve was calculated as a measure for 
glucose tolerance (E). An i.p. insulin tolerance test (1U/kg lean body mass) was performed in 4h-fasted 
mice at week 3. Blood glucose levels were measured at the indicated time-points, and the AUC of the 
glucose excursion curve was calculated as a measure for insulin resistance (F). Results are expressed 
as means ± SEM. * P<0.05 HFD vs LFD, # P<0.05 PBS vs SEA (n = 11-13 animals per group in A-E and 3-6 



























Figure 5. SEA treatment promotes adipose tissue Th2 polarization, and accumulation of eosinophils 
and alternatively-activated M2 macrophages. Mice were fed a LFD or HFD for 12 weeks, after which 
they were treated i.p. with PBS or 50 µg SEA once every 3 days for a period of 4 weeks. At sacrifice 
(week 4), gonadal adipose tissue was collected and processed as described in the legend of Fig. 3. 
Following fixation, SVF cells were stained and analyzed by flow cytometry. Gating schemes for ex vivo 
analysis of lymphocyte subsets are shown in Supplemental Fig. 1. The numbers of eosinophils (A) and 
M1 and M2 macrophages (B) per gram tissue were determined, and the M2/M1 ratio was calculated 
(C). The numbers of CD4+ T cells and ILCs were determined (D). Intracellular cytokine production was 
analyzed after 4h stimulation with PMA and ionomycin in the presence of brefeldin A. Following gating 
on Aqua-CD45+ cells, lymphocyte subsets were analyzed by selecting for Thy1.2+ cells to enrich for 
T cells and ILCs. CD4+ T cells were subsequently identified as Lineage+CD4+ cells, in which the lineage 
cocktail included antibodies against CD3, CD11b, CD11c, B220, GR-1 and NK1.1. ILCs were identified 
as Lineage-CD4- cells. Representative flow cytometry plots show the gating strategy for analysis of 
cytokine-expressing CD4+ T cells and ILCs (E). The frequencies of cytokine-expressing T cells (F) and 
ILCs (G) were determined. mRNA expression of the indicated genes was analyzed as described in the 
legend of Fig. 3 (H). Retnla encodes Fizz1; Chil3 encodes Ym1. Results are expressed as means ± SEM. 
*P<0.05 HFD vs LFD, #P<0.05 PBS vs SEA (n = 9-13 animals per group for all measurements except for 
intracellular analysis of IL-5 (n = 3-7).
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As classical activation of liver macrophages has also been observed in diet-induced obesity 
(39), we determined the effect of SEA treatment on the hepatic immune cell composition. 
Analysis of myeloid cells showed that HFD did not affect liver eosinophil numbers (Fig. 6A). 
Assessment of CD45+Siglec-F-CD11bloF4/80hi macrophages (Fig. 6B), which were identified 
previously as Kupffer cells (40), showed that HFD promoted CD11c expression in these cells 
with no effect on Ym1 expression (Fig. 6C), thereby strongly decreasing the Ym1/CD11c ratio 
(Fig. 6D).  HFD also decreased the numbers of CD4+ T cells and ILCs (Fig. 6E), although analysis 
of cytokine production (Fig. 6F) showed that HFD did not affect expression of Th2 cytokines 
by T cells (Fig. 6G). HFD reduced the frequency of IL-5- and IL-13-expressing ILCs (Fig. 6G). 
SEA injections promoted eosinophil infiltration (Fig. 6A), but did not affect macrophage 
polarization (Fig. 6B,C), which was also confirmed by qPCR analysis (Fig. 6I). In line with our 
findings in WAT, SEA strongly increased expression of IL-4, IL-5 and IL-13 by CD4+ T cells in 
the liver (Fig. 6G), without a pronounced effect on the expression of type 2 cytokines by ILCs 
(Fig. 6H). Taken together, these findings  indicate that helminth-derived molecules improve 
metabolic homeostasis, associated with the induction of eosinophils and Th2 cells in WAT and 
liver, and M2 macrophage polarization in WAT. 
discussion
Over the past decade, it has become increasingly clear that multiple facets of the Th2-
associated immune response promote metabolic homeostasis (6). Landmark studies have 
shown that infection of diet-induced obese mice with the rodent nematode N. brasiliensis 
ameliorates whole-body insulin sensitivity and glucose tolerance (18;26). In the present 
study, we analyzed which aspects of whole-  body energy metabolism and WAT immune cell 
composition are affected by helminths, using a model of chronic S. mansoni infection. Unlike 
N. brasiliensis, which gives a strong Th2 response that mediates parasite clearance within two 
weeks, S. mansoni establishes a chronic infection, characterized by the presence of Th2 cells, 
alternatively activated macrophages, and a regulatory network (29). To study the effect of Th2-
inducing conditions in a pathogen-free setting, we next exposed mice on a HFD to repetitive 
injections with S. mansoni soluble egg antigens.
We report that chronic exposure to S. mansoni induces a type 2 immune response in 
adipose tissue and improves both insulin sensitivity and glucose tolerance. These findings 
indicate that the beneficial effect of chronic S. mansoni infection on whole-body metabolic 
homeostasis, as reported previously for short-lived infection with N. brasiliensis (18;26), is a 
hallmark of helminth infection. Unique to our study, we have performed in-depth metabolic 
profiling, which showed that helminth infection specifically reduced fat mass and dampened 
HFD-induced adipocyte hypertrophy. However, we surprisingly did not find any changes in 
food intake or energy expenditure in our experimental conditions, leading us to speculate 
that chronic S. mansoni infection may affect nutrient efficiency by impairing intestinal lipid 
absorption. Another possibility is that dietary fat could be incorporated into eggs by the 
worms and next excreted through the feces. Further studies are required to clarify this specific 
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point. Remarkably, infection improved fasting plasma glucose and insulin levels, whole-body 
glucose tolerance and insulin sensitivity in HFD-fed mice. Among the possible underlying 
mechanisms, we found that S. mansoni reversed HFD-induced inhibition of peripheral glucose 
uptake, which may be secondary to tissue-specific improvement of insulin sensitivity, as 
S. mansoni-infected HFD-fed mice exhibited higher insulin-induced PKB phosphorylation in 
WAT than uninfected controls. 
Except for small effects on adipocyte volume, fasting insulin and energy expenditure, 
none of the metabolic parameters analyzed were affected by S. mansoni infection in mice on 
LFD, suggesting that helminths improve metabolic homeostasis independently of putative 






































Figure 6. SEA treatment promotes accumulation of eosinophils and Th2 polarization in liver. Mice were 
fed a LFD or HFD for 12 weeks, after which they were treated i.p. with PBS or 50 µg SEA once every 3 days 
for a period of 4 weeks. At sacrifice, livers were collected and a small piece was snap-frozen for qPCR 
analysis. From the remaining liver tissue, CD45+ cells were isolated and analyzed by flow cytometry. Gating 
schemes for ex vivo analysis of lymphocyte subsets are shown in Supplemental Fig. 1. The numbers of 
eosinophils (A) were determined. Kupffer cells were gated based on CD11b and F4/80 expression in Aqua-
CD45+Siglec-F- cells (B). The number of CD11c+ and Ym1+ Kupffer cells (C) per gram liver were determined, 
and the Ym1+/CD11c+ ratio was calculated (D). The numbers of CD4+ T cells and ILCs were determined (E). 
Intracellular cytokine expression was analyzed as described in the legend of Fig. 5. The gating strategy for 
analysis of cytokine-expressing CD4+ T cells and ILCs is shown (F). The frequencies of cytokine-expressing 
CD4 T cells (G) and ILCs (H) were determined. mRNA expression of the indicated genes was analyzed as 
described in the legend of Fig. 3 (I). Emr1 encodes F4/80; Itgax encodes CD11c; Retnla encodes Fizz1; Chil3 
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S. mansoni-induced pathologies. We cannot exclude the possibility that part of the effect may 
be secondary to body weight loss or increased glucose/lipid metabolism by the helminths 
themselves. However, sustained exposure to SEA did not significantly affect body weight, 
but improved HOMA-IR, whole-body glucose tolerance and insulin sensitivity, in line with 
a previous report (41). Taken together, these findings suggest that the beneficial effects of 
helminths on metabolic homeostasis are not secondary to parasitism on host metabolism, 
but likely due to a direct effect on metabolic tissues or immune cells. 
We demonstrate that S. mansoni infection reduced diet-induced body weight gain and 
improved HOMA-IR, once infection was established beyond 6 weeks. Glucose tolerance 
and peripheral glucose uptake were also improved after 11 but not 5 weeks of infection 
(Supplemental Fig. 3). Since egg production by adult worms triggers the development of a 
type 2 response ~6 weeks after infection (42), it is therefore likely that the beneficial effect 
of helminths on metabolic homeostasis may be mediated by the presence of eggs. This is 
further supported by our data showing that S. mansoni egg-derived soluble molecules improve 
glucose tolerance and insulin sensitivity in HFD-fed mice. Interestingly, improvements in 
metabolic homeostasis were also found in obese mice treated with the LewisX-containing 
glycan LNFPIII (41). Of note, we have demonstrated previously that omega-1, a LewisX-containing 
immunomodulatory RNase isolated from SEA, skews strong Th2 responses (43;44). Whether 
omega-1 contributes to the beneficial effect of helminth infection or SEA injection on energy 
homeostasis requires further study.
It is well-established that adipocyte hypertrophy in response to HFD induces cell 
necrosis, leading to the infiltration of M1 macrophages which later form crown-like 
structures around the necrotic cells (45;46). Chronic S. mansoni infection did not reduce M1 
gene expression or cell numbers, suggesting that M1 macrophages continue to reside in 
WAT, even though glucose homeostasis improves. In line with this, SEA injections did not 
affect M1 cell numbers. These findings differ from a study by Fujisaka et al. (47) in which 
the anti-diabetic drug pioglitazone reduced expression of the CD11c-encoding gene, and 
lowered M1 cell numbers in gonadal WAT in HFD-fed mice. In addition, both infection with 
N. brasiliensis and pioglitazone treatment reduced total WAT macrophages (18;47), whereas 
chronic S. mansoni infection or SEA administration increased WAT macrophage numbers, as 
a result of an increase in M2 numbers. Taken together, these findings indicate that the M2/
M1 ratio, rather than an increase or decrease in a particular macrophage subset, might be 
critical for metabolic homeostasis.
Mechanistically, the rise in WAT M2 macrophage numbers following chronic S. mansoni 
infection or repeated SEA administration may be a result of local macrophage proliferation, 
which has been reported in the pleural cavity upon infection with the filarial helminth 
Litomosoides sigmodontis in response to IL-4 (48). An alternative explanation could be that 
S. mansoni or SEA induce WAT monocyte infiltration and differentiation into M2 macrophages, 
which is plausible since we observed a significant increase in blood CD11b+Ly6C+ inflammatory 
Ym1-expressing monocytes during chronic infection (data not shown). Of note, it is rather 
unlikely that helminth-derived molecules trigger M2 polarization by directly interacting with 
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macrophages, as it has been described that SEA treatment does not induce expression of Chil3 
(encoding Ym1), Mrc1 and Arg1 by bone marrow-derived macrophages in vitro (27). 
Importantly, it was demonstrated recently that maintenance of M2 macrophages in WAT 
depends on the presence of IL-4-secreting eosinophils (18), which are sustained by IL-5- and 
IL-13-producing ILC2s (19). In our study, we showed that chronic S. mansoni infection and SEA 
treatment promoted eosinophil accumulation in WAT, consistent with a previous reports on N. 
brasiliensis infection (18;19), and increased the mRNA levels of the type 2 cytokines IL-4 and IL-5. 
By analyzing intracellular IL-4, IL-5 and IL-13 cytokine production by lymphocytes isolated from 
gonadal WAT of SEA-treated mice, we found that CD4+ T cells, but not ILCs, produced increased 
levels of these type 2 cytokines. Recent literature described that IL-13 production by ILC2s in 
response to S. mansoni egg challenge peaks after 7 days of challenge and is reduced to baseline 
by day 21 (49). Since we analyze cytokine responses after 4 weeks of SEA administration, we 
speculate that ILC2 cytokine production has already diminished. Therefore, it is still possible 
that S. mansoni-induced ILC2s may be the first trigger for eosinophilia and accumulation of M2 
macrophages in WAT. Then, at a later stage of infection or after long-term helminth antigen 
exposure, Th2-derived cytokines such as IL-4 may mediate M2 proliferation (48). Of note, we 
analyzed expression of a variety of eosinophil-attracting chemokines and eotaxins in WAT, but 
found no effect of SEA treatment (data not shown). Taken together, the interaction between 
the different cell types involved, as well as their relative contribution to the beneficial effect 
of helminths on WAT insulin sensitivity and whole-body metabolic homeostasis, requires 
further studies.
In addition to profound effects of SEA treatment on immune cells in WAT, we also observed 
increased eosinophilia and Th2 cytokine expression in the liver, suggesting that the adipose 
tissue is not an exclusive target of S. mansoni-derived antigens. Interestingly, it has been 
reported that both IL-4 and IL-13 may contribute to glucose homeostasis by directly regulating 
hepatic insulin sensitivity and glucose production, respectively (21;50). Helminth molecules 
may indeed work as a double-edged sword, acting on inflammatory and metabolic pathways 
in WAT and liver. The exact contribution of the liver to the whole-body metabolic beneficial 
phenotype observed in response to SEA treatment remains to be clarified. 
In conclusion, our work has revealed that chronic infection with S. mansoni, as well as SEA 
treatment, protects against metabolic disorders in a mouse model of HFD-induced obesity. 
We have established that S. mansoni reduces adipocyte size and promotes peripheral glucose 
uptake and WAT-specific insulin sensitivity. Through analysis of immune cell composition at the 
cellular level, we show that SEA injections strongly increase eosinophils and Th2 cells in both 
WAT and liver, although they only promote M2 macrophage polarization in WAT. Collectively, 
our data identify S. mansoni-derived egg antigens as attractive agents for therapeutic 
manipulation of the immune system in the context of metabolic disorders. Several clinical trials 
are currently registered to assess the safety or efficacy of helminth therapy for the treatment 
of various inflammatory diseases in humans. As helminth infections can induce pathological 
conditions, studies are now focusing on helminth-derived molecules (51;52). The identification 
of single active molecules and the mechanisms by which they improve whole-body metabolic 
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homeostasis may offer new insights toward the development of novel therapeutics for the 
treatment of metabolic syndrome. 
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Figure S1. Gating strategies. Isolated cells were pre-gated on Aqua-CD45+ single cells (A). The gating 
strategy for analysis of eosinophils, CD11c+ M1 macrophages and Ym1+ M2 macrophages is shown, 
including Fluorescence Minus One (FMO) controls for Ym1 and CD11c, in a representative sample from 
the chronic infection study (B) and the i.p. injection study (C). The gating strategy is shown for NK cells, 
NKT cells, CD4+ T cells, CD8+ T cells and B cells in a representative sample from the chronic infection study 
(D), and for CD4+ T cells and innate lymphoid cells (ILCs) in in a representative sample from the i.p. study 
(E). For ex vivo analysis of CD4+ T cells and ILCs, the lineage cocktail included antibodies against CD11b, 
CD11c, B220 and GR-1. Note: Gating on CD4+ T and ILCs with CD3 in the lineage channel gave similar results. 
Representative samples were chosen from gonadal adipose tissue; gating strategies were similar for the 
analysis of myeloid and lymphoid subsets in visceral adipose tissue and liver. 
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Figure S2. Lymphocyte composition of WAT. Mice were fed a LFD or a HFD for 6 weeks before infection 
with S. mansoni cercariae or sham-infection for 12 weeks. At sacrifice (week 12), various adipose tissues 
were collected and their stromal vascular fractions (SVF) were isolated. Following fixation, SVF cells were 
stained and analyzed by flow cytometry. The gating strategy is shown in figure S1D. The numbers of 
CD45+ leukocytes and indicated lymphocyte populations per gram tissue for gonadal (A) and visceral (B) 
WAT were determined. Results are expressed as means ± SEM. *P<0.05 vs LFD, #P<0.05 vs sham-infected 
group (n = 12-18 animals per group in A, and 5-13 animals per group in B).
Figure S3. S. mansoni infection does not affect glucose tolerance or uptake after 5 weeks of 
infection. Mice were fed a LFD or a HFD and were infected with S. mansoni as described in the legend 
of Fig. S2. An intravenous glucose tolerance test (2g D-glucose with 50% [6,6-2H2]glucose / kg BW) was 
performed in 6h-fasted mice at week 5. Blood glucose levels were measured at the indicated time 
points and the area under the curve (AUC) of the glucose excursion curve was calculated (A). Blood 
was also collected for determination of the time-dependent change in [6,6-2H2]glucose concentration 
by gas chromatography mass spectrometry. For each mouse, a decay curve was fitted of which the 
slope represents peripheral glucose uptake (B). Results are expressed as means ± SEM. *P<0.05 vs LFD 
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Chapter 6
abstract
Chronic low-grade inflammation associated with obesity is one of the major contributors to 
insulin resistance, enhancing the risk for type 2 diabetes and cardiovascular diseases. The 
mannose receptor (MR) is an endocytic C-type lectin receptor predominantly expressed by 
dendritic cells and macrophages, including alternatively activated M2 macrophages that 
protect against insulin resistance. To investigate the role of MR on whole-body metabolic 
homeostasis, wild-type (WT) and MR knockout (MR-/-) mice were studied following 18 weeks 
of low-fat diet (LFD) or high-fat diet (HFD). Although no metabolic phenotype was observed 
in LFD-fed MR-/- mice, on HFD we found significant reductions in total body weight (-8.3%), 
fat mass gain (-25.6%), and liver weight (-16.6%) compared to WT mice. Furthermore, MR 
deficiency lowered HFD-induced alterations in both whole-body glucose tolerance and insulin 
sensitivity (-22.9% and -17.1%, respectively), as assessed by intraperitoneal glucose and insulin 
tests. This effect was associated with enhanced locomotor activity, food intake and energy 
expenditure in MR-/- mice when compared to WT. Remarkably, analysis of the immune cell 
composition of metabolic organs indicated that HFD decreased white adipose tissue (WAT) 
eosinophil numbers in WT but not MR-/- mice. In addition, MR-/- mice were less susceptible to 
HFD-induced classical activation of macrophages, in both WAT and liver. In conclusion, we 
show that whole-body MR deficiency lowers HFD-induced chronic low grade inflammation 
of metabolic tissues and protects against insulin resistance in obese mice, suggesting that MR 
might play an unexpected role in the development of metabolic disorders.
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introduction
The mannose receptor (MR, CD206) is an endocytic C-type lectin receptor implicated in 
binding of glycoproteins from endogenous and microbial origin, and in antigen presentation 
(1). Over the past decade, it has become clear that the MR may play a pivotal role in regulating 
type 2 inflammatory responses. For example, MR is required for Th2 polarization by human 
monocyte-derived dendritic cells stimulated with helminth antigens (2) and Der p 1 allergen 
(3). In line with these findings, lack of MR was shown to promote Th1 cytokine production 
following Schistosoma mansoni infection (4), and to reduce IgE production in response to 
allergen sensitization (5). Furthermore, MR-deficient mice exhibit defective clearance of 
endogenous serum glycoproteins (6), and it was recently described that MR expression by 
macrophages mediates collagen uptake (7), suggesting that the receptor may also contribute 
to tissue repair and remodeling.
MR is predominantly expressed by subpopulations of dendritic cells and macrophages, 
including microglial cells (8;9), although its expression is not only restricted to leukocytes. For 
example, in mice, MR is also expressed by hepatic, splenic, lymphatic and dermal microvascular 
endothelia, and by glomerular kidney mesangial cells, tracheal smooth muscle cells, and 
retinal pigment epithelium (1;9;10). Macrophage subpopulations are traditionally classified 
along a linear scale, on which pro-inflammatory M1 macrophages represent one extreme, 
and alternatively activated M2 macrophages the other (11). While classical activation of 
macrophages depends on T helper 1-associated cytokines like IFN-y (12;13), M2-like activation 
is mediated by type 2 cytokines, like IL-4 and IL-13, which concomitantly promote upregulation 
of MR expression (14;15).
While accumulation of TNF-α-secreting M1 macrophages has been reported in both liver 
and white adipose tissue (WAT) of obese mice, M2 macrophages prevail in lean adipose tissue 
and liver (16-19), where they can mediate energy homeostasis via multiple routes. WAT M2 
macrophages were shown to secrete IL-10, which can act directly on adipocytes to potentiate 
insulin signaling and therefore inhibit TNF-α-induced insulin resistance (18;20). In addition, 
M2 macrophages mediate tissue repair (reviewed in (21)) and regulate thermogenesis by 
promoting biogenesis of beige fat in response to cold (22;23). In liver, M2-like Kupffer cells were 
suggested to directly modulate hepatic metabolism in favor of β-oxidation and mitochondrial 
oxidative phosphorylation (16). The M2 phenotype is sustained by cells that secrete type 2 
cytokines, like eosinophils (24) and type 2 innate lymphoid cells (25), which thereby also 
contribute to metabolic homeostasis.
Although expression of MR is a hallmark of the M2 phenotype (14), and a close link has been 
described between MR and type 2 inflammation, the role of the MR in metabolic homeostasis 
remains unclear. In the present study, we therefore studied whole-body insulin sensitivity and 
glucose homeostasis, and immune cell polarization in metabolic organs from wild-type (WT) 
and MR-deficient mice (MR-/-) fed a low-fat diet (LFD) or high-fat diet (HFD). We report that 
MR-/- mice are less susceptible to HFD-induced obesity, insulin resistance and inflammation 
of metabolic tissues than WT mice, suggesting that the MR plays an unexpected role in the 




MR deficiency protects against HFD-induced obesity
Before being put on LFD or HFD, three-month-old WT and MR-/- mice were similar in terms of 
body weight, lean mass, fat mass, and fasting plasma glucose and triglyceride levels (Table S1). 
However, MR-/- mice had slightly higher fasting plasma cholesterol levels, and a trend for 
lower insulin levels (Table S1). To investigate the impact of MR deficiency on whole-body 
energy and metabolic homeostasis, C57BL/6 WT and MR-/- mice were fed a LFD or HFD for 18 

































Figure 1. MR deficiency protects against HFD-induced weight gain, fat mass gain and adipocyte 
hyperplasia. Wild-type (WT) and MR-deficient (Mrc1) mice were fed a LFD or a HFD for 18 weeks. 
Throughout the experimental period, body weight (A) and body composition were monitored, and fat 
mass (B) and lean mass (C) were determined. At sacrifice, the weight of the different white fat pads (D) and of 
the subcutaneous brown fat (E) were measured, as well as the adipocyte mean volume (F) and the number 
of adipocytes (G). Liver weight was determined at sacrifice (H), and food intake was assessed using fully 
automated single-housed metabolic cages at week 16 (I). Results are expressed as means ± SEM. * P<0.05 
HFD vs LFD, # P<0.05 WT vs Mrc1 (n = 10-15 animals per group in A-E,H, and 4-8 animals per group in F,G,I). 
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without affecting lean mass (Fig. 1C) in both WT and MR-/- mice. However, MR-/- mice gained 
significantly less body weight than WT mice (Fig. 1A), secondary to a decrease in fat mass gain 
(Fig. 1B). Analysis of the individual fat pads showed that MR deficiency impaired HFD-induced 
weight gain of WAT (Fig. 1D) and brown adipose tissue (Fig. 1E). White adipocyte volume 
was not significantly different between genotypes (Fig. 1F), but the number of adipocyte 
cells was lower in HFD-fed MR-/- when compared to WT mice (Fig. 1G). MR deficiency also 
impaired HFD-induced gain of liver mass (Fig. 1H), suggesting a reduction in hepatic steatosis. 
Importantly, the effects of MR deficiency on body composition were not due to a decrease 
in food consumption, since lack of MR was rather accompanied by a mild increase in caloric 
intake (Fig. 1I). 
Furthermore, HFD reduced locomotor activity (Fig. 2A) and energy expenditure (EE; Fig. 2B) 
in WT mice, but not in MR-/- mice. In both genotypes, HFD reduced carbohydrate oxidation 
(CHO; Fig. 2C) and increased fatty acid oxidation (FAO; Fig. 2D), although MR-/- mice were found 
to oxidize slightly more carbohydrates (Fig. 2C). Taken together, these findings show that MR-/- 
mice are partly protected against HFD-induced obesity, an effect associated with increased 
locomotor activity, food intake and energy expenditure. 
MR deficiency improves whole-body glucose tolerance and insulin sensitivity in 
HFD-fed mice
We next investigated the effect of MR deficiency on fasting plasma parameters in LFD- and 
HFD-fed mice. In both genotypes, HFD increased plasma glucose (Fig. 3A) and insulin levels 
(Fig. 3B), HOMA-IR (Fig. 3C), and total cholesterol (Fig. 3D), without affecting triglyceride levels 
(Fig. 3E). However, lack of MR significantly decreased the HFD-induced rise in plasma insulin 
levels (Fig. 3B) and improved HOMA-IR (Fig. 3C), suggesting a lower insulin resistance than 
WT mice. In line with these findings, HFD-fed MR-/- mice exhibited a better glucose tolerance, 
as assessed by an intraperitoneal glucose tolerance test (ipGTT Fig. 3F), without a change in 
insulin levels (Fig. 3G), indicating improvement in whole-body insulin sensitivity. This was 
confirmed by an intraperitoneal insulin tolerance test (ipITT) showing that acute injection of 
insulin lowered glucose levels to a larger extent in MR-/- mice compared to WT mice (Fig. 3H). 
Taken together, these findings suggest that MR-/- mice are less susceptible to HFD-induced 
metabolic dysfunctions than WT mice.
MR deficiency attenuates HFD-induced inflammation in adipose tissue 
Based on the finding that M2 macrophages protect against insulin resistance (26), and the 
association between the MR and the M2 phenotype (14), we next investigated whether MR 
deficiency affects adipose tissue inflammation. We isolated the stromal vascular fraction (SVF) 
from gonadal WAT and analyzed the immune cell composition by flow cytometry. Analysis 
of myeloid cells  (Fig. 4A) indicated that HFD reduced the numbers of eosinophils (Fig. 4B) 
and neutrophils (Fig. 4C) only in WT mice and not in MR-/- mice. Furthermore, HFD increased 
the number of M1 macrophages in WT mice (Fig. 4D), thereby decreasing the M2/M1 ratio 







Figure 2. HFD does not affect locomotor activity and energy expenditure in MR-/- mice. Wild-type (WT) 
and MR-deficient (Mrc1) mice were fed a LFD or a HFD for 18 weeks. At week 16, mice with free access to 
food and water were subjected to individual indirect calorimetric measurements using fully automated 
metabolic cages. Spontaneous locomotor activity (A), energy expenditure (EE; B), carbohydrate oxidation 
(CHO; C) and fatty acid oxidation (FAO; D) were determined. Results are expressed as means ± SEM. 
* P<0.05 HFD vs LFD, # P<0.05 WT vs Mrc1 (n = 6-8 animals per group).
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or genotype (Fig. 4E), MR-deficient mice had higher numbers of M2 macrophages, and were 
partly protected against HFD-induced M1 polarization (Fig. 4F). As a consequence, HFD did not 
alter the M2/M1 ratio in MR-/- mice (Fig. 4G). These findings were confirmed by quantitative PCR 
(qPCR), which indicated that lack of MR reversed HFD-induced increases in gene expression 
levels of Itgax (encoding CD11c), and the chemokine receptor Ccr2 (Fig. S1A). Interestingly, 
neither diet nor genotype affected the numbers of eosinophils, neutrophils and inflammatory 
monocytes in the blood (Fig. S2), suggesting that the observed changes in myeloid immune 
cell composition are adipose tissue-specific. 
Cells that secrete type 2 cytokines were shown to promote alternative activation of 
macrophages (13). Therefore, T cell and ILC responses in WAT of HFD-fed mice were analyzed 
next (Fig. 4G). MR deficiency significantly increased the frequency of ILCs, but not CD4+ T cells 
(Fig. 4H). Analysis of cytokine expression following ex vivo stimulation with phorbol myristate 
acetate (PMA) and ionomycin showed that IL-13 expression by WAT CD4+ T cells and ILCs was 
not significantly different between genotypes (Fig. 4I). We confirmed these findings by qPCR, 
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Figure 3. MR deficiency improves whole-body glucose tolerance and insulin sensitivity in HFD-fed 
animals. Wild-type (WT) and MR-deficient (Mrc1) mice were fed a LFD or a HFD for 18 weeks. At week 
18, mice were fasted for 4h and plasma was collected to determine glucose (A) and insulin levels (B), 
HOMA-IR (C), and total cholesterol (D) and triglyceride levels (E). An intravenous glucose tolerance test 
(2g D-glucose/kg body weight) was performed in 6h-fasted mice at week 17. Blood glucose levels were 
measured at the indicated time points and the area under the curve (AUC) of the glucose excursion curve 
was calculated as a measure for glucose tolerance (F). 15 minutes after the i.p. bolus of glucose, blood 
was also collected for analysis of plasma insulin levels (G). An i.p. insulin tolerance test (1U/kg lean body 
mass) was performed in 4h-fasted mice at week 15. Blood glucose levels were measured at the indicated 
time points (H). Results are expressed as means ± SEM. * P<0.05 HFD vs LFD, # P<0.05 WT vs Mrc1. Figures 
F, and H: only statistical significance of HFD WT vs HFD Mrc1 is shown (n = 10-15 animals per group in A-E, 
and 3-10 animals per group in F-H).
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Figure 4. MR-deficient mice are less sensitive to HFD-induced inflammation in adipose tissue. 
Wild-type (WT) and MR-deficient (Mrc1) mice were fed a LFD or a HFD for 18 weeks. At sacrifice, gonadal 
adipose tissue was collected and the stromal vascular fraction (SVF) was isolated. Following fixation and 
permeabilization, SVF cells were stained and analyzed by flow cytometry. Cells were pre-gated for Aqua-
CD45+ single cells. The gating strategy is shown for eosinophils, neutrophils, CD11c+ M1 macrophages 
and YM1+ M2 macrophages (A). The numbers of eosinophils (B), neutrophils (C), total macrophages (D) 
and M1 and M2 macrophages (E) per gram WAT were determined and the M2/M1 ratio was calculated (F). 
Following gating on Aqua-CD45+ single cells, lymphocyte subsets were analyzed by selecting for Thy1.2+ 
cells to enrich for T cells and ILCs. T cells were subsequently identified as Lineage+CD4+ cells, in which the 
lineage cocktail included antibodies against CD3, CD11b, CD11c, B220, GR-1, and NK1.1. ILCs were identified 
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which indicated that expression of pro- and anti-inflammatory cytokines was largely similar 
between groups (Fig. S1A). 
MR deficiency attenuates HFD-induced activation of Kupffer cells
Obesity has also been associated with classical activation of liver macrophages (19). Therefore, 
CD45+ cells were isolated from liver and the hepatic immune cell composition was studied. 
Analysis of myeloid cells (Fig. 5A) showed that neither HFD nor genotype affected the numbers 
of eosinophils (Fig. 5B), neutrophils (Fig. 5C), monocytes (not shown), or CD45+SiglecF-
CD11bloF4/80hi macrophages (Fig. 5D), which were previously identified as Kupffer cells (27). 
Although we did not observe an effect of diet or genotype on YM1 expression by Kupffer cells, 
HFD significantly increased the expression of CD11c by these cells in WT mice, as expected (19). 
Remarkably, CD11c expression by Kupffer cells from MR-/- mice was not affected by HFD-feeding 
(Fig. 5E). These findings were confirmed and expanded by qPCR analysis, which showed that 
HFD-feeding induced expression of Itgax, Nos2, Ccl2 and Ccr2 in WT but not MR-/- mice (Fig. S1B).
Analysis of cytokine responses (Fig. 5F) indicated that HFD reduced the frequency of 
type 2 cytokine-expressing CD4+ T cells (Fig. 5G) and ILCs (Fig. 5H) in the livers of WT mice. 
Furthermore, expression of the ILC2-associated marker ICOS was decreased as a consequence 
of HFD (Fig. 5I). Although not significant, similar trends were observed for MR-/- mice fed a HFD. 
These findings were confirmed by qPCR (Fig. S1B). Taken together, the results indicate that MR 
deficiency reduces susceptibility to HFD-induced classical activation of macrophages, in both 
WAT and liver. 
discussion
Alternatively activated M2 macrophages prevail in lean adipose tissue and protect against diet-
induced metabolic disorders (26). Because the MR is highly expressed by M2 macrophages (14), 
we explored the role the MR in the context of diet-induced obesity using MR-/- mice. We report 
that lack of MR did not affect whole-body glucose tolerance and insulin sensitivity in mice 
fed a LFD, but counterintuitively improved metabolic homeostasis in mice fed a HFD despite 
considerable weight gain. Specifically, MR-/- mice on HFD were less susceptible to fat mass 
gain and adipocyte hyperplasia, had a higher locomotor activity, and showed better insulin 
sensitivity and glucose tolerance than WT mice on HFD. Immune profiling indicated that in line 
with their metabolic phenotype, MR-deficient mice were less sensitive to HFD-induced classical 
activation of M1-like macrophages, in both liver and adipose tissue. Furthermore, in WAT, HFD 
reduced eosinophil and neutrophil numbers in WT but not MR-/- mice. Contrary to expectations, 
as Lineage-CD4- cells (G). The numbers of CD4+ T cells and ILCs per gram WAT were determined (H). 
Intracellular IL-13 expression was analyzed after 4h stimulation with PMA and ionomycin in the presence 
of Brefeldin A, the frequencies of IL-13+ CD4+ T cells and the frequencies of IL-13+ ILCs are shown (I). Results 
are expressed as means ± SEM. * P<0.05 HFD vs LFD, # P<0.05 WT vs Mrc1 (n = 10-15 animals per group in 
A-F, and 5-10 animals per group in G-I).
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Figure 5. MR-deficient mice are less sensitive to HFD-induced activation of Kupffer cells. Wild-type 
(WT) and MR-deficient (Mrc1) mice were fed a LFD or a HFD for 18 weeks. At sacrifice, CD45+ liver cells 
were isolated and analyzed by flow cytometry as described in the legend of Figure 4. The gating strategy 
is shown for eosinophils, neutrophils, CD11c+ Kupffer cells and YM1+ Kupffer cells (A). The numbers of 
eosinophils (B), neutrophils (C), Kupffer cells (D), and CD11c+ and YM1+ Kupffer cells (E) per gram of liver 
tissue were determined. Intracellular cytokine expression was analyzed after 4h stimulation with PMA and 
ionomycin in the presence of Brefeldin A. The gating strategy, as described in the legend of Figure 4, is 
shown for CD4+ T cells and ILCs (F). The frequencies of IL-5+ and IL-13+ CD4+ T cells (G) and IL-5+ and IL-13+ 
ILCs (H) are shown, and the expression of ICOS by ILCs was analyzed (H). Results are expressed as means 
± SEM. * P<0.05 HFD vs LFD, # P<0.05 WT vs Mrc1 (n = 10-15 animals per group).
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M2-like activation and type 2-associated cytokine expression by T helper cells and ILC2s were 
not as strongly affected by genotype. These effects were surprising, given the association 
between MR and the M2 phenotype (14), and the pivotal role MR plays in the initiation of 
type 2 immune responses (2-5). The question whether immune- on non-immune-mediated 
mechanisms promote metabolic health in MR-deficient obese mice needs to be addressed. 
We observed that MR-deficient mice are less susceptible to HFD-induced classical activation 
of macrophages. A possible immune-based explanation may be provided by our finding that 
M1 macrophages can also express MR, albeit to a much lower extent than M2 macrophages 
(unpublished data). In this context, it is worth mentioning that macrophage-associated 
scavenger receptors have been described to promote either pro- or anti-inflammatory responses 
depending on the co-receptor they form complexes with (28), and it has been suggested that 
the MR can form complexes with other receptors (29). Taken together, these observations 
may indicate that the MR can deliver a signal directly into the MR-bearing macrophage, which 
may result in polarization of either pro- or anti-inflammatory macrophages, depending on the 
nature of the co-receptors. Future studies are needed to elucidate whether MR expression by 
macrophages indeed mediates a pro-inflammatory phenotype under HFD conditions. 
It is important to consider that MR-/- mice lack whole-body expression of the Mrc1 gene. In 
the mouse adult brain, MR is expressed by microglia and astrocytes, although its activities and 
involvement in brain functions are largely unknown (30). Of note, hypothalamic inflammation 
has been described to contribute to HFD-induced weight gain by promoting accumulation 
of microglia and astrocytes in various regions of the hypothalamus that coordinate the 
regulation of peripheral nutrient metabolism and energy expenditure (31;32). To study whether 
neuroinflammation differs between WT and MR-/- mice, we performed qPCR analysis on whole 
hypothalamus. Although we observed the classical HFD-induced increase in some markers of 
inflammation, we did not find significant effects of genotype on expression of inflammatory 
genes (not shown). Recent literature suggested that the brain can also regulate metabolic 
homeostasis through the cholinergic anti-inflammatory reflex. In this reflex, molecular 
products of inflammation promote the release of acetylcholine by the vagus nerve, which 
reduces inflammation (33). It was recently demonstrated that neuronal deletion of Pten, a 
negative regulator of the PI3K pathway, activates the anti-inflammatory reflex, which promotes 
WAT M2 polarization and protects against insulin resistance in mice on HFD (34). The question 
whether MR deficiency affects HFD-induced neuroinflammation and/or activation of the 
anti-inflammatory reflex, and the possible consequences for metabolic disorders, remains an 
intriguing area of research. 
MR expression is not only restricted to leukocytes (1), and the beneficial effect of MR 
deficiency on metabolic homeostasis might therefore be due to effects beyond the immune 
system or the brain. For example, high-fat diet-feeding increases LPS translocation from the 
gut (35), and it has been suggested that this so-called metabolic endotoxemia can contribute 
to M1 polarization in WAT (36). It would therefore be important to establish whether lack of 
MR affects LPS translocation and its circulating plasma level in response to HFD. Furthermore, 
MR on lymphatics is required for lymphocyte trafficking from the periphery into the draining 
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lymph nodes (37). MR deficiency may therefore prevent the induction of a strong immune 
response to HFD-feeding. Lastly, MR can also be expressed by cells in metabolic organs where 
it can play a functional role. Expression of MR by liver sinusoidal endothelial cells has been 
associated with clearance of lysosomal enzymes and collagen (6;38;39), and it was suggested 
that MR is required for the growth of skeletal muscle myofibers (40). We did not observe a 
metabolic phenotype in the LFD-fed MR-/- animals, but we cannot exclude the possibility 
that expression of MR in metabolic tissues may mediate insulin resistance when the system is 
triggered by HFD-feeding. 
In conclusion, our work has revealed an unexpected role for the MR in the development 
of obesity-induced metabolic disorders. Contrary to expectations, we have established that 
MR-/- mice are less susceptible to HFD-induced weight gain, insulin resistance and glucose 
intolerance. These effects were associated with increased locomotor activity and energy 
expenditure, and decreased classical activation of WAT and liver macrophages. Whether the 
protective effect of MR deficiency can be attributed to MR expression by immune or non-
immune cells remains an important area of research. Understanding these processes may 
offer valuable insights towards the development of targeted therapeutics for the treatment 
of metabolic syndrome. 
materials and methods
Animals and diet
All experiments were performed in accordance with the Guide for the Care and Use of 
Laboratory Animals of the Institute for Laboratory Animal Research and have received 
approval from the university Ethical Review Boards (Leiden University Medical Center, Leiden, 
The Netherlands). Male MR-/- mice on a CD57BL/6 background, generated as described 
previously (6), were provided by Dr. Sven Burgdorf (University of Bonn, Germany). MR-/- 
mice and age-matched C57BL/6 WT mice from the same breeding facility were housed in a 
temperature-controlled room with a 12 hour light-dark cycle. Throughout the experiment, 
food and tap water were available ad libitum. 8 – 10 week old mice were randomized 
according to total body weight, lean and fat mass, and fasting plasma glucose, insulin, TC 
and TG levels, after which they were fed a high-fat diet (HFD, 45% energy derived from 
fat, D12451, Research Diets) or a low-fat diet (LFD, 10% energy derived from fat, D12450B, 
Research Diets) for 18 weeks. Diets were similar in composition in all respects apart from 
the total fat content. 
Plasma analysis
Blood samples were collected at 1:00 pm using chilled paraoxon-coated capillaries from the 
tail tip of 4h-fasted mice 18 weeks after the start of LFD- or HFD-feeding. Blood glucose level 
was determined using a Glucometer (Accu-Check, Roche Diagnostics). Using commercially 
available kits and standards according to the instructions of the manufacturer, we determined 
total cholesterol and triglycerides (Instruchemie) and plasma insulin (Chrystal Chem).
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Glucose and insulin tolerance tests
Glucose tolerance was assessed by an ipGTT 17 weeks after the start of LFD- or HFD-feeding. 
Mice were fasted for 6h, and the tests were carried out at 2:00 pm. After an initial blood 
collection (t=0), an i.p. injection of glucose (2g D-Glucose/kg total body weight, Sigma-Aldrich) 
was administered in conscious mice. Blood glucose was measured by tail bleeding at 15, 30, 
60, 90 and 120 minutes after glucose administration using a Glucometer (Accu-Check, Roche 
Diagnostics). At 15 minutes, blood was also collected for analysis of plasma insulin levels as 
described above.
Whole-body insulin sensitivity was assessed by an ipITT at 15 weeks post-infection. 
Mice were fasted for 4h, and the tests were carried out at 1:30 P.M. After an initial blood 
collection (t=0), an i.p. bolus of insulin (1 U/kg lean body mass; NOVORAPID, Novo Nordisk) 
was administered to the mice. Blood glucose was measured by tail bleeding at 15, 30, 60, and 
90 min after insulin administration using a Glucometer.
Body composition and indirect calorimetry
Body composition was measured by MRI using an EchoMRI (Echo Medical Systems). Groups of 
eight mice with free access to food and water were subjected to individual indirect calorimetric 
measurements at 16 weeks after the start of the experiment for a period of 5 consecutive days 
using a Comprehensive Laboratory Animal Monitoring System (Columbus Instruments). Before 
the start of the measurements, the animals were acclimated to the cages and the single housing 
for a period of 48 h. Feeding behavior was assessed by real-time food intake. Spontaneous 
locomotor activity was determined by the measurement of beam breaks. Oxygen consumption 
and carbon dioxide production were measured at 15-min intervals. Energy expenditure and 
carbohydrate and fatty acid oxidation were calculated and normalized for body surface area 
(kg0.75), as previously described (41). 
Isolation of adipocytes and SVF from adipose tissue
Adipose tissues from the gonadal regions were collected. Two small fractions were taken for 
determination of adipocyte morphology and qPCR analysis, while the remainder was used 
for immune cell profiling by flow cytometry. For determination of adipocyte morphology, 
adipocytes were treated as described previously (Chapter 5, this thesis). The adipocyte size 
distribution, mean adipocyte diameter and volume, and adipocyte number per fat pad were 
calculated (42). For immune cell profiling by flow cytometry, adipose tissues were minced 
and digested for 1 h at 37°C in HEPES buffer (pH 7.4) containing 0.5g/l type 1 collagenase 
from Clostridium histolyticum (Sigma-Aldrich), 2% (w/v) dialyzed bovine serum albumin (BSA, 
fraction V, Sigma-Aldrich) and 6 mM glucose. Disaggregated adipose tissues were passed 
through 100 μm cell strainers which were washed with PBS supplemented with 2.5 mM EDTA 
and 5% FCS. After centrifugation (350 g, 10 minutes, room temperature), the supernatant of 
the filtrate was discarded and the pellet was treated with erythrocyte lysis buffer. The cells 
were washed once more and counted manually. Isolated SVF cells were split in two and either 
processed directly for the analysis of myeloid cells, or cultured for 4 hours in culture medium 
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in the presence of 100 ng/mL PMA, 1 µg/mL ionomycin and 10 µg/mL Brefeldin A (all Sigma-
Aldrich). Following staining with the live/dead marker Aqua (Invitrogen), cells were fixed with 
1.9% paraformaldehyde (Sigma-Aldrich) and stored in FACS buffer (PBS, 0.02% sodium azide, 
0.5% FCS) at 4°C in the dark until subsequent analysis.
Isolation of CD45+ cells from liver tissue
Livers were minced and digested for 45 minutes at 37°C in RPMI 1640 + Glutamax (Life Technologies) 
containing 1 mg/mL collagenase type IV from Clostridium histolyticum, 2000 U/mL DNase (both 
Sigma-Aldrich) and 1 mM CaCl2. The digested liver tissues were passed through 100 μm cell 
strainers which were washed with PBS supplemented with 2.5 mM EDTA and 5% FCS. Following 
centrifugation (530 g, 10 minutes, 4 degrees), the supernatant of the filtrate was discarded, after 
which the pellet was resuspended in PBS + 2.5 mM EDTA and 5% FCS and centrifuged at 50 g 
to remove hepatocytes (3 minutes, 4 degrees).  Next, supernatants were collected and pelleted 
(530 g, 10 minutes, 4 degrees). The pellet was treated with erythrocyte lysis buffer, and the cells 
were washed once more with PBS + 2.5 mM EDTA and 5% FCS. CD45+ cells were isolated using 
LS columns and CD45 MicroBeads (35 µL per liver, Miltenyi Biotec) according to manufacturer’s 
protocol. Isolated CD45+ cells were counted and processed as described for the SVF. 
Flow cytometry
For analysis of myeloid subsets, cells were permeabilized with 0.5% saponin (Sigma-Aldrich) in 
which they were also stained. Cells were incubated with an antibody against YM1 conjugated 
to biotin, washed, and stained with streptavidin-PerCP (BD Biosciences) and antibodies 
directed against CD45 (FITC), CD11b (PE-Cy7), CD11c (HV450), F4/80 (APC), Siglec-F (PE) and Ly6C 
(APC-Cy7). Analysis of lymphocyte subsets in CD45+ cells isolated from liver was done using 
antibodies against CD45 (FITC), NK1.1 (PE), CD3 (APC), CD4 (PE-Cy7), CD8 (APC-Cy7), and B220 
(eFluor450) diluted in FACS buffer. Finally, in PMA/ionomycin-stimulated samples, cytokine 
production of Th2 cells and ILCs was analysed following permeabilization as described above, 
using antibodies against CD11b (FITC), CD11c (FITC), GR-1 (FITC), B220 (FITC), NK1.1 (FITC), 
CD3 (FITC), CD4 (PerCP-eF710 or PE-Cy7), Thy1.2 (APC-eFluor780), and IL-13 (eFluor450). The 
stimulated CD45+ cells isolated from liver were also stained for ICOS (PE-Cy7) and IL-5 (PE), while 
the stimulated SVF was additionally stained for CD45 (PE). Flow cytometry was performed 
using a FACSCanto (BD Biosciences), and gates were set according to Fluorescence Minus One 
(FMO) controls. Antibody information is provided in Table S2.
RNA purification and qRT-PCR 
RNA was extracted from snap-frozen adipose tissue samples (~20 mg) using Tripure RNA 
Isolation reagent (Roche Diagnostics). Total RNA (1 µg) was reverse transcribed and quantitative 
real-time PCR was then performed with SYBR Green Core Kit on a MyIQ thermal cycler (Bio-Rad) 
using specific primers sets (available upon request). mRNA expression was normalized to RplP0 
mRNA content and expressed as fold change compared to non-infected LFD-fed mice using 
the ∆∆CT method. 
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Statistical analysis
All data are presented as mean ± standard error of the mean (SEM). Statistical analysis was 
performed using GraphPad Prism version 6.00 for Windows (GraphPad Software, La 
Jolla, CA, USA) with two-tailed unpaired Student’s t tests. Differences between groups 
were considered statistically significant at P < 0.05. For repeated measurements, data were 
analysed assuming the same scatter to increase power. 
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Figure S2. Diet and genotype do not affect myeloid cells in blood. Wild-type (WT) and MR-deficient 
(Mrc1) mice were fed a LFD or HFD for 18 weeks. At sacrifice, blood was collected and fixed using Lyse/
Fix buffer (BD Biosciences). Blood cells were counted, stained and analyzed by flow cytometry. The 
gating strategy is shown for eosinophils, neutrophils, monocytes, inflammatory monocytes, and YM1+ 
inflammatory monocytes (A). The numbers of eosinophils (B), neutrophils (C), inflammatory monocytes 
(D) and YM1+ inflammatory monocytes (E) per mL blood were determined. Results are expressed as means 
± SEM. * P<0.05 HFD vs LFD, # P<0.05 WT vs Mrc1 (n = 10-15 animals per group).
Figure S1. Analysis of inflammatory markers in adipose tissue and liver by qPCR. Wild-type (WT) and 
MR-deficient (Mrc1) mice were fed a LFD or HFD for 18 weeks. At sacrifice gonadal WAT and liver tissues 
were collected and immediately snap-frozen. mRNA expression of the indicated genes in gonadal WAT (A) 
and liver (B) was quantified by RT-PCR relative to RplP0 gene and expressed as fold difference compared 
to the LFD-fed mice. Primer sequences are provided on request. Results are expressed as means ± SEM. * 
P<0.05 HFD vs LFD, # P<0.05 WT vs Mrc1 (n = 4-6 animals per group). Genes encode the following proteins: 
F4/80 (Emr1); CD68 (CD68); CD11b (Itgam); YM1 (Chil3); FIZZ1 (Retnla); Arginase-1 (Arg1); CD11c (Itgax); iNOS 
(Nos2); IL-4 (Il4); IL-13 (Il13); IL-10 (Il10); MCP-1 (Ccl2); CCR-2 (Ccr2); TNF-α (Tnf ); IFN-γ (Ifng); IL-1β (Il1b); IL-6 (Il6).
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Table S1. Baseline characteristics of WT and MR-deficient mice. 
WT Mrc1 P-value
Body weight 27.04 ± 0.39 26.12 ± 0.43 0.12
Lean mass 25.27 ± 0.39 24.43 ± 0.42 0.15
Fat mass 1.28 ± 0.10 1.11 ± 0.08 0.18
Glucose 8.78 ± 0.20 8.45 ± 0.27 0.33
Insulin 0.49 ± 0.04 0.38 ± 0.04 0.07
Total Cholesterol 2.56 ± 0.06 2.79 ± 0.07 0.03
Triglycerides 0.54 ± 0.02 0.50 ± 0.02 0.21
Baseline characteristics of wild-type (WT) and MR-deficient (Mrc1) mice were determined at the start of the experiment. 
Body weight and body composition are shown, and plasma glucose, insulin, total cholesterol and triglyceride levels in 
4h-fasted mice. Results are expressed as means ± SEM (n = 25 for WT and 22 for Mrc1).
Table S2. Antibody information.
Target Clone Conjugate Manufacturer
B220 RA3-6B2 eFluor450 eBioscience
B220 RA3-6B2 FITC eBioscience
CD3 17A2 APC eBioscience
CD3 17A2 FITC eBioscience
CD4 GK1.5 PE-Cy7 eBioscience
CD4 GK1.5 PerCP-eF710 eBioscience
CD8a 53-6.7 APC-Cy7 Biolegend
CD11b M1/70 PE-Cy7 eBioscience
CD11b M1/70 FITC eBioscience
CD11c HL3 Horizon V450 BD Biosciences
CD11c HL3 FITC BD Biosciences
CD45.2 104 FITC Biolegend
CD45.2 104 PE Biolegend
F4/80 BM8 APC eBioscience
GR-1 RB6-8C5 FITC BD Biosciences
IL-5 TRFK5 PE Biolegend
IL-13 eBio13A eFluor450 eBioscience
ICOS C398.4A PE-Cy7 Biolegend
Ly-6C HK1.4 APC-Cy7 Biolegend
NK1.1 PK136 PE BD Biosciences
NK1.1 PK136 FITC eBioscience
Siglec-F E50-2440 PE BD Biosciences








what was already known about th2 Polarization, 
helminths, and metabolic disorders?
Helminths are the strongest natural inducers of type 2 immune responses, and many 
advances in dissecting the mechanisms underlying Th2 polarization have been made using 
either models of helminth infection or helminth-derived products. It is now recognized that 
helminth molecules can interact with a variety of receptors on dendritic cells (DCs), including 
TLRs and CLRs, which either bind or internalize antigens to condition DCs for Th2 skewing via 
different mechanisms. For example, various reports have indicated that signaling through 
members of the NF-κB and ERK pathways seem to play a role in Th2 polarization. In addition, 
filarial-derived cystatins were suggested to regulate immune cell polarization via signaling-
independent mechanisms, by interfering with antigen processing. In terms of DC-derived 
polarizing signals, up- or downregulation of various soluble factors and/or surface molecules 
was shown to contribute to Th2 skewing. Furthermore, various reports have described a role for 
T cell-DC interactions and the T cell receptor (TCR) in T cell skewing. Specifically, Th1-inducing 
antigens were shown to promote stronger T cell-DC interactions than Th2-inducing antigens 
(reviewed in (1)). 
Over the past five years, the mechanisms underlying Th2 polarization have received 
accelerating interest, since it is now recognized that multiple facets of the Th2-associated 
immune response are involved in metabolic regulation (2). For example, IL-4 can regulate the 
balance between fatty acid and glucose oxidation in hepatocytes (3), and a negative association 
between metabolic syndrome and helminth infection has been reported (reviewed in (4)). 
Furthermore, using mouse models of Nippostrongylus brasiliensis infection, a rodent nematode 
spontaneously cleared within two weeks, it has been demonstrated that infected mice on a 
high-fat diet (HFD) are protected from glucose intolerance, associated with increased white 
adipose tissue (WAT) eosinophilia and the expression of M2-related genes (5;6). In a follow-up 
Summary of what was already known
•	 Helminth-derived molecules can bind a variety of receptors on DCs, including TLRs 
and CLRs
•	 Helminth-derived molecules can modulate DCs for Th2 polarization via signaling-
dependent and -independent mechanisms
•	 Th2 skewing by DCs seems to require upregulation of Th2-polarizing signals and / or 
downmodulation of Th1-polarizing signals
•	 Th1-inducing antigens promote stronger T cell-DC interactions than Th2-inducing 
antigens
•	 N. brasiliensis infection protects mice against HFD-induced insulin resistance and 
glucose intolerance, increases adipose tissue ILC2s and eosinophils, and promotes 
the expression of M2-related genes in WAT
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study, N. brasiliensis was shown to promote accumulation of adipose tissue eosinophils via 
the induction of group 2 innate lymphoid cells in mice on a chow diet (7). These landmark 
studies are a major contribution to the field, and highlight the interplay between helminths 
and metabolic disorders as an exciting area that needs further dissection.
how did our studies advance the field?
Mechanisms of Th2 polarization: lessons from studying omega-1
Using Schistosoma mansoni soluble egg antigens (SEA), it had been described that schistosome 
antigens can modulate DCs for Th2 polarization by signaling through p42/p44 MAPK (ERK1/2), 
which lowers IL-12 production and suppresses Th1 polarization (8). Likewise, it was recently 
suggested that nuclear accumulation of the atypical NF-ĸB family member Bcl3 is required 
for SEA-induced Th2 polarization by downregulating IL-12 mRNA (9). By studying omega-1 in 
chapter 2, we describe a signaling-independent mechanism through which schistosomes can 
suppress Th1-polarizing signals. Omega-1, a glycosylated T2 ribonuclease (RNase) secreted by 
S. mansoni eggs, was previously identified as the major immunomodulatory component in SEA 
(10;11). Using recombinant mutants of omega-1 and a co-culture model of human monocyte-
derived DCs and allogeneic naïve T cells, we demonstrate that omega-1 requires both its 
glycosylation and its RNase activity to condition DCs for Th2 polarization. Mechanistically, 
omega-1 is bound by its glycans and subsequently internalized via the mannose receptor 
(MR), after which the molecule impairs protein synthesis by degrading both ribosomal and 
messenger RNA. Interestingly, various Th2-inducing allergens are also RNases (12;13), as well as 
the endogenous eosinophil-derived neurotoxin that can amplify DC-mediated Th2 polarization 
(14). Together, these reports suggest that any RNase that ends up in the cytosol of DCs may 
harbor Th2-priming capacities, through cleavage of ribosomal and/or messenger RNA (1). By 
doing so, RNases may inhibit the production of IL-12 and other Th1-inducing molecules like 
Delta-4 (15). 
It has been proposed that the mere absence of IL-12 and other Th1-inducing molecules 
promotes a Th2 response (16), but the results presented in chapter 3 argue against this 
hypothesis. In this chapter, we studied the role of the mTOR pathway in T helper polarization 
by moDCs, building on various reports that suggest involvement of mTOR in T helper cell 
differentiation (17;18). We show that omega-1 and SEA skew Th2 independent of the mTOR 
pathway, and additionally demonstrate that blocking the mTOR pathway in LPS-matured 
moDCs using rapamycin induces a profound Th2 response. These data, together with our 
finding that co-stimulation of moDCs with rapamycin and helminth antigens results in an 
additive effect on Th2 cytokine production, led us to conclude that there are mTOR-dependent 
and -independent mechanisms for Th2 skewing. Interestingly, we also show that rapamycin, 
unlike SEA and omega-1, skews a very potent Th2 response without affecting LPS-induced 
IL-12. These data complement early findings showing that mice lacking IL-12 do not develop a 
Th2 response to microbial pathogens (19), and suggest that there are active signals involved 




In chapter 4, we therefore searched for Th2-associated polarizing signals in the DC proteome, 
since maturation of DCs is largely controlled at the posttranscriptional and posttranslational 
level (20;21). We employed LC-FTICRMS, a high-throughput gel-free technique for accurate 
mass measurement and relative quantitation (22), to analyze proteomes of monocyte-derived 
DCs from nine different donors. We found that SEA and omega-1 strongly increase relative 
expression of 60S acidic ribosomal protein P2 (RPLP2), which we speculate represent a feedback 
mechanism secondary to SEA- and omega-1-induced ribosome degradation. In addition, SEA 
and omega-1 decreased expression of HLA-B, involved in MHC class I-dependent antigen 
presentation, and CD44, a surface molecule that was previously shown to promote CD4 T cell 
proliferation by mediation calcium signaling (23). Decreases in HLA-B and CD44 may suggest 
that Th2-inducing conditions interfere with efficient antigen presentation to T cells. Indeed, 
both SEA and omega-1 decreased expression of proteins in a protein network enriched for 
antigen processing and presentation, which supports the hypothesis that weak interaction 
between T cells and DCs at the level of the immunological synapse may contribute to Th2 
polarization by helminth antigens. We also performed GeneMANIA analysis (24), which predicts 
associations of input genes and related genes, with less stringent thresholds. Analysis of 
6h-stimulated samples suggests that SEA and omega-1 may affect cellular glucose metabolism. 
However, these results are speculative and need experimental confirmation.
Of note, at the start of the LC-FTICRMS project, we hoped to identify novel Th2-associated 
protein networks. However, we confidently identified only few Th2-associated differentially 
expressed proteins, which mostly confirmed previously established hypotheses. Because of 
time and money investments required for an LC-FTICRMS study, we therefore propose that 
this method is most suitable for screening of samples in which strong effects on proteomes 
are expected.  
In conclusion, our work on DCs and T cell polarization has shed light on the requirements 
for Th2 skewing by omega-1, which needs both its glycosylation and its RNase activity. We 
further show that omega-1 does not engage the mTOR pathway to skew T cells, even though 
blocking mTOR using rapamycin enables DCs to polarize a very potent Th2 response. Lastly, 
our proteomics study revealed that omega-1 promotes an increase in relative expression of 
RPLP2, a ribosomal protein, while downregulating proteins involved in antigen presentation. 
Together, these results highlight that there may be multiple routes for Th2 skewing, involving 
both signaling-dependent and -independent mechanisms. Follow-up studies will guide design 
of drugs that reprogram the innate immune system to induce a type 2-associated immune 
response, which would be desirable in the context of active type 1-mediated metabolic 
disorders such as obesity and type 2 diabetes. 
Helminths and high-fat diet-induced metabolic disorders 
Chapter 5 builds on landmark studies showing that conditions that induce type 2 inflammatory 
responses improve metabolic disorders. We demonstrate that chronic infection with S. mansoni 
protects against high fat diet-induced weight gain, insulin resistance and glucose intolerance 
in mice. We further show that infection does not affect energy expenditure, but enhances 
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peripheral glucose uptake and adipose tissue insulin signaling. These effects were associated 
with the induction of white adipose tissue (WAT) eosinophilia and M2 polarization. Before our 
study, the effect of helminths on metabolic homeostasis had only been reported in the context 
of infection with N. brasiliensis, a natural nematode of rodents, and little was studied beyond 
whole-body glucose tolerance and insulin sensitivity (5;6). Our study on chronic infection 
with S. mansoni thus strengthens and complements these findings, and advances the field 
by providing data on a wide array of metabolic parameters in the context of a helminth that 
chronically infects millions of people worldwide (25). 
In addition, chapter 5 describes that the beneficial effect of S. mansoni infection can be 
recapitulated in a pathogen-free setting, through repetitive injections with SEA. Specifically, 
SEA protected against HFD-induced insulin resistance and glucose intolerance without affecting 
body weight. Although the beneficial effect of SEA injections on glucose and insulin tolerance 
had been described previously (26), we are the first to have performed in-depth metabolic 
characterization of SEA-injected mice. In addition, we studied immune cell polarization at the 
cellular level, and describe that SEA induces a Th2 response, eosinophilia and M2 polarization 
in WAT. In liver, SEA also promoted eosinophilia and a Th2 response, which may contribute to 
glucose homeostasis by directly regulating hepatic insulin sensitivity and glucose production 
via IL-4 and IL-13, respectively (3;27). 
Among the different type-2-associated immune cells, the M2 macrophage probably plays 
the most central role in the maintenance of glucose homeostasis (2;28). A hallmark of the 
M2 phenotype is enhanced expression of the MR (29), which we showed in chapter 2 to be 
required for internalization of omega-1 and subsequent Th2 polarization. Although the MR 
is widely used as an M2 marker, its role in metabolic homeostasis was not yet studied. In 
chapter 6, we explored the role the MR in the context of diet-induced obesity using whole-
body MR-/- mice, and describe that MR deficiency protects against high-fat diet-induced 
metabolic disorders. Specifically, in mice fed a HFD, lack of MR strongly reduced fat mass gain, 
adipocyte hyperplasia, glucose intolerance and insulin resistance, and restored locomotor 
activity and energy expenditure. Thus, despite considerable weight gain, the MR-/- mice were 
more healthy than WT obese mice. In line with the metabolic phenotype, lack of MR protected 
mice from HFD-induced classical activation of macrophages in adipose tissue and liver. 
The protective effect of MR deficiency on HFD-induced metabolic disorders was surprising, 
given the association between MR and the M2 phenotype (29), and the pivotal role MR plays 
in the initiation of  type 2 immune responses (30-33). Since we also observed low expression 
of MR by M1 macrophages, we speculate that MR can deliver signals directly into MR-bearing 
macrophages through interaction with co-receptors, which might result in a pro-inflammatory 
phenotype under HFD conditions. It is also important to consider that MR-/- mice lack whole-
body expression of the Mrc1 gene, and that MR expression is not restricted to leukocytes 
(34). For example, MR is expressed by microglia and astrocytes in the brain (35). Interestingly, 
hypothalamic inflammation has been described to contribute to HFD-induced weight gain 
(36), and activation of the cholinergic anti-inflammatory reflex was recently demonstrated 




metabolic homeostasis can be attributed to immune cell signaling, altered neuroinflammation, 
defects in the anti-inflammatory reflex, or effects beyond the immune system or the brain, 
remains to be determined.
In sum, our work on helminths and high-fat diet-induced metabolic disorders has provided 
valuable insights into the effects of helminths and their molecules on metabolic homeostasis. 
Of particular interest may be the finding that chronic helminth infection enhances peripheral 
glucose uptake and insulin action in WAT, an effect that may be secondary to the induction of 
a type 2-associated immune response. Furthermore, our findings on the beneficial effect of 
SEA on metabolic homeostasis identify helminth molecules as attractive agents for therapeutic 
manipulation of the immune system in the context of metabolic disorders. Lastly, our data on 
the unexpected role of MR in the development of metabolic homeostasis provide a novel lead 
for studying the etiology of diet-induced metabolic disorders. 
Summary of the new findings
In this thesis, we studied the S. mansoni egg-derived molecule omega-1, a T2 RNase with 
strong Th2-polarizing capacities. We investigated how this molecule modulates dendritic 
cells for Th2 skewing at the molecular level. Furthermore, we analyzed the effect of high-fat 
diet-feeding in mice chronically infected with S. mansoni or chronically exposed to SEA. 
Lastly, we performed in-depth metabolic and immune cell profiling of MR-deficient mice 
fed a HFD. The main findings are:
•	 Omega-1 requires both its glycosylation and its RNase activity to condition DCs for 
Th2 polarization (Chapter 2)
•	 Omega-1 is bound and internalized via its glycans by the MR, and impairs protein 
synthesis by degrading both ribosomal and messenger RNA  (Chapter 2)
•	 SEA and omega-1 skew Th2 without affecting the mTOR pathway (Chapter 3)
•	 Blocking the mTOR pathway using rapamycin primes DCs for Th2 skewing without 
affecting IL-12 production (Chapter 3)
•	 SEA and omega-1 alter the DC proteome, with the most pronounced effect on 60S 
acidic ribosomal protein P2 and proteins involved in antigen presentation (Chapter 4)
•	 Chronic S. mansoni infection and SEA treatment protect against metabolic disorders 
in HFD-induced obesity, and strongly increase adipose tissue eosinophilia and M2 
polarization (Chapter 5)
•	 Chronic S. mansoni infection reduces adipocyte size and increases peripheral glucose 
uptake and WAT insulin sensitivity in HFD-fed mice (Chapter 5)
•	 Chronic administration of SEA promotes a Th2 response in WAT and liver of HFD-
induced obese mice (Chapter 5)
•	 MR deficiency protects against HFD-induced insulin resistance and glucose intolerance 




directions for future research1
The studies presented in this thesis shed new light on the mechanisms of DC-mediated Th2 
polarization by helminth antigens. They further demonstrate that chronic S. mansoni infection 
and SEA administration protect against diet-induced metabolic disorders, and propose that 
the MR plays an unexpected role in the development of diet-induced insulin resistance. As 
this thesis progressed, so did the field, and our findings together with several exciting (new) 
areas of research fuel directions for future studies.
DC metabolism and Th2 polarization
Recent studies indicate that modulation of metabolic pathways within immune cells can 
regulate their function and, thereby, the outcome of the immune response (38). For example, 
BMDCs switch their core metabolism from mitochondrial oxidative phosphorylation to 
glycolysis upon TLR-ligation, and inhibition of this switch interferes with maturation, IL-12 
expression, and the ability to induce CD4+ T cell proliferation (39;40). The question whether 
helminths or their products affect glycolytic reprogramming in DCs, and how this relates to 
Th2 polarization, constitutes an exciting new area of research. 
The T cell receptor
It has been suggested that T cells are polarized towards Th2 if the interaction between DCs 
and T cells is weak (41-43). Interestingly, others have demonstrated that omega-1 reduces the 
capacity of BMDCs to form T cell–DC conjugates and diminishes the frequency of CD4+ T cells 
progressing through the cell cycle (11). Novel techniques allow for the analysis of DC-T cell 
interactions in vivo, through intravital dynamic 2-photon microscopy (43). Future studies 
could therefore explore the strength of TCR signaling in the context of helminth-induced Th2 
polarization in vitro and in vivo. 
DCs and the microenvironment
Accumulating evidence points towards a crucial role for the microenvironment in which DCs 
are primed for T cell polarization. For example, epithelial-derived cytokine alarmins like thymic 
stromal lymphopoietin (TSLP) and IL-33 condition DCs to skew Th2 (44-46), IL-33 treatment 
improves Th2 cytokine production and expulsion of Trichuris muris (47), and mice deficient for 
the IL-33 receptor T1/ST2 fail to develop a Th2 response to S. mansoni eggs (48). Importantly, 
T1/ST2 is not only present on DCs but also on lymphocyte subsets including ILC2s, which were 
shown to potentiate Th2 responses by promoting DC migration and interacting with T cells 
via MHC-II (49;50). In addition, it has been suggested that DCs require B cells for the initiation 
of a Th2 response since B cells enable proper localization in the lymph node (51). Together, 
these studies highlight the importance of studying polarizing alarmins and accessory cells 
in the search for mechanisms of Th2 polarization. 
1 Parts of this section are based on the review “Priming dendritic cells for Th2 polarization: lessons learned 




Helminths, immune cells, and protection against metabolic disorders
It has been demonstrated that maintenance of M2 macrophages in WAT depends on the 
presence of IL-4-secreting eosinophils (5), which are sustained by IL-5 and IL-13-producing 
ILC2s (7) in non-infected mice. In our study, we observe an increase in cytokine-producing 
Th2 cells and eosinophils following chronic exposure to S. mansoni or SEA, but the relative 
contribution of each cell type to the beneficial effect on WAT insulin sensitivity and whole-body 
metabolic homeostasis remains unknown. Future studies are needed using mice deficient in 
different immune cell types or their effector cytokines, in order to understand how helminths 
promote metabolic homeostasis. 
Furthermore, in relation to the role of the MR in the development of diet-induced 
metabolic disorders (chapter 6), the use of conditional knockout mice or adoptive transfer 
experiments should elucidate whether the protective effect of MR deficiency on high-fat 
diet-induced insulin resistance can be attributed to MR expression by immune or non-
immune cells. 
Helminth molecules and direct interaction with metabolic cells 
A recent landmark study demonstrated that SEA can directly suppress lipogenesis in primary 
hepatocytes (26), which led us to hypothesize that helminth molecules may protect against 
metabolic disorders by acting as a double-edged sword (Figure 1). Helminth antigens may 
regulate glucose homeostasis directly by modulating metabolic pathways, or indirectly 
by polarizing a type 2 immune response. Future studies should therefore focus on the 
identification of the cellular targets of helminth antigens, as well as the specific helminth-


















Figure 1. S. mansoni and protection against metabolic disorders: A double-edged sword? S. mansoni 
egg-derived molecules may protect against metabolic disorders by skewing a type 2 immune response, 




To date, the mechanisms that govern Th2 polarization are still not fully understood. Future 
studies should focus on pinpointing the requirements that qualify DCs for Th2 skewing, 
bearing in mind that DCs operate in a microenvironment that may influence priming. It is now 
recognized that type 2 immune responses can also regulate energy metabolism, and studying 
how helminths generate Th2 responses and contribute to metabolic homeostasis will therefore 
not only shed light on the mechanisms that promote control of parasite infection, but may 
provide valuable leads for the development of pharmaceutical agents for the treatment of 
metabolic disorders.
Remaining questions
•	 Do helminth antigens affect DC metabolism and does this contribute to the initiation 
of a Th2 response?
•	 Does the strength of TCR signaling play a role in Th2 polarization by helminth antigens?
•	 What is the role of the microenvironment in DC-mediated for Th2 polarization?
•	 What is the contribution of different immune cells to the beneficial effect of helminth 
antigens on diet-induced metabolic disorders, and how do these immune cells interact?
•	 Do helminth molecules act on non-immune cells to promote metabolic homeostasis?
•	 Which helminth-derived single molecules contribute to metabolic homeostasis?
•	 Can the protective effect of MR deficiency on diet-induced obesity be attributed to 
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Het afweersysteem, ook wel het immuunsysteem genoemd, beschermt ons tegen pathogene 
ziekteverwekkers zoals virussen, bacteriën en parasitaire wormen. Het immuunsysteem kan 
grofweg worden onderverdeeld in twee takken: de aspecifieke afweer en de specifieke 
afweer, die samenwerken als er een infectie optreedt. Pathogenen die door de huid of de 
slijmvliezen het lichaam weten binnen te dringen, stuiten als eerste op de witte bloedcellen 
van de aspecifieke afweer. Onderdeel van de aspecifieke afweer zijn de dendritische cellen 
(DCs), die in staat zijn om de specifieke afweer te activeren. Zodra een DC een pathogeen tegen 
komt, presenteert de DC delen van het pathogeen (antigenen) op zijn buitenzijde en migreert 
naar een lymfeklier. Daar bevinden zich de T-helpercellen, onderdeel van de specifieke afweer. 
Komt de DC een T-helpercel tegen die gericht is tegen het gepresenteerde antigen, dan wordt 
de T-helpercel geactiveerd. De T-helpercel geeft vervolgens specifieke signalen af, die helpen 
bij het activeren van andere witte bloedcellen die de ziekteverwekker opruimen. 
Niet alle ziekteverwekkers worden bestreden met hetzelfde type afweerreactie, binnen 
de T-helpercellen worden dan ook verschillende soorten onderscheiden. Zo activeren virale 
of bacteriële infecties veelal T-helper-1 (Th1)-cellen, die helpen bij het initiëren een type 1 
afweerreactie. Parasitaire wormen wekken daarentegen een type 2-afweerreactie op, waarin 
de Th2-cellen centraal staan. De activatie van verschillende typen T-helpercellen wordt 
T-helpercel-differentiatie genoemd. Dit proces wordt aangestuurd door de DCs die in staat 
zijn verschillende antigenen van elkaar te onderscheiden: op basis van het type antigeen 
geven de DCs signalen af die de T-helpercel-differentiatie beïnvloeden. Een DC heeft in zijn 
interactie met het specifieke afweersysteem dus twee belangrijke taken: het presenteren 
van de antigenen die vereist zijn voor T-cel-activatie, en het afgeven van signalen die de 
differentiatie van T cellen sturen.  
Naast het afweren van pathogenen heeft het immuunsyteem ook andere functies. Zo 
helpen bepaalde type 2-afweercellen (de M2-macrofagen) bijvoorbeeld bij het opruimen 
van dode lichaamscellen. Helaas kan het immuunsysteem zich ook tegen ons keren: als 
verschillende componenten van het immuunsysteem uit balans zijn, kunnen er allergieën en 
auto-immuunziekten ontstaan. Recent onderzoek heeft aangetoond dat het immuunsysteem 
ook ontregeld is bij mensen met overtollig vetweefsel, wat de kans op diabetes type 2 vergroot. 
Afweerreacties en diabetes type 2
Patiënten met diabetes type 2, beter bekend als ouderdomsdiabetes, zijn minder gevoelig voor 
het hormoon insuline. Insuline zorgt ervoor dat glucose uit het bloed kan worden opgenomen 
door alle cellen in het lichaam, die dit gebruiken om energie van te maken. Als de cellen in het 
lichaam echter niet meer reageren op insuline, oftewel insulineresistent zijn geworden, blijven 
de bloedsuikerspiegels hoog wat op lange termijn zenuwen en bloedvaten kan beschadigen. 
Vetweefsel van muizen op een normaal dieet bevat vooral type 2-afweercellen, die het 
vetweefsel gezond houden en de werking van insuline bevorderen. In vetweefsel van muizen 
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met overgewicht ontstaat echter een chronische ontsteking, gekenmerkt door een groot 
aantal type 1-afweercellen die de werking van insuline belemmeren. Om diabetes type 2 te 
kunnen behandelen, is het dus essentieel dat de type 1-afweercellen in het vetweefsel weer 
plaats maken voor type 2-afweercellen.
Zoals hierboven beschreven zijn type 2-afweercellen bij uitstek aanwezig tijdens infecties 
met parasitaire wormen. Daarnaast is aangetoond dat een infectie met de parasitaire worm 
Nippostrongylus brasiliensis een positief effect heeft op de insulinegevoeligheid in muizen 
met overgewicht. Door te onderzoeken hoe parasitaire wormen een type 2-afweerreactie 
bewerkstelligen, kunnen we dus ook meer leren over hoe diabetes type 2 bestreden zou 
kunnen worden.
Leren van wormen
Naar schatting een kwart van de wereldbevolking is geïnfecteerd met parasitaire wormen, 
vooral in tropische landen. Er zijn veel verschillende soorten parasitaire wormen, waaronder de 
Schistosoma-platwormen die vaak worden gebruikt in onderzoek naar type 2-afweerreacties. 
Dit komt doordat de antigenen van Schistosoma-eitjes (SEA) sterkte Th2-sturende capaciteiten 
bezitten, zowel in vivo (in de muis) als in vitro (in het laboratorium). 
Om uit te kunnen zoeken hoe het komt dat SEA DCs aanzet tot Th2-differentiatie, wordt 
vaak gebruik gemaakt van een in vitro DC-model. Dat houdt in dat DCs in het laboratorium 
worden blootgesteld aan SEA, waarna de DCs worden gekweekt met T-helpercellen om de 
differentiatie te bestuderen. Met behulp van dit model is ontdekt dat een klein eiwit in SEA, 
genaamd omega-1, sterke Th2-sturende capaciteiten heeft. Door het effect van omega-1 op 
DCs te bestuderen, proberen we te ontrafelen welke mechanismen ten grondslag liggen aan 
Th2-differentiatie. 
Onderzoek beschreven in dit proefschrift
Hoofdstuk 2 beschrijft onderzoek met behulp van het DC-model naar het molecuul omega-1. 
Omega-1 is een enzym dat RNA kan knippen (dit wordt RNase-activiteit genoemd) en dat 
suikermoleculen op zijn oppervlak heeft (glycosylering). Zowel na het inactiveren van 
de RNase-activiteit als na het weghalen van de glycosylering bleek omega-1 niet meer in 
staat DCs aan te zetten tot Th2-differentiatie. Nader onderzoek wees uit dat omega-1 zijn 
suikermoleculen gebruikt om te binden aan de mannosereceptor op het oppervlak van DCs, 
zodat het kan worden opgenomen door deze cellen. Eenmaal in de cellen bleek de RNase-
activiteit van omega-1 van belang. Op basis van informatie uit het DNA maakt een cel eiwitten 
met behulp van RNA. Door RNA te knippen, belemmerde omega-1 de eiwitproductie in de 
DCs. In het kort blijkt glycosylering dus nodig te zijn voor de opname van omega-1 via de 
mannosereceptor, waarna de RNase-activiteit essentieel was om de DCs aan te zetten tot 
Th2-differentiatie. 
Hoe het belemmeren van eiwitproductie door omega-1 precies leidt tot een signaal 
voor Th2-differentiatie werd onderzocht in hoofdstuk 3, wederom met het DC-model. We 




binnen en buiten de cel integreert en daardoor celgroei en activatie van witte bloedcellen 
kan beïnvloeden. Deze signaleringsroute kan worden geblokkeerd door het geneesmiddel 
rapamycin. Dit medicijn wordt gebruikt om afstoting na orgaantransplantatie te voorkomen, 
omdat het middel het immuunysteem onderdrukt. Rapamycin bleek, net als omega-1, DCs 
aan te zetten tot Th2-differentiatie. Dit leidde tot de hypothese dat stimulatie met omega-1 
wellicht een effect heeft op de activiteit van de mTOR-signaleringsroute. Dit was echter niet 
het geval: omega-1 had geen effect op activatie van het mTOR-eiwit of op andere eiwitten 
binnen de mTOR-signaleringsroute. Bovendien leidde co-stimulatie van DCs met rapamycin èn 
omega-1 tot een sterkere Th2-differentiatie dan stimulatie met alleen rapamycin of omega-1. 
Uit deze resultaten kan geconcludeerd worden dat DCs op verschillende manieren aangezet 
kunnen worden tot Th2-differentiatie: via mTOR-afhankelijke en -onafhankelijke mechanismen.
In hoofdstuk 4 werden DCs na stimulatie met omega-1 bestudeerd met behulp van 
massapectrometrie, een techniek voor het identificeren en kwantificeren van eiwitfragmenten. 
In de gestimuleerde cellen werden in totaal 208 verschillende eiwitten geïdentificeerd en 
gekwantificeerd. Uit een nadere analyse bleek dat de aanwezigheid van omega-1 een sterk 
effect had op de eiwitten betrokken bij antigeenpresentatie: in vergelijking met DCs die niet 
waren gestimuleerd, bezaten DCs na stimulatie met omega-1 minder van deze eiwitten. 
Eerder is al aangetoond dat een zwakke interactie tussen DCs en T-helpercellen tijdens 
de antigeenpresentatie kan leidden tot Th2-differentiatie. Omdat omega-1 zorgt voor een 
verlaging van de eiwitten betrokken bij antigeenpresentatie, suggereren de resultaten dat 
Th2-differentiatie door omega-1 wellicht ook tot stand komt door een zwakke interactie tussen 
DCs en T-helpercellen. Om deze hypothese te toetsen is verder onderzoek nodig.
Zoals in de inleiding beschreven, is recent aangetoond dat een infectie met de worm 
N. brasiliensis de insulinegevoeligheid kan bevorderen in muizen met overgewicht. Echter, 
N. brasiliensis is een worm die alleen knaagdieren voor een korte duur kan infecteren. In 
hoofdstuk 5 is onderzocht of Schistosoma-wormen, die wereldwijd meer dan 200 miljoen 
mensen chronisch infecteren, hetzelfde effect hebben op het glucosepijl. Om dit te bestuderen 
zijn muizen met obesitas blootgesteld aan Schistosoma mansoni. Muizen op een hoog-vet-
dieet met een chronische S. mansoni infectie werden minder dik, de cellen in het lichaam 
namen glucose sneller op en de muizen waren gevoeliger voor insuline, in vergelijking met 
niet-geïnfecteerde soortgenoten. Dit ging gepaard met een type 2-afweerreactie in het 
vetweefsel. Het positieve effect van S. mansoni-wormen op de insulinegevoeligheid bleek 
te reproduceren door de muizen te injecteren met enkel SEA, wat perspectief biedt voor een 
eventuele therapeutische toepassing van wormen als bescherming tegen diabetes type 2. 
Tot slot is in hoofdstuk 6 gekeken naar de rol van de mannosereceptor (MR) in het ontstaan 
van insulineresistentie. In hoofdstuk 2 was met behulp van omega-1 al aangetoond dat de 
MR een belangrijke rol speelt in Th2-differentiatie. Daarnaast was ook al bekend dat de MR 
in grote mate aanwezig is op M2-macrofagen (onderdeel van de type 2-afweerreactie), en 
juist laag tot expressie komt op M1-macrofagen (onderdeel van de type 1-afweerreactie). Om 
de rol van de MR in het ontstaan van insulineresistentie te onderzoeken, zijn muizen waarin 
de MR door middel van genetische manipulatie werd uitgeschakeld (MR-knockout muizen) 
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blootgesteld aan een hoog-vet-dieet. In vergelijking met gewone muizen, waren er in de 
MR-knockout muizen tegen de verwachting in juist minder M1-macrofagen te vinden in het 
vetweefsel en in de lever. Dit ging gepaard met een verhoging van de insulinegevoeligheid. 
Hoe de afwezigheid van de mannosereceptor een positief effect op de suikerhuishouding 
veroorzaakt, is nog onduidelijk en vraagt om verder onderzoek.
Conclusie
Het onderzoek beschreven in dit proefschrift draagt bij aan een beter begrip van de 
mechanismen die ten grondslag liggen aan Th2-differentiatie. Daarnaast laten de studies zien 
dat wormmoleculen in muizen met obesitas bijdragen aan een gezonde suikerhuishouding. 
Er is echter nog veel onbekend over het ontstaan van type 2-afweerreacties. Daarom 
is het noodzakelijk om verder onderzoek te verrichten naar wormmoleculen, DCs en 
Th2-differentiatie. Dit is niet alleen relevant voor het verschaffen van inzichten in basale 
immunologische processen, maar draagt ook bij aan het ontwikkelen van therapieën voor 
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